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HISTORICAL 
The hypophysis cerebri (pituitary gland) is attached to 
the tuber cinereum region of the hypothalamus, a part of the 
vertebrate forebraln forming the floor of the third ventricle, 
by the infundibular stalk (64). The hypophysis is a composite 
structure consisting of an anterior lobe (adenohypophyeis or 
para distalis), an intermediate lobe (pars intermedia) and a 
posterior lobe (neurohypophysis or pars nervosa). 
In his review of the first evidence suggesting a function 
for the pituitary gland, Sir Henry H. Dale (16) recalls the 
discovery In 1895 of a pressor (blood pressure increase) 
effect due to an Intravenous injection of pituitary gland ex­
tract. In 1898, other investigations showed this pressor 
action was obtained only from the posterior lobe. Eight years 
later, after discovering the oxytocic (uterine contracting) 
properties of a posterior lobe extract, Dale verified the re­
ported antidiuretic properties of these extracts. Observa­
tions of the destruction of these activities by hot acids and 
alkalis and tryptic digestion led Dale to assume a single sub­
stance having the character of a relatively simple polypep­
tide . 
Abel and Pincoffs (l), in 1917), reported that secondary 
albumoses (proteoses) and possibly peptones (polypeptides) 
were found to be present In all of the therapeutically used 
extracts of the posterior lobe of the hypophysis cerebri which 
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were examined. 
Smith (122), in 1927, observed that hypophysectomlzed 
animals, that is, animals from which the entire pituitary 
gland was removed, decreased in body weight, had inhibited 
skeletal growth, and pronounced atrophy of the adrenal cortex, 
thyroids and reproductive organs. Also noted were decreases 
in size of the liver, spleen and kidney, a cessation of fol­
licular growth and a filling of the ovaries with interstitial 
tissue in the female or a loss of libido sexualis and sperma­
togenesis in the male. Daily transplantations of anterior 
lobe tissue in these animals caused a resumption of body 
growth and a return of the reproductive organs to their normal 
size. Li and Evans (67) proposed the name adrenocortico-
trophic hormone (ACTH) for the substance in these implants 
which affects the adrenal cortex in preference over the names 
adrenotrophic or corticotrophic hormone. In 1951, the Journal 
of the American Medical Association (127) suggested the 
corticotropin nomenclature for this substance. 
In 1928, Kamm and his co-workers (57) were able to sep­
arate the oxytocic principle from the pressor principle of 
acetone-desiccated posterior lobe tissue by a hot dilute 
acetic acid extraction followed by salt and solvent precipi­
tation techniques. They concluded that these substances were 
of a basic nature and probably amines. By 1933 the peptide 
nature of these biologically active materials had been 
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revealed (25) and work continued on the purification and 
chemical properties (25, 54, 55, 87, 88) of these hormones 
using electrophoretic, countercurrent distribution and paper 
chromatographic methods. 
In June of 1953, Tuppy (130) reported the amino acid 
sequence of oxytocin which was conclusively proved by the 
synthesis reported in July by du Vigneaud et. al. (24). 
du Vigneaud and his co-workers (24) also postulated the 
structure of lysine vasopressin (LVP), the porcine hormone, 
and reported the synthesis of this octapeptide. The struc­
ture of bovine vasopressin (AVP) was published in September 
by R. Acher and Jacqueline Chauvet (3) and verified by the 
synthesis of this hormone by du Vigneaud et al. (23) the fol­
lowing year. The bovine hormone differed from the porcine 
molecule in that arginine in the former replaced the lysine 
residue in the latter. An excellent review of the isolation, 
proof of structure and synthesis of the vasopressins has been 
written by du Vigneaud (22). 
It was obvious in the purification of oxytocin and vaso­
pressin that the posterior lobe of the pituitary gland con­
tained a rich pool of peptides of varying size and complexity. 
Wlnnick et al. (134) and Ramachandran and Winnick (92) in 
their study of the peptides of beef and pork posterior pitui­
tary lobe (pars nervosa plus pars Intermedia) found that pep­
tides constituted 3-4^ of the weight of desiccated tissue. 
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In addition to oxytocin, vasopressin, and melanocyte-stimulat-
.ing hormone (MSH or intermedin) , 30 different peptides, com­
prising approximately one-third of the total peptide material, 
were isolated and studied. In size the peptides ranged from 
simple aipeptides to one with perhaps as many as 84 residues. 
Hypothalamic extracts (134) showed no significant peptide 
pool and resembled brain in having very high levels of 
glutamine and glutamic acid. 
In 1951, Bargmann and Scharrer (S) proposed that in high­
er vertebrates the synthesis of the posterior lobe peptide 
hormones occurred in neurosecretory cells of the nuclei supra-
opticus and paraventricular!s of the hypothalamus from whence 
they pass to the pars nervosa by way of the hypothalamohypo-
physea-L tracts. A review of the data for this conclusion was 
given by Scharrer and Scharrer (116) at the 19 53 Laurentian 
Hormone Conference. kcCann and Brobeck (7£) showed that 
hypothalamic lesions which destroyed a significant fraction 
of trie supraopticohypophyseal tract blocked ACTH secretion 
as measured by ascorbic acid depletion, adrenal weight main­
tenance or blood ACTH concentration. They also reported that 
commercial Pitressin, of which presumably vasopressin was the 
active factor, produced ACTH secretion in the lesioned animals 
when injected intravensouly• The conclusion reached was that 
the supraopticohypophyseal tract may play a role in the regu­
lation of ACTH secretion by release of antidiuretic hormone 
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into the hypophyseal portal vessels. 
Investigations Into the factors underlying the normal 
secretion of ACTH concerned two aspects of the. problem. 
First, the method of maintaining a steady secretion of ACTH 
in the normal animal; and, secondly, the mechanism involved 
in increasing ACTH secretion under physiological or psycho­
logical stress. As previously cited (67), ACTH maintains 
the structure and function of the adrenal cortex. In his 
review of the features of the adrenal cortex, Bayers (106) 
discusses the pituitary adrenocortical system and its role 
in homeostasis, maintenance of a steady state in an organism 
through all types of stress; the reader is referred to that 
article for a detailed presentation of the experimental evi­
dence . Indices for the assessment of adrenocortical activity 
are four: 
I. Alterations in the adrenal cortex. 
1. Size of the gland - enlargement of the gland occurs 
within 6 to 24 hours after severe stress. Adrenal 
weight increases proportionately to the doses of 
administered ACTH. 
2. Histochemical changes - A close parallelism exists 
between intensity of sudanophilic substance and the 
concentration of cholesterol in the gland which fluc­
tuates according to the ACTH level. The glomerular, 
sudanophobic, fascicular and reticular zones of the 
6 
adrenal cortex may show different degrees of deple­
tion and accumulation of lipid in response to stress. 
3. Chemical changes. 
a. Cholesterol - approximately b% of the net weight 
of the tissue is cholesterol, which is depleted 
by ACTH; much evidence suggests that cholesterol 
is a precursor to the cortical steroids. 
b. Ascorbic acid - administration of ACTH causes the 
concentration of adrenal ascorbic acid to fall 
appreciably within 20 minutes after injection into 
rats. This phenomenon constitutes the basis of 
the well-known Bayers ACTH assay (107). 
c. Phosphate - administration of ACTH in the rat 
increases the rate of turnover of radioactive 
phosphorus in the adrenal cortex. 
II. Alterations in the organism. 
1. Lymphocytes - Lymphocytosis in the adrenolectomized 
animal or of a patient with Addison's disease re­
flects low adrenocortical hormones while the lympho­
cytopenia of Gushing's syndrome is a result of an 
elevated cortical hormone titer. ACTH initiates 
lymphocytopenia and this can be employed as a 
measure of adrenocortical activity. 
2. Eosinophils - The drop in the number of eosinophils 
after the administration of ACTH is expressed in per-
7 
oentage of the pre-injection count and is a less . 
variable response than the lymphocyte response. 
Intravenous injections of epinephrine also produces 
a rail in the circulating eosinophils. 
3. Metabolic changes - Other changes due to deficiencies 
in cortical hormones include insulin hypersensitiv­
ity, lack of diuresis after administration of water, 
and failure to retain sodium under circumstances of 
sodium deprivation. 
III. Urinary steroids - The cortical hormones, including 
cortisone and 17-hydroxycorticosterone, extracted 
from human urine promote liver-glycogen deposition 
( LG-D ), maintain life, offer cold-protection (CP), 
improve work performance and prevent water intoxica­
tion when injected into adrenolectomized animals. 
The LGD and CP tests are relatively good indices of 
adrenocortical activity but are tedious and time-
consuming . Chemical measurement of cortical steroids 
extracted from urine is done by phosphomolybdic acid 
reduction, copper reduction, or formaldehyde produc­
tion by periodic acid. Sayers ( 106) does not believe 
that a measurement of 17-ketosteroids in the urine 
is of value in assessing the rate of the cortical 
hormone secretion of man. 
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IV. Blood corticoïde - Although appreciable quantities 
of cortical hormones are present in adrenal venous 
blood, unequivocal responses by bioassay methods are 
not obtained. However, G-uillemin et al. (28, 30, 41) 
have perfected a method for assessing the concentra­
tion of plasma free corticosteroids using a fluoro-
metric technique. Mote's review (82) discusses the 
physiological bases for the action of ACTH in human 
beings. 
In his review of the neural control of the pituitary 
gland in 1951, Harris (44, p. 563) concluded that: 
The glandular tissue of the neurohypophysis, which 
exists in the infundibular lobe, infundibular stem 
and median eminence of the tuber cinereum, is 
richly innervated by the supraoptico-hypophyslal 
tract of nerve fibers. 
(See composite diagram of a sagittal section through the 
hypothalamus and pituitary gland, Fig. 1.) 
Psychological or physiological stress causes the release 
of antidiuretic hormone through excitation of the gland medi­
ated by the supraoptico-hypophyslal tract in the normal ani­
mal. Electrical stimulation of this tract causes an inhibi­
tion of a water diuresis; increase in the relative urinary 
chloride; increase in the uterine activity in the oestrous 
or oestrogenized animal; increase in intestinal activity; 
appearance of an antidiuretic substance in the urine; and 
the ejection of milk from the cannulated lactiferous duct of 
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a lactating mammary gland. These changes are caused by the 
liberation of the antidiuretic (pressor) and oxytocic sub­
stances into the blood. 
Harris (45) in reviewing the regulation of ACTH release 
from the adrenohypophysis considered three views put forward 
at that time : 1) ACTH secretion is regulated by the systemic 
blood level of adrenalin (epinephrine); 2) ACTH secretion is 
regulated by the systemic blood level of the adrenal cortical 
hormones ; 3) ACTH secretion is controlled by the hypothalamus 
acting through the hypophyseal portal vessels. For a. detailed 
discussion of these views the reader is referred to this 
review. In crief the arguments msrtialed against adrenalin 
as tne underlying mechanism of ACTH release are: l) com­
pletely sympathecto2iized animals resist many forms of stress 
almost as well as intact anima-.s and 2) audiogenic stimula­
tion, Known to cause discharge of ACTH in normal rats, pro­
duced a response in rats witn removed adrenal medullas. 
Pre treatment of an animal with adrenal cortical extract or 
crystalline cortical steroids prevents adrenal ascorbic acid 
depletion v:hicn normally follows temperature or chemical 
stress• The level of the adrenal cortical hormones influences 
but is not tne only factor which regulates the secretion of 
ACTH since adrenal atrophy occurs in rats with anterior i:itui-
tar-y giand transplants. Pituitary transplants and grafts show 
that normal ACTH secretion requires the hypophyseal portal 
11 
vessels connecting the hypothalamus and adrenohypophysis. 
Harris (45, p. 6 53) concludes, with Portier, that a dual 
mechanism of ACTH release operates 
. . • one purely humoral in response to systemic 
stimuli, and the other probably neuro-humoral 
mediated by the hypothalamo-hypophyseal neuro­
vascular pathway and coming into play under the 
influence of nervous or emotionel stimuli• 
Hume (53) proposed a theory on the neuro-endocrine re­
sponse to injury cased on the experiments! evidence obtained 
in his own laboratory and by other workers. In the normal 
state, a humoral su us tance is secreted by the hypothalamus, 
moves througn the portal system to the adenohypophysis end 
maintains the normal production of ACTH. See Fig. 2-1. 
In emergency mechanisms, the traumatized area causes 
nerve impulses to actuate the hypothalamus to release a 
humoral sucstance B (Fig. 2-2), which stimulates ACTH produc­
tion. The hormone probably reaches the pituitary partly by 
the hypophyseal portal system because the speed of ACTH re­
lease after stress, in the form of histamine, would not 
permit systemic circulation to act upon the hypophysis and 
lesions in the median eminence region prevent increased ACTH 
release following trauma. Severe trauma, rs shown in Fig. 
•£-$ procacly occurs through a similar mechanism as moderate 
trauma but with an additional humoral sucs tance acting 
directly on the hypothalamus. It is possible, Hume (53) sug­
gests, that sucs tances A and B can be identical. Arguments 
Fig. fc. Diagrams illustrating the hypothalamic-pituitary-
adrenal relationships (53) 
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are presented against Sayers1 (106) theory of decreased cir­
culating corticoïde causing the stimulation of ACTH release 
although they may account for deceleration of ACTH secretion 
when the stressing stimulus is lessened. In elegant experi­
ments employing a radio coil allowing remote control stimu­
lation of the hypothalamus, Hume (53) demonstrated that 
stimulation.of the median eminence or the posterior tuber 
cinereum of the dog produced ACTH release as measured by 
eosinopenia. Since this is also true in the sympathectomized 
dog, ACTH release does not depend on epinephrine release. 
Gulllemin and Fort1er (31) showed that rats could be 
brought to a "state of resistance" by Phenergan, an anti­
histamine drug, which caused a complete inhibition of the 
normal adrenal ascorbic acid discharge to histamine injec­
tion. However, neurotropic stimuli including auditory stimu­
lation and immobilization; and systemic stress, cold exposure, 
resulted in a depletion of adrenal ascorbic acid. They con­
clude that histamine is not an important factor in the hypo-
thai amohypophyseal interaction due to neurotropic stress and 
can also be disregarded as the only humoral agent responsible 
for pituitary stimulation by systemic stress. 
Slusher and Roberts (121), in 1954, were able to extract 
an aqueous non-protein fraction from bovine brain containing 
active material which caused eosinopenia in rats and an in­
crease in oxygen consumption by rat adenohypophyseal tissue 
14 
In vitro ; however no adrenal ascorbic acid depletion in the 
rat was evident. Another material, lipoprotein in nature, 
found only in the posterior hypothalamus caused eosinopenia 
and adrenal ascorbic acid depletion. The lipid portion of 
this active complex, which was thought to represent the ACTH-
releasing neurohumor, and could be removed after prolonged 
dialysis, was non-saponifiable and not cholesterol. 
Gulllemin (39) reported that SKF-501 (N-[9-fluorenylj -N-
ethy 1-/3 -chloroethylamine, HCL), SKF-688A, Dlbenzyline, 
( N-phenoxy-isopropyl-N-benzyl-/3 -chlorothylamine, HCL) and 
atropine sulfate were effective blocking agents against the 
stress-inducing, normally ACTH releasing compounds: adrena­
line, non-adrenaline and acetylcholine respectively. However, 
these pharmacological blocking agents did not significantly 
alter the ACTH release measured by adrenal ascorbic acid de­
pletion (AAAD) induced by other systemic or neurotropic 
stresses; thus neither adrenaline, non-adrenaline nor acetyl­
choline can be the sole humoral agent Involved in pituitary 
stimulation. Gulllemin (39) showed that expiants of posterior 
hypothalamus or eminentla media caused the release of ACTH 
in vitro from anterior pituitary tissue cultures. Saffran 
and Schally (103), using an in vitro assay (104) to determine 
factors stimulating ACTH release, found hypothalamic tissue 
or brain cortex, in the presence of epinephrine or arterenal, 
increased the release of ACTH. The greatest stimulation of 
15 
ACTH release occurred with posterior pituitary lobe tissue 
plus arterenol; they concluded that the neurohypophysis is 
probably Involved in the ad enohypophy se al- adreno cortical re­
sponse system. Contrary to the claims of Slusher and Roberts 
(121), Saffran and Schally ( 10,3) found that the anterior and 
posterior parts of the hypothalamus were equally effective in 
causing ACTH release. In a later publication in the same 
year, Saffran et al. (105) extracted a corticotropin-releasing 
factor (CRF) from beef and hog posterior pltultarle's and 
showed it to be distinct from vasopressin and oxytocin by 
its oehavior in several paper chromatography solvent systems-
Crude vasopressin (200 U/mg.) prepared from beef posterior 
pituitaries contained CRF activity but further purification 
to 400 U/mg. caused a loss of most of the CRF activity. Since 
CRF contaminated vasopressin and ap%e ared at ninhydrin-stain-
ing areas on paper chromatography, it was assumed to be prob­
ably peptide in nature. These investigators believed that 
hcCann and Broceck's (72) results with Pitressln could be 
explained by CRF contamination and further postulated that 
CRF is elaborated within neurosecretory cells in the hypo­
thalamus (as stated previously for oxytocin and vasopressin 
(116)) and stored until needed in the neurohypophysis. 
Gulllemin and Hearn (32) also found, in a similar assay, that 
Pitressln increased ACTH release whereas highly purified 
arglnine-vasopressin had no effect. In work conducted at the 
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same time, Martini and Morpurgo (71) noted that Pitressln 
produces a significant fall of adrenal cholesterol after sub­
cutaneous injections of 0.3 U/rat whereas Pitocin at the same 
concentration has no significant effect. They cited these 
results in support of the argument that posterior pituitary 
hormones may activate the anterior lobe to discharge ACTH and 
that antidiuretic hormone may be the neurohumoral transmitting 
agent. 
For a more detailed review of the literature concerning 
the pituitary-adrenal relationship to June of 1955, the 
publication of G. hi. H. Long (69) may be consulted. 
Meanwhile, work had continued on the purification, iso­
lation and amino acid sequence of corticotropin and finally 
resulted in the complete elucidation of the structure in 
1954. An excellent early review of this work is presented 
by Hays and White (47) while a more complete discussion is 
offered by C. H. Li (66). Scientists associated with the 
American Cyanamid Company (10, 66, 117, 118) published a 
series of papers on /3-corticotropin which constitute an ex­
cellent review of the methodology involved in peptide hormone 
research. Seven active components, /3 -corticotropin repre­
senting the most abundant one (ça. 50/6), were isolated from 
the porcine oxycellulose-treated starting material, ft -Corti­
cotropin gave three smaller active molecules Pg, P3 and P4 
having 28, 30 and 31 amino acid residues respectively upon 
17 
pepsin digestion (10, 118). As in other peptide hormones, 
a species difference exists for the ACTH molecule in the pig, 
cow and sheep. The corticotropins have a definite melanocyte-
stimulating activity which can be readily understood in their 
sequential similarity to the MSH molecules as indicated in 
Fig. 3. 
In early 1956, Porter and Rumsfield (90) reported 
adrenal ascorbic acid depletion (AAAD) in the hydrocortisone-
inhibited ret upon injection with lyophilized hypothalamico-
hypophyseal portal vessel plasma. This plasma showed no ACTH 
activity in the hypophysectomized ret. Similarly tested 
lyophilized carotid artery plasma gave no ACTH secretion in 
the hydrocortisone-treated Intact rat. The active substance 
in portal plasma was non-dialyzable and present as a single 
fraction of the alcohol fractionated plasma proteins. A sig­
nificant AAAD occurred when Pitressln was injected into the 
hydrocortisone-inhibited, intact rats confirming the work 
previously cited- Rumsfield and Porter concluded that the 
active substance "is either a large protein molecule or is 
bound to a large protein molecule and is probably not identi­
cal with vasopressin. 11 
Gulllemin et al. (33) reported preliminary studies on 
the isolation of a CRF active (as assayed by the in vitro 
technique) complex or mixture of polypeptides, DA, from hog 
and beef hypothalamus. One active fraction, D, obtained by 
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paper chromatography, was extracted from Pro topitultrln, 
Pitressln, hypothalamus and posterior pituitary with the 
hypothalamic fraction approximately 100 times jnore active 
than posterior pituitary D. D was well separated from vaso­
pressin, had no ACTH potentiation of the adrenals and showed 
MSH activity. This work was reported in greater detail in 
1957 (34). Schally and Saffran (114) reported that histamine 
and purified lysine vasopressin did not accelerate the release 
of ACTH by isolated cultures of rat pituitaries. In contrast, 
purified CRF preparations in minute doses significantly In­
creased the release of ACTH. Swingle e_t al. (128) showed 
that commercial Pitressln exhibited ACTH-releasing activity 
when incubated with pituitaries and the incubation fluid 
infused intravenously into hypophysectomlzed rats. The ORE 
could be separated from the pressor component by Craig counter-
current distribution or by destroying the latter by acid 
hydrolysis. These Investigators concluded that the ACTH-
releasing agent was not histamine or a histamine-like sub­
stance . McDonald _et al. (76, 77) studied the effect of 
Pitressln on the adrenocortical activity in man and reported 
a stimulation of the pituitary-adrenal system. Commercial 
and synthetic lysine vasopressin were found equipotent in 
producing AAAD in rats with hypothalamic lesions; therefore, 
kcCann and Fruit (73) concluded that LVP is the neurohumor 
responsible for ACTH release. McDonald et_ al. (75) conducted 
20 
investigations in normal human subjects by simultaneous 
determinations of urine osmolality and plasma hydrocortisone 
level under stresses of fluid deprivation, hypertonic saline, 
nicotine, hand immersion in ice water and insulin induced 
hypoglycemia. The data indicated that endogenous ADH release 
may occur without an increase of ACTH and an increase in ACTH 
release may occur without evidence of ADH. These observations 
failed to support the concept that endogenous ADH release 
stimulates the release of ACTH. 
Guillemin et al. (29) reported that the variation in con­
centration of plasma free corticosteroids gave an excellent 
ACTH log dose response and further showed (35) that fraction 
D, previously described and characterized by its in vitro 
activity, stimulated the discharge of ACTH in vivo in rats 
with either hypothalamic lesions or pharmacological blockade. 
Royce and Sayers (95) published experiments showing that one 
unit of Pitressin was equivalent to 0.1 mu of ACTH measured 
by AAAD in the hypophysectomized rat and achieved similar 
results with highly purified arginine vasopressin (AVP). 
Pitressin at 0.2 U has no significant AAAD in the hypophy­
sectomized rat but potentiates the activity of ACTH by a fac­
tor of 1.55 and Pitressin also depletes AAA in the decapitated-
lesioned rat, showing it to have an extrapituitary action. 
Hilton et al. (48) showed a direct vasopressin stimulation of 
the isolated adrenal gland to produce 17-hydroxycorticoids in 
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the dog. In a later report in 1958, Royce and Sayers (96) re­
ported an acid extraction of a GRF active, pepsin labile frac­
tion from calf brain median eminence area tissue. The activ­
ity was not adsorbed by oxycellulose and could not be account­
ed for by the pressor activity present and its known ACTH-
releasing action. Royce and Sayers (96) found no difference 
in the AAAD response to ACTH in the hypophysectomized or medi­
an eminence lesioned animals. Schally et al. (115) showed 
that hog hypothalamic and hog and beef posterior pituitary 
extracts gave a CRF activity as measured in the in vitro 
assay. Porcine brain extracts showed no activity. Purified 
CRF, octained by paper chromatography, of neurohypophyseal 
origin significantly increased the release of ACTH at doses 
of lyumg., and upon hydrolysis gave cystine, aspartic acid, 
glutamic acid, glycine, proline, lysine, phenylalanine, 
alanine, serine and histidine as the amino acid composition. 
De Garihle at al. (18) were able to obtain peptide fractions 
containing CRF activity by using dialysis and Amberlite 
IRC-50 column chromatography on extracts of posterior pitui­
tary of beef and hog. The active fractions showed CRF activ­
ity in botn in vitro and in vivo assays and contained minute 
amounts (1-2 U/mg.) of vasopressin, Indicating CRF and vaso­
pressin to be two chemically distinct substances. 
In a presentation at a meeting in April, 1959, of the 
Federation of American Societies for Experimental Biology, 
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Royce and Sayers (97) reported experiments showing a crude 
acetic acid extract of pituitary stalk-median eminence tissue 
derived from calf hypothalamus containing a pepsin-labile 
factor capable of inducing near-maximal AAAD in rats with 
hypotnalamic lesions at a dose of 24-53 f of protein. This 
same dose failed to elicit AAAD in intact rats pretreated 
with desoxycorticosterone acetate (DCA or DOCA); therefore, 
they concluded that one site of DCA blockade of ACTH release 
must occur at the adenohypophysis level. Schally and Guille-
min (111) were able to concentrate CRF by chromatography on 
carboxymethyl cellulose (CMC) column employing a protopitui-
trin or pitressin Intermediate starting material. The pressor 
and CRF activity curves were almost identical and the assays 
were conducted at "safe11 doses corresponding to 10 or 30 mU 
of pressor activity. G-uillemin _et al. (30) reported later 
that doses of 30 mU of highly purified natural lysine vaso­
pressin (LVP 287 U/mg.) are inactive in rets with hypothala­
mic lesions or pharmacological blockade• They concluded 
that the CRF activity of their fraction D must be attributed 
to a substance other than vasopressin. In opposition to 
Royce and Sayers (96), however, Guillemin et al. (30) found 
that animals with "effective" hypothalamic lesions have an 
inferior sensitivity to that of hypophysectomized rats toward 
ACTH. The smallest effective dose is 1 mU versus 0.1 mU for 
the hypophysectomized rat. Lerner and Lee (65) reported the 
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acsence of corticotropic activity in ce -MSH as measured by 
AAAD. Steelman and Gulllemin (124) showed that highly puri­
fied oc -MSH (lxlO7 U/mg. ) when studied for ACTH activity in 
vivo gave a response of less than 0.18 ACTH USP U/mg. for 
the AAAD assay and 0.1 ACTH USP U/mg. for the.plasma B assay. 
The in vitro assay gave 3.6 ACTH USP U/mg. This difference 
in activity, approximately 30 fold, was tentatively related 
to unequal rates of absorption by the adrenal tissue in vitro 
and unequal rates of inactivation and disappearance of the 
substance in vivo. /3 -hSH did not show adrenocorticotropic 
activity. In their re-evaluation of the in vitro pituitary 
incubation system used to demonstrate CRF activity, G-uillemin 
and Schaily (36) showed that the effect of CRF material, pre­
pared as described eerlier (ill), could not be explained on 
the basis of the inhibition of ACTH inactivation. Further­
more CRF did not act by potentiating ACTH at the adrenal level 
or by an inherent adrenocorticotropic activity, and the most 
active fraction stimulated ACTH-release in vivo at a dose of 
60 mr . 
Nichols and Gulllemin (84) in experiments designed to 
study the effects of endogenous and exogenous vasopressin on 
ACTH in ufrânesthetized trained dogs showed that no correla­
tion was observed between the di scharge of ACTH as measured 
by plasma free 17-hydroxycorticosteroid (170HC) and the re­
lease or inhibition of release of antidiuretic hormone (ADH). 
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These investigators further commented that if this phenomena 
is due only to a large difference in sensitivity to their 
respective affectors, this must mean a factor of -3.5x10 to 
g 
7.1x10 between the amount of vasopressin, necessary for maxi­
mal antidiuresis and the threshold dose for ACTH stimulation; 
or, a differential release of vasopressin from the posterior 
lobe - to the periphery for antidiuresis or to the anterior 
pituitary for ACTH secretion. McCann and Haberland (74) re­
ported that rats with "acute" hypothalamic lesions were one-
third as sensitive to ACTH than the hypophysectomized rats, 
a result agreeing qualitatively with G-uillemin _et al. (30) 
cut disagreeing with Royce and Sayers (96). Using this 
observation to interpret their assay results, McCann and 
Haberland (74) were able to show the presence of a CRF in 
acid extracts of beef or rat stalk-median eminence area with 
10 to 20/i of the CRF activity apparently due to vasopressin. 
Although Royce and Sayers (96) could effect some purifica­
tion by oxycellulose treatment, McCann and Haberland found 
that oxycellulose almost quantitatively adsorbed all active 
material. They also published data indicating that the hydro­
cortisone inhibited ret, as used in the Porter and Jones (89) 
assay, gives a response significantly less, 82+10 to 1-33+14 
for 6 mU of ACTH, than that of the lesioned animal. DeWied 
and Mirsky (21) found that the minimal dosage of intra­
peritoneal^ injected Pitressin necessary to produce a slg-
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nifleant decrease in AAA was more than 10 times greater In 
the hydrocortisone-treated than In the-normal rat. Twice the 
Intravenous dosage was required for AAAD in the treated ani­
mal than for the untreated animal. Identical adrenal cortical 
responses were obtained in the hydrocortisone-treated rats 
with similar intravenous doses of Pitressin, arginine vaso­
pressin and synthetic lysine vasopressin. Rumafield and 
Porter (100) demonstrated the presence of ACTH-releasing 
activity in protein fraction III of portal vessel plasma as 
measured by AAAD in the steroid-depressed rat. The activity 
attributable to III0 was lost during dialysis against a buffer 
containing 15-2;i ethanol and was not due to contamination 
with nonepinephrine, epinephrine, histamine or serotonin. 
Porter and Rumsfield (73) showed that fraction III0 consisted 
of three major protein components with isoelectric points at 
pH 4.4, pH 5.1 and pH 6.6 and the active peak had a mobility 
in veronal buffer (pH 8.6; m = 0.1) of -1.91+0.41 cm.^ volt-^ 
— 1 5  
sec. xlO~ by starch column electrophoresis. The CRF activ­
ity of fraction III0 was trypsin and pepsin labile, destroyed 
by refluxing with 0.1 N NaOH but not by refluxlng in 0.1 N 
HCl for two hours. Preliminary results Indicated the lyophil-
ized portal plasma dissolved in Cohn buffer at pH 6.9 lost 
the active substance upon dialysis against distilled water 
suggesting that the plasma protein serves a role in transport 
of the CRF in portal blood• 
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Rumsfieia and Porter (99) made an acetone extraction of 
beef hypothalamus which was evaporated to dryness and taken 
up in ether. The ether solution was extracted with 0.9$ 
saline solution which showed ACTH-releasing activity as 
measured by the Porter and Jones (89) assay. An aliquot of 
the saline phase equivalent to 15 "hypothalami11 was lyophil-
ized, dissolved in ammonium formate buffer and chromatograph­
ed on a Dowex 50x2 column. Ninhydrin analysis revealed 18 
peaks with only one, containing two ninhydrin positive com­
ponents as indicated by paper chromatography in five solvent 
systems, possessing ACTH-releasing activity. Countercurrent 
distribution of the active peak gave partition coefficients 
in see-butano 1-0.05;'= acetic acid of approximately 0.11 and 
0.37. Descending paper chromatography gave Rp values much 
higher ,than those obtained for the vasopressins. Gros and 
De Gar1hie (42) obtained an ACTH-releasing preparation by 
submitting hog posterior pituitary powder to an acetic acid 
extraction which was lyophilized to a small volume and acetone 
precipitated. The fraction containing small amounts of vaso­
pressin and ACTH-releasing activity was subjected to counter-
current distribution for ab transfers. The CRF fraction, 
assayed by the in vitro method (18), was well-removed from 
the vasopressin area and showed three or four peptides when 
paper electrophoretographed. Column electrophoresis of the 
CCD CRF fraction gave an apparently homogeneous peptide which 
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gave an excellent CRF response at doses of IT. 
In the spring of 1960, Guillemin et. al. (38) reported 
that when CRF concentrates (111) are subjected to counter-
current distribution in three systems, LVP and CRF activities 
are widely separated. Since no CRF activity was demonstrable 
under the LVP peak, the distinct chemical entity of each of 
these substances was confirmed. However, since the CRF activ­
ity corresponded with the <x: -MSH peak in the three CCD's and 
were not separable by paper strip or zone electrophoresis, 
it was uncertain whether oc-MSH and CRF were one and the same 
molecule. Schally and Gulllemin (112) studied the behavior 
of oxytocin, lysine and arginine vasopressin, ACTH, oc-MSH 
and CRF on CMC and IRC-50 cation exchange columns. CRF activ­
ity based on an in vivo assay followed oxytocin and preceded 
LVP and A VP, oc-MSH and ACTH on CMC, but followed oxytocin 
and LVP on IRC-50. In their investigation of the ACTH-
releasing factor present in Pitressin, Sideman and Sobel (120) 
studied its electrophoresis fractions and found the pressor 
and ACTH-releasing activities occurred in the same area. 
Amino acid analysis of the peptide gave only those eight con­
tained in LVP and comparison of the two activities during 
mild acid and alkaline hydrolysis, lodination and incubation 
with placental extract indicated parallel alteration. These 
researchers concluded that LVP causes ACTH release in the 
guinea pig and may be a hypothalamic mediator in that species. 
Royce and Sayers (98) subjected a glacial acetic acid ex­
tract of a portion of calf tissue including median eminence 
and pituitary stalk (SME) to chromatography on a carboxymethyl 
cellulose column using a discontinuous gradient elution of 
0.0b, 0.1, 0.2 and 0.4 M ammonium acetate buffer. Cortico­
tropin releasing activity was found in the 0.01 M and 0.10 M 
fractions; the 0 05 M fraction had no activity whereas the 
bulk of the pressor activity emerged with the 0.2 M buffer 
with a small response elicited by the 0.40 M fraction which 
contained the ACTH activity exclusively. The 0.10 M fraction 
had no detectable pressor or ACTH activity at a dose of 0.3 
SME (4.3>#g of protein) but gave significant CRF response. 
The data indicated the possibility of the existence of two 
chemically distinct CRTs in SME tissue if the fractionation 
techniques were adequate. 
In June of 1960, G-uillemin et al. (37) and in a more 
detailed report later (109) reported the chemical and physio­
logical evidence for the existence of two corticotropln-
releasing factors in hog posterior pituitary extracts. A 
single peak obtained by CMC chromatography contained LVP, 
oc-MSH and all the CRF activity (112) ; this was subjected to 
CCD and LVP was well separated from oc-MSH (38). The oc-MSH 
area contained CRF activity which could be separated on 
analytical scale CMC columns. The CRF was a peptide or group 
of peptides containing the amino acids of «-MSH plus 
29 
threonine, alanine and leucine. This peptide, designated 
oc-CRF, was active in releasing ACTH only at relatively high 
levels of 2-3 r in vivo or 0.5 -f in vitro and had an inherent 
ACTH activity of 0.1 U/mg., pressor activity of 0.1 to 0.2 
n 
U/mg. and MSH activity of 0.1 to 0.3x10 U/mg. Earlier work 
(34, 36, 112, 115) indicated a vasopressin-related CRF with 
activities at lower dose levels and thus the CCD pressor area 
was carefully explored. Paper chromatography revealed a 
small peptide, related to vasopressin on the basis of amino 
acid composition, active at 0.05Y in vitro or 0.1f in vivo 
and designated /3-CRF. These Investigators (37, 109) believe 
oc-CRF may serve as a biosynthetlc precursor of ACTH and fur­
ther propose /3-CRF as the true chemical mediator for the 
release of ACTH. De Garihle et al. (18) fractionated hog 
posterior pituitary by 1) extracting with dilute acetic acid; 
2) fractional precipitation with acetone; 3) countercurrent 
distribution; and 4) zone electrophoresis on a cellulose 
column. Peaks 3 and 4 of the electrophoresis possessed CRF 
activity and represented approximately 10# of the starting 
material; peak 3 gave an amino acid analysis including those 
found in oc-MSH plus threonine and leucine. Fraction 3 
possessed an MSH activity amounting to 1-2.5/6 of that of pure 
oc-MSH and gave CRF activity at doses of 0.5-1.Or ; fraction 
4 showed the same degree of CRF activity. In addition De 
Garihle et al. (19) tested the in vitro CRF activity of sev­
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eral peptides synthesized by Kappeler and Schwyzer (58). 
Two of these peptides, a heptapeptide having an amino acid 
sequence of c?c-MSH from position 4 through 10 with a gluta-
mine at 5, and a decapeptide with the sequence of the first 
10 amino acids of oc-MSH with the exception of the acetyl 
group on serine 1 and a glutamine at 5, gave excellent ACTH-
releasing activity at O.iy . Rappeler and Schwyzer (58) re­
port that the heptapeptide has £.8xl05 U/g. MSH-activity, as 
compared with oc-MSH (2xl0^"° U/g.), /?b-MSH (2x10^ U/g.) and 
oc^-ACTH (0.5x10^ U/g • ), but no ACTH activity. 
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DISCUSSION 
Statement of Problem 
In the spring of 1956, at the time the work reported 
here was begun, reports in the literature strongly suggested 
the existence of a neurohumor which was released from the 
hypothalamus under conditions of psychological or physio­
logical stress. This chemical mediator, transmitted by the 
portal vessels, brought about secretion of adrenocorticotropic 
hormone from the adenohypophysis. The goals of this investi­
gation were: l) to isolate the corticotropin-releasing fac­
tor (CRF); 2) to determine its chemical nature and molecular 
structure; and 3) to confirm the structure by synthesis if 
feasible• Because of evidence that CRF was probably a pep­
tide or family of peptides, It was considered useful to make 
preliminary investigations of the nature of the peptide pool 
contained in hog hypothalamic and posterior pituitary lobe 
starting material. 
Experimental Results ; 
In 1954, iicCann and Brobeck (72) reported that secretion 
of ACTH in rats was brought about by large doses of Pitressin, 
a commercial product obtained from porcine posterior pitui­
tary lobe by a procedure first employed by Kamm and co-workers 
(57). Later, Saffran et al. (103, 104, 105) reported the 
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presence of a corticotropin-releaslng factor In water extracts 
of rat neurohypophysis and G-uillemin and Hearn (32) attributed 
the ACTH hypophysotrope activity of Pitressin to a contaminant 
of probable hypothalamic origin. Gulllemin e_t al. (33) ob­
tained a CRF active fraction from Pitressin Intermediate B, 
a fraction In the Kamm procedure (132). Because of the ease 
of procurement of porcine posterior pituitary, and its report­
ed CRF.activity, it was selected as the chief starting mate­
rial in this investigation. 
In the beginning years of this work, the only assay 
facilities available to us were located at the Baylor Univer­
sity College of Medicine, Houston, Texas under the supervision 
of Dr. Roger Gulllemin. This assay limitation necessitated 
repetition of proven methods known to result in highly active 
fractions to produce starting materials for further purifica­
tion procedures. It was thought that this path would yield 
the greatest information with the smallest possible number of 
assays. The procedure for the preparation of "D " material 
reported in abstract by Gulllemin et al. (32) and later in 
greater detail (34) was the method chosen at the beginning. 
Acetone-desiccated hog posterior pituitary lobe, gen­
erously donated by the Armour Laboratories or Princeton Lab­
oratories Inc. was subjected to the Kamm extraction procedure 
(57). Seventy grams of this material gave an average of 4.7 
g. of Pitressin Intermediate B (132), a light, tan powder 
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assaying 4-5 U/mg. of pressor activity, and referred to as 
Kamm product. 
A methanol extract of the Kamm product prepared by ex­
tracting 3 g. with methanol:water (10:1 v/v) resulted in aver­
age yields of u.8 g. of lyophilized product having a pressor 
activity of 2-3 U/mg. This product gave a cleaner pattern 
in the subsequent paper chromatography step and aided in ob­
taining a nearly preesor-free active fraction. 
A modification of the solvent system used by Gulllemin 
et al. (32) was employed for further fractionation of methanol 
extract by paper chromatography. Their solvent I consisting 
of acetone:0.05# aqueous urea:diethylene glycol (6:3:1) was 
modified by using deionlzed water instead of the urea solu­
tion. Twenty papers, each streaked with 50 mg. of methanol 
extract for a total of 1.0 g., gave an average yield of 0,05 
g. of CRF active fraction D found at Rp 0.9-1.0. Solvent I 
revealed at least eight ninhydrin positive components, all 
presumably heterogeneous, present in methanol extract. A 
pooled sample of fraction D (FD 126) amounting to 0.588 g. 
had a pressor activity of 1-2 U/mg.; an MSH Melanophore Index 
of 3-4 for 2f ; 4, 5+ for 4 r and 5-5+ for 8f compared to 
2-3 for 1.25r and 3-4 for 2-5 r of standard and CRF activity 
giving a 210$ increase in compound B at a dose of 100T . Of 
the CRF activity, approximately 180$ of the 210$ increase can 
now be explained by the presence of vasopressin. 
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Many experiments were performed on FD 126 or similarly 
obtained fractions with the object of selecting a desirable 
method for purifying the active CRF material. 
Paper chromatography of FD 126 in BAW (4:1:1) gave eight 
ninhydrin positive spots at Rp's of 0-07+3, 0.16"*"^, 0.22+2, 
0.28+3, G.32+2, 0.44*2, 0.55*4 and 0.74+4. 
Carboxymethyl cellulose, prepared by the method of Sober 
and Peterson (85), was used for a column (CMW 2) employing 
0,2 M ammonium acetate, pH 4.5 as the eluting buffer. Folin 
analysis revealed the presence of five peaks in 24.8 mg. of 
a D-like starting material, all showing heterogeneity on 
chromatography on paper in BAW (4:1:1). At least 13 differ­
ent ninhydrin positive components were present in the frac­
tions Investigated. 
A 210 mg. sample of FD 126 was subjected to 450 transfers 
at 25°C in the Automatic Countercurrent Distribution apparatus 
in a solvent system of sec-butanol-O.5$ trichloroacetic acid 
(CCD 24). A ninhydrin analysis of the completed distribution 
gave eight peaks, none of which conformed to theoretical 
curves calculated at the corresponding partition coefficient 
value. Paper chromatography of the four fractions investi­
gated at K values of 0,142, 0.223, 0.332 and 0.574 showed from 
three to five ninhydrin positive components present in each 
fraction. The speed and resolving power of this technique 
made it a valuable tool in later purification steps. 
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The technique of one dimensional paper chromatography 
followed by electrophoresis in a direction 90° to the solvent 
development (59, 86) was used for analysis of FD 126; the 
presence of 10 to 14 peptides was revealed; on elution and 
hydrolysis, these were found to range in size from 5 to 13 
amino acids• 
In summary, fraction D appears to consist of at least 
eight and possibly as many as 14 peptides ranging in size 
from 5 to 13 amino acids. Countercurrent distribution 
affords a rapid method for obtaining useful quantities of 
peptides which could be subjected to more refined techniques 
yielding homogeneous materials. 
The tedium and limitations involved in the preparation 
of fraction D by paper chromatography led to a search for 
other methods of producing fraction D or D-like material of 
equal biological activity. Crude starting materials were 
used in experiments employing chromatopiles, hyflo-supercel 
columns, powdered cellulose columns, countercurrent distribu­
tion and ion exchange columns. 
A sample of pro topituitrin (Parke-Davis), subjected to 
chromatography by the chromatopile technique (Chromatopile 
2), gave seven peaks when developed with Solvent I. All frac­
tions obtained were heterogeneous as revealed by paper chroma­
tography in Solvent I. Fraction 400-550 gave a potency of 
2.0 for a dose of 100r and fraction 550-750 assayed at 2.1 
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while fraction 750-950 showed no activity at the same dose 
in the in vitro assay• The recovery of material amounted to 
only 44$ of the starting material. This method, considering 
the low recovery, low resolving power, and work involved 
seemed to offer no advantage to the paper chromatographic 
preparation of D. 
A column (Cell. 5) prepared by packing a heavy slurry of 
Whatman Cellulose powder in n-butanol under 60 cm. of air 
pressure was charged with a sample of Kamm product dissolved 
in a solution of n-buta.no 1, acetic acid and water. A step­
wise gradient elution scheme of increasing polarity was used 
to elute the peptide materials from the column. Folin analysis 
did not permit determination of the number of peaks present 
but subsequent paper chromatography of the 35 fractions col­
lected revealed at least 30 ninhydrin positive components. 
Pressor activity was absent in peak 16 but peak 21 gave 
approximately 2 U/mg. The column gave fairly good resolution 
of peptide components but required 5 weeks for development, 
making it unsuitable for preparation of labile biologically 
active materials. 
Countercurrent distribution of a sample of methanol 
extract (CCD 6) in n-butano1-0.09 M p-toluenesulfonic acid 
at 25°C gave 11 overlapping peaks when analyzed by the Folin 
method; each fraction examined proved to be heterogeneous in 
subsequent paper chromatography experiments. 
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Polycarboxylic acid resins have been used effectively 
for the separation of protein and peptide mixtures (81). A 
sample of methanol extract chromatographed on IRC-50 resin 
(IRC-50 8) equilibrated with 0.2 M ammonium acetate at pH 4.69 
and gradient eluted to 0.2 M ammonium hydroxide gave no 
homogeneous fractions. 
Hyflo-supercel columns, under the conditions employed, 
also proved incapable of resolving adequately the peptide 
mixtures represented by pro topituitrin, Kamm product, or 
methanol extract. It became obvious that no single fraction­
ation technique would provide homogeneous material and that 
a combination of procedures would have to be used. 
The Kamm procedure (57) used in the preparation of the 
Kamm fraction reported here, Protopituitrin or Pitressin 
(132) requires a heating step to 95°C and an acetone-desic­
cated posterior pituitary lobe starting material. The effect 
of heating and acetone extraction on the CRF activity was not 
previously investigated and the success of Acher et al. (4, 
5, 6) in purifying oxytocin and vasopressin by a cold, dilute 
sulfuric acid extraction of acetone-desiccated posterior lobe 
tissue prompted the following experiments. 
A yield of 48 g. of wet posterior pituitary lobe, ob­
tained from about 1 lb. of whole glanas was homogenized in 
200 ml. of O.'côfo acetic acid, filtered, and the acetic acid 
extraction and filtration repeated twice more on the residue. 
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The combined filtrate, concentrated to a volume of 150 ml., 
was made 5$ in trichloroacetic acid and filtered. The pre­
cipitate resulting from the addition of 82.5 g. of ammonium 
sulfate was collected and dried and extracted three times with 
glacial acetic acid. The Kamm product finally obtained 
weighed about 50 mg. with a pressor activity of 4.0 U/mg. 
giving a weight yield of approximately 0.5$ calculated on the 
basis of dry weight of tissue. A paper chromatogram of this 
material gave five ninhydrin positive areas, three of which 
were eluted and obtained as p. lyophllized powder. The com­
ponents at Rf 0.14 (LVP 40 U/mg.) and 0.17 (LVP 140 U/mg.) 
gave CRF responses of 390$ and 344$ respectively for a 60Y 
dose. In the light of present knowledge of the ACTH-releas­
ing capabilities of vasopressin (30, 96, 133) the extremely 
large doses of 2400 mU and 8400 mU for the two assays would 
account for all the CRF response observed. 
Hypothalamic tissue, treated similarly to the posterior 
pituitary lobe described above, gave 41.6 mg. of Kamm product 
from 29.3 g. of wet starting material. The Kamm product which 
had a pressor activity of 0.072 U/mg. and no CRF activity at 
a 600 Y dose, gave four ninhydrin positive components when 
chromatogrephed in BAW (4:1:5). Materials obtained from the 
areas having Rp's at 0.15 and 0.19 gave no CRF activity at 
80 Y dose levels. The residue from the dilute acetic acid 
extraction gave a Kamm product having a pressor activity of 
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0.124 U/mg. when subjected to the regular Kamm'procedure (57). 
Since the cold, dilute acetic acid extraction did not 
yield any vasoprèssin-free CRF active material, an experiment 
using freshly obtained pituitary glands processed by the Kamm 
procedure was performed. Desiccation of 77.3 g. of wet 
posterior lobe tissue was accomplished by a once repeated 
addition of 6000 ml. of acetone at 3-5°C yielding 15.1 g. of 
dried glands. The tissue was homogenized in the recommended 
quantity of 0.25$ acetic acid and subjected to the Kamm pro­
cedure (57). The final yield of methanol extract was. 188 mg. 
which gave 7.5 mg. of D material. Fraction D had a pressor 
activity of 0.06 U/mg. and when injected at doses of 100Y 
(6 mU LVP) and 25r(0.15 mU LVP) gave plasma steroid increases 
of 210$ and 91$ respectively. This activity cannot be attrib­
uted to the vasopressin present and must be due to a material 
having CRF- or ACTH-like activity. Unfortunately no ACTH 
assay was performed but similar material prepared by other 
investigators using an identical procedure showed no ACTH 
activity (33). Fraction D possesses MSH activity as reported 
here and elsewhere (33) and the possibility exists that the 
response in the CRF assay was due to oc-MSH ( 124) or oc-CRF 
(37, 109). To test this possibility, 5 mg. of the D material 
was distributed in a CCD for 59 transfers in a eec-butanol-
0.5)o TCA solvent system. The area including that known to 
contain oc-MSH (K = 2.1) (63) and an adjacent area of a higher 
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K value gave no CRF activity when assayed. Therefore the 
CRF activity in the original D material could hardly have 
been due to oc-MSH or oc-CRF unless these were inactivated 
before assay. The total weight recovered was over four times 
that of the starting material indicating possible contamina-
f 
tion;.,with ïCA which could have caused partial hydrolysis of 
- / ' * i 
the active peptide in the 15 day Interim occurring between 
. the completion of the CCD and the assay. 
Six hundred and thirteen grams of brain tissue, includ­
ing the hypothalamus, after desiccation with 22.5 1. of ace­
tone at 3-5°C, blendoring and lyophilization gave 145.-6 g. .of 
tan powder. Seventy grams of thé powder gave 0.20 g. of Kamm 
product (LVP < 0.02 U/mg.), a peptide mixture containing at 
least 13 ninhydrin positive components, which in turn yielded 
60 mg. of methanol extract (LVP < 0.02 U/mg.). Fraction D 
prepared from the methanol extract, which gave no CRF activity 
when assayed at 100r , showed 14 ninhydrin positive spots 
when fingerprinted. An aqueous extract of hypothalamic pow­
der, having no MSH activity at doees of 2.5 or 5.0-r, contain­
ed 16 ninhydrin-stainlng spots. 
Dilute acetic acid extractions of the residue remaining 
after evaporation of the acetone used in the hypothalamic 
desiccation procedure gave a material, consisting of at least 
eight ninhydrin positive components, having no CRF activity 
at a 100 r dosage. Rumsfield and Porter (99) were able to 
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obtain by a 0.9$ saline extraction of an acetone extract of 
beef hypothalamic sections a CRF active fraction which was 
fractionated into 19 ninhydrin positive peaks. Observations 
here and by Rumsfield and Porter (99) disagree with those of 
Winnick et al. (134) that no significant peptide pool exists 
in the hypothalamus. Experiments indicate that the hypo­
thalamus contains 4-5$ of the peptides found in the posterior 
pituitary by weight and the mixture numbers a minimum of 14-19 
different ninhydrin positive components. 
A collection of 522 g. of posterior pituitary lobes 
weighing 90.3 g. after acetone desiccation yielded 7.13 g. 
of Kamm product having a pressor activity of 8.8 U/mg. The 
Kamm product gave 12 distinct spots and a large area of 
streaking in a fingerprint experiment. A methanol extract 
prepared from the Kamm product gave 0.53 g. (2.05 U/mg. of 
pressor activity); an aqueous extract of the residue amounted 
to 1.90 g. (5.0 U/mg. pressor activity) giving a weight re­
covery of 81$ but only 42$ of the original pressor activity. 
Although Inconclusive evidence is available, it appears that 
pressor inactivation occurs during the methanol extraction. 
The CRF activity obtained in fraction D can be wholly explain­
ed by the presence of the lysine vasopressin present in the 
sample• 
An aqueous extract performed on the original posterior 
pituitary powder according to the method of Landgrebe and 
42 
Waring (61) gave material having high MSH activity and a com­
position of 14 ninhydrin positive spots as revealed by finger­
printing. 
In summary, no CRF activity was obtained from hypothal­
amic tissue by cold or hot 0.25$ acetic acid extractions, or 
by acetone extraction of the frozen tissue when assayed at 
the 100 f level. Aqueous extractions of hypothalamic tissue 
failed to show MSH activity at doses of 2.5 or 5T • Cold 
acetic acid extractions of posterior lobe tissue gave no CRF 
active fractions which could not be explained by the pressor 
activity present whereas there are conflicting data available 
for the results of hot extractions according to the Kamm pro­
cedure . The active material, FD (12-14-59) gave a 210$ in­
crease at 100 r (6 mU LVP) whereas a similarly obtained 
fraction, FD (2-2-60) gave an 85$ increase at 100 f (-30 mU 
LVP). However, the assay for the latter gave very high con­
trols which makes it appear that all of the activity can be 
explained by the vasopressin contamination of the sample. 
The actual increase in compound B was 20.4+2.8/100 ml. plasma 
for FD (12-14-59) and 17.4+1.9/100 ml. plasma for FD (2-2-60); 
these values are probably not significantly different due to 
the large standard errors of the mean. Thus, a tentative 
conclusion from the results of these experiments include the 
probability that a CRF material other than vasopressin is 
present in fraction "D" of posterior lobe origin and because 
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of the known MSH activity of D, may be oc-CRF. 
The active CRF fractions were in such small quantity 
that in order to obtain amounts sufficiently large to perform 
many purification steps and degradation studies, larger 
amounts of starting material were necessary. 
Ten grams of combined Kamm product (LVP 5-2 U/mg.) stored 
in a deep freeze for about one year, was distributed In 
n-butanol:acetic acid:water (4:1:5), 200 ml. per phase, for 
14 transfers at 25-30°C (CCD 39). Most of the weight and 
pressor activity remained in the first four tubes; tube 0, 
2.28 g. (LVP 8.0 U/mg.); tube 1, 2.15 g. (LVP 9,99 U/mg.); 
tube 2, 1.09 g. (LVP 9.62 U/mg.); and tube 3, 0.71 g. (LVP 
4.22 U/mg.). An overall weight recovery of 75.8$ was ob­
tained with a complete recovery of pressor activity. 
Continuous electrophoresis fractionation (Ce 208-2,3) 
were performed on CCD 39 peaks 2 and 3 using conditions sim­
ilar to those employed by Gulllemin et al. (34). Ce 208-2, 
using CCD 39 peak 2 as starting material, gave a weight re­
covery of 69$ and a pressor recovery of 47$ while Ce 208-3 
with CCD 39 peak 3 as starting material gave a 66$ weight 
recovery but a pressor recovery of 63$. Both electrophoresis 
experiments gave pressor peaks at fraction 15-16 and the ex­
tent of purification reflected the pressor activity of the 
starting material; in Ce 208-2, 15-16 assayed 50.0 U/mg. and 
in Ce 208-3, 15-16 assayed 35.8 U/mg. The fractions obtained 
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in the pressor active area showed heterogeneity in ninhydrin 
positive components. The CRF assays of Ce 208-2 indicated 
activity in fraction 15-16 at doses of 0.6 of and in fraction 
17-18 at doses of 2>4r . All other fractions tested gave 
CRF activity at doses of 45T. Almost all of the activity 
in fraction 15-16 can be accounted for by vasopressin, which 
also accounts for the entire activity of fraction 27-28. The 
activity exhibited by fraction 21-22 In the CRF assay can be 
explained In large measure (60/&-75/& of total) by the ACTH and 
vasopressin activity known to be present. Although not 
assayed for ACTH, the activity found in the CRF assay for the 
fractions adjacent to fraction 21-22, namely 19-20, 23-24 and 
24-26, can be explained in the same fashion. Fraction 17-18 
appears too far removed from the ACTH area and contains too 
little vasopressin to account for all of the CRF activity 
determined. Since fraction 15-16 of a later continuous 
electrophoresis (Ce 225, 226) was shown to contain MSH activ­
ity, the possibility that oc-CRF was present can explain the 
response obtained from the CRF assay of fraction 17-18. 
A preliminary CCD consisting of 59 transfers was con­
ducted on 10.1 mg. of Ce 208-2 fraction 21-22 (CCD 42). The 
small amount of CRF activity found in peaks 0 and 2 can prob­
ably be attributed to pressor active contamination, although 
no pressor assays were conducted. However, an estimate of 
the vasopressin content can be attempted from the assay of 
similar areas in CCD 44 conducted on the same starting mate­
rial . Peak 1 is far too active in the CRF assay to be ex­
plained by the proposed pressor activity; thus CRF, probably 
as «-CRF which has been reported to move with oc-MSH at a 
K .value of '2«1 (5, 38), or ACTH must be responsible for the 
activity. Peak 1 gave three ninhydrin positive components 
upon paper chromatography in SAW (4:1:5) at Rp values of 
0.176, 0.50 and 0.73. Schally et al. ( 110) report an Re­
value of 0.62 for oc-MSH in the same solvent system. 
The preceding experiment was repeated with 32-2 mg. of 
Ce 208-2 (21-22) giving a weight recovery of 110$ and a 
pressor recovery of 114#. The distribution was pooled into 
seven areas; fractions 2 to 6 gave CRF activity at injections 
of nearly equal pressor content but varying in amount from 
10 to 501 . Fractions 3 and 5, corresponding to areas having 
K values approximating those of lysine vasopressin and oc-MSH 
respectively, were further investigated for ACTH content. Two 
separate assays indicated no ACTH present in fractions 3 and 5 
and a repeat of the CRF assay indicated a release of steroid 
nearly equal to the first assay, but higher control values 
resulted in a lower per cent Increase. Shepherd et al. (117) 
employing a similar system obtained a slow and fast component 
having both corticotropin and intermedin activity. Fraction 
1 was therefore assayed for ACTH and was found to be Inactive. 
The ACTH known to be present in Ce 208-2 (21-22) was not found 
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in fractions 1, 3 or 5 and may be in the other fractions not 
investigated or inactivated during the experiment, a less 
likely possibility. CCD 44 revealed the presence of two sep­
arable CRF active materials ; one moving with the vasopressin 
fraction and possibly chemically related to it and another 
in the a-MSH area. Unfortunately no MSB assays were per­
formed on any of the seven fractions obtained or on the 
starting material. Approximately one-half of the CRF activity 
of peak 3 can be attributed to the vasopressin Injected using 
the value obtained in the later assay (3-17-60) however only 
one-fourth of the CRF activity of peak 5 can be explained by 
vasopressin contamination. 
None of the fractions obtained from CCD 44 were found to 
be homogeneous by paper chromatography in BAW (4:1:5). Frac­
tion 3 contained six ninhydrin positive components whereas 
fraction 5 had only four. 
A 50 transfer countercurrent distribution (CCD 41) was 
conducted on 1.5 g. of peak 1, CCD 39 (LVp = 9.99 U/mg.) in. 
sec-butanol-O. 5$ TCA at 25°C. A pressor recovery of 57$ was 
obtained with the vasopressin peak at tube 18 (K = 0.56) 
giving 0.1066 g. of fraction 3 having a pressor activity of 
61.3 U/mg. This affords a rapid means of obtaining material 
of high pressor activity although only 57$ of the starting 
pressor activity was recovered. Paper chromatography indi­
cated all fractions to be heterogeneous. The ninhydrin posi­
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tive area at a K of 0.25 in CCD 41 is believed to be due to 
ammonium salts, possibly ammonium sulfate. Fraction 5 of 
CCD 41 (30 mg.) was subjected to countercurrent distribution 
(CCD 45) in sec-butanol-O.5$ TCA'to determine the complexity 
of the peptide mixture and to test the reproducibility of the 
technique. The color analysis indicates the heterogeneity 
of the starting material by the unsymmetrical pattern obtained 
for the peak (K = 6.37). A shift of this magnitude in the K 
value range encountered here is not of great significance. 
The heterogeneity of the peak was further indicated by the 
six spots obtained on paper chromatography. No explanation 
of the poor ninhydrin analysis obtained in CCD 45 has been 
found• 
Light et, al. (68) were able to prepare vasopressin of 
a high degree of purity (240-280 U/mg.) by ion exchange 
chromatography on Amberlite IRC-50. A 98.8 mg. sample of 
CCD 41 peak 3 (LVP = 61.3 U/mg.) was chromatographed using the 
conditions reported by Light et al. (68) in the hope of ob­
taining vasopressin of very high purity and to determine the 
resolving power of the column when more complex starting 
materials than reported were employed. A weight recovery of 
50$ and a pressor recovery of 25$ was obtained in contrast to 
the 75-100$ activity recoveries reported in the published ex­
periment. This discrepancy cannot be explained, although in 
our hands, this method never resulted in better than 30$ 
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activity yields. The peak 2, eluted at approximately 2.5 
hold-up volumes, gave 5 mg. of material with a pressor assay 
of about 220 U/mg. and three ninhydrin positive components 
upon paper chromatography in BAW (4:1:5) with the heaviest 
staining spot at an Rp of 0.29. 
The most active CRF fractions obtained In the work re­
ported thus far, albeit not the only ones, were located in 
the vasopressin area (CCD 44, Ce 208) which corroborated the 
published work of Schally et al. (115) and Guillemin et al. 
(34). In opposition to this view was the experimental evi­
dence presented by Rumsfleld and Porter (79), Royce and 
Bayers (97) and De Garihle et al. (18, 42). 
It became imperative to conduct a series of experiments 
employing materials In quantities that would permit varied 
purification steps carefully followed by a sufficient number 
of assays which would enable an unequivocal conclusion to be 
drawn regarding the nature of the CRF(s). 
To this end, 28.86 g. of Pooled Kamm product (LVP = 
4.% U/mg.) was submitted to a 14 transfer distribution (CCD 
47) in BAW (4:1:5), a procedure identical to CCD 39. Results 
of pressor, weight and Folln analysis almost identical to 
CCD 39 were obtained with a final weight recovery of 87# and 
a pressor recovery of 91#. 
Schally et al. (115) reported that CRF had an Rp value 
slightly higher than lysine vasopressin in a BAW (4:1:5) paper 
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chromatogram, therefore the leading edge of the pressor peak 
of CCD 39, tubes 2 and 3, were used for subsequent purifica­
tion procedures. The lysine vasopressin contamination would 
also be lessened and more easily removed if the starting 
material were less active in that hormone. The continuous 
electrophoresis step, although useful, was of limited resolv­
ing ability and time consuming when large samples were to be 
fractionated. Therefore, CCD 47 was followed by another CCD 
in a different solvent system which would yield a smaller 
quantity of more active material to be subjected to con­
tinuous electrophoresis. 
A total of four countercurrent distributions were con­
ducted on peaks 2 and 3 of CCD 47 In sec-butanol-O.b% TCA at 
3-5°C. The pressor peaks of CCD 48, 49 and 50 were located 
by assay of the distribution tubes. Again the area on the 
descending part of the pressor curve, fraction 2, was pooled 
and isolated for further purification. The weight recovery 
was about 75-85/® and the pressor assay of fraction 2, CCD 48, 
indicated a 3-fold vasopressin purification. 
It was believed the presence of ammonium sulfate caused 
l) the very high partition coefficients found for lysine vaso­
pressin in CCD 48, 49 and 50; 2) the intense ninhydrin color 
encountered at a K of about 0.7 in CCD 48 and 49, the two 
experiments analyzed; and 3) the unusual loss of lower phase 
found In each distribution nearly mirroring the ninhydrin 
50 
peak. 
Two continuous electrophoresis experiments using condi­
tions Identical to Ce 208-2,3 were conducted on peak 2 of 
CCD 48, 49, 50 and 51. Ce 225 used 0.3 g. of fraction 2 from 
CCD 48 (LVP =9,7 U/mg.) and 0.3 g. of fraction 2 from CCD 
49; Ce 226 Was run on 0.35 g. of CCD 50 and 0.19 g. of CCD 
51. The pressor recovery of Ce 225 amounted to 68# compared 
to a weight recovery of 67# for the combined experiments. 
A CRF assay was performed on Ce 225 and a pressor assay 
was conducted on both Ce 225 and Ce 226. Fraction 13-14 of 
Ce 225 was assayed at doses of 0.9, 1.8, 3.6 and 7.2 T and 
the elicited response was used as a standard of activity 
arbitrarily based on one unit per microgram as indicated by 
the increase in compound B per 100 ml. of plasma. This unit 
was designated a Ce U and was the unit used for graphing CRF 
activity in Ce 225, PC 120, IRC-50 19, PC 121 and CCD 52. 
Comparisons made between the CRF response of Ce 225, 13-14 
and synthetic lysine vasopressin indicate the plasma compound 
B levels at injections of 0.9 and 1.8 if of Ce 225, 13-14 were 
probably due to vasopressin present while the greater re­
sponses at the higher doses were due to contamination with 
oc-CRF. De Garihle et al. (18), Guillemin et, al. (37) and 
Schally et al. (109) reported an MSH activity for oc-CRF 
equal to 5-6x10® U/g. for the former and 0.1-0.3xl010 U/g. 
for the latter two groups of Investigators or 1-2# and 10-20# 
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of the activity of oc-MSH respectively. In a later continuous 
electrophoresis experiment not reported here, Miss Evelyn 
Weber found the greatest MSH activity In fractions 11-12 and 
13-14. It is not unlikely that fraction 13-14 of Ce 225 
would contain oc-CRF since it is a known contaminant of 
oc-MSH and active at minimum doses of 1-2T ( 13, 37, 109). 
The LVP and CRF peaks were superimposable as indicated 
in their separate assays in Ce 225. The LVP peak of Ce 226 
was found to occur in the identical position as In Ce 225 
and an approximate 5-fold vasopressin purification was found 
in both experiments. 
Considerable CRF activity occurred In fraction 17-18 
(LVP 12-4 U/mg.) of Ce 225 and a preparative paper chromato­
gram was conducted with a 10 mg. sample employing BAW (4:1:5) 
at 3-5°C. The eluates from 3 mm. segments of the developed 
chromatogram were analyzed by the Folln and ninhydrin methods 
and certain selected segments were assayed for LVP and CRF 
activity. Although the pressor peak was displaced to a higher 
Rp, 0.25, than the 0.11 and 0.12 reported previously (7, 99), 
both activities were superimposable with no separation evi­
dent. The higher Rp value may be a temperature dependent 
phenomena. 
The total material obtained at the LVP and CRF peak com­
prised of 47.5 mg. of Ce 225, 15-16 (LVP 50 U/mg.) and 26.9 
mg. of Ce 226, 15-16 (LVP 80 U/mg.) was subjected to chroma-
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tography on a column of Amberlite IRC-50 resin buffered at 
pH 6.41 with 0.5 M ammonium acetate. This technique was 
known to produce a highly purified lysine vasopressin in our 
hands (see IRC-50 18) and was based essentially on the method 
of Light et al. (68) except that the temperature of the ex­
periment was lowered to 3-5°C. The Folln analysis revealed 
a large peak with a small shoulder on the descending slope 
occurring at the hold-up volume and a well-defined symmetrical 
peak at 3.2 hold-up volumes. Weight recovery of the column 
was 67% whereas the pressor recovery was about 30#. Fraction 
3, 8.3 mg., gave a pressor activity of 160 U/mg. and an ex­
cellent CRF response at 0.17 f • Fraction 1 gave a CRF re­
sponse at 60Y which could not be explained by the vasopressin 
Injected. An MSH assay on that fraction showed strong activ­
ity present which may reveal the presence of oc-MSH and 
oc-CRF. A similar MSH assay on fraction 3 gave a response 
equal to 6%.5 U/mg., comparatively small and perhaps due to 
a tailing off of peak 1. The tubes selected for CRF and LVP. 
assays in peak 3 indicated no separation of these activities; 
however, the activity curve did not coincide with the Folln 
analysis, showing heterogeneity of the material. This was 
further corroborated by paper chromatography, which showed 
the presence of four ninhydrin positive components. 
Paper chromatography followed by electrophoresis showed 
a large ninhydrin positive area at an Rp of 0.2 and a distance 
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of 18.8 cm. The lower third of this spot was a yellow color 
when sprayed with ninhydrin, which could be due to proline 
containing peptide contaminants besides lysine vasopressin. 
Another light spot appeared at Rp 0.16 and 6.9 cm. 
Schally et al. (115) used an acetone:water (3:2 v/v) 
paper chromatography system in their preparation of a highly 
purified CRF fraction. A 2 mg. quantity of IRC-50 19 peak 3 
was streaked on a paper chromatogram (PC 121) and developed 
in the Schally system with the exception that urea was not 
used (108). A ninhydrin-sprayed center strip showed a pre­
dominant area at Rp 0.73 and a very lightly stained area at 
0.o4. The chromatogram was cut into 1 cm. segments which were 
eluted; the eluant was then used for LVP and CRF assays as 
well as for ninhydrin and Folln analysis. The CRF and LVP 
activity curves coincide with each other and with the nin­
hydrin and Folln curves within experimental error; therefore, 
no separation of the two activities was observed. Inactiva-
tion of the pressor and CRF activity occurred to the extent 
of 85/» in this experiment, the identical percentage of pressor 
inactivation obtained when a sample of the same starting mate­
rial was allowed to remain dissolved in an acetone:water solu­
tion for the same time and temperature. Schally (108) also 
noted this Inactivation; it is difficult to suggest reasons 
other than possible oxidation effects or disruption in the 
tertiary structure of the molecule (93). Schally et al. 
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(115) reported an Rp of 0.69 for lysine vasopressin and a 
value of 0.-35-0.46 for CRF. The vasopressin peak In this 
experiment had an Rp of 0.73 and the CRF activity found at an 
Rp of 0.47 could be explained by vasopressin contamination. 
A countercurrent distribution (CCD 52) was conducted on 
2.5 mg. of IRC-50 19, peak 3 In sec-butanol-0.5# TCA for 130 
transfers at 3-5°C. The greatest amount of material, as re­
vealed by Folln and ninhydrin analysis, occurred at a K value 
of 0.646. Pressor and CRF assays were performed on the lower 
phase of tubes selected from this area. Two separate CRF 
assays indicated that no observable separation of CRF activ­
ity from the pressor activity curve was obtained. Further, 
the vasopressin curve fitted a theoretical curve calculated 
for a K of 0.646 precisely for the descending slope but with 
slight deviation on the lower arm of the ascending slope. 
Unfortunately, such poor results were obtained in the 
ninhydrin and Folln analysis that very little correlation 
between them could be made. The entire peak covered a range 
of roughly 0.1 on the optical density scale for both analyses 
and the variations In the base lines were great enough to 
give results of dubious significance. However, the analyses 
indicate the presence of very little material in this area 
other than the CRF and LVP active component or components. 
Recovery of CRF activity calculated by summation of the 
assay curve equalled 66# in the 7-29-60 assay and 100# in the 
8-19-60 assay. The pressor recovery amounted to 94#. 
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The material isolated from tubes 46-59, assayed for 
pressor activity, gave a response of 120-150 U/mg. This value 
should probably be higher since the accuracy of the amount 
weighed for assay was questionable. At any rate it indicates 
a material of pressor content nearly equal to the starting 
material, IRC-50 19, peak 3 (LVP = 160 U/mg.). 
An amino acid analysis was performed on fraction 2 of 
CCD 52 using the procedure of Spackman et al. (123). Such a 
small amount of material was used that the limits of preci­
sion of the method were approached; a precision of 100+3# for 
loads from 0.1 to 3.0 micromoles of each amino acid is pos­
sible with the automatic recording apparatus. The manual 
operation employed here had greater inherent technical errors 
and the precision would probably be less. The size of the 
sample calculated from the amino acid analysis was about 
0-25 mg. A weight of approximately 1 mg., obtained on a 
humid day with a microbalance, was recorded for the sample; 
however, moisture and probably TCA from the solvent employed 
in the countercurrent distribution may have been present. 
The amino acids found are those contained in lysine — -
vasopressin in approximately equimolar quantities with the 
exception of serine. The tyrosine peak was contaminated and 
the value reported was only an approximation and should prob­
ably be higher. When based on a milliliter sample of hydroly-
sate, the LVP amino acids appear in 0.12>AM quantities while 
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serine was 0.041. If, as the pressor assay indicates, lysine 
vasopressin comprised 57> of the analyzed sample then a pep­
tide containing serine and all of the other amino acids 
except cystine found in 0.04 micromolnr quantities would ex­
plain the results obtained. The contaminant, probably CRF, 
would contain the following amino acids: aspartic acid, 
serine, glutamic acid, proline, glycine, phenylalanine, lysine 
and possibly tyrosine. Schally et al. (115) reported the same 
amino acids for their CRF plus cystine, alanine and histidine 
but no tyrosine. Schally (108) also reported the destruction 
of CRF activity cy thioglycolate treatment which is known to 
reduce the disulfide cridge of vasopressin. 
It appeared unlikely that the CRF of Schally et al. 
(116) could ce identical to the serine containing contaminant 
found in CCD b2, peek 2. It is more likely that peak 2 of 
CCD 52 was highly purified lysine vasopressin with a small 
peptide contaminant containing serine end perhaps proline and 
glycine in small amounts. 
If the weight and pressor content of the sample analyzed 
for amino acids vere more accurately known then the molar 
quantities of the amino acids present in the lysine vasopres­
sin could be calculated. Also if the tyrosine content of the 
sample were less doubtful s move definitive statement of the 
nature of CCD c&, peak 2 could be made. However even with 
these uncertainties taken into consideration, it seems un-
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likely that any but the amino acids present in lysine vaso­
pressin were contained in the CRF active material of that 
fraction. 
Schally ejt al. (115) used a m-cresol:water solvent system 
to separate lysine vasopressin from CRF by paper chromato­
graphy . A ^-dimensional paper chromatogram using BAW (4:1:5) 
followed by m-cresol:water (95:5) gave three distinct nin­
hydrin positive spots for IRC-50 19, peak 3. The Rp1s were 
0, 0 for one spot; 0.30, 0 for the second; and 0.35, solvent 
front (with tailing) for the third in the two systems. 
Since two of the spots did not move in the m-oresol:water 
direction, this solvent system was employed in an attempt to 
separate the CRF and lysine vasopressin activities as reported 
by Schally ert al. (115). These investigators reported Rp 
values of 0.85 and 0.46-0.64 for lysine vasopressin and CRF 
respectively at room temperature. The remaining sample of 
IRC-50 19, peak 3 was dissolved in 50 A ..of water and a 10 X 
aliquot was set aside for a pressor assay. The remainder was 
chromatogrammed (PC 12%) in m-cresol:water (95:5) for 13.5 
hours at 3-5°C• The paper was divided into three segments 
having Rp areas of 0-0.33 (fraction 1), 0.33-0.66 (fraction 
2) and 0.66-1.0 (fraction 3) which were extracted with oold 
dilute acetic acid. The extracts were lyophilized, re-ex­
tracted and centrifuges to remove the paper and lint and 
relyophilized. A pressor assay showed 66.5% of the activity 
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in fraction 1, 9.7# In fraction 2 and 23.8# in fraction 3 
based on an overall recovery of 54.8# of the original activ­
ity. Schally (108) and his co-workers (115) do not mention 
this splitting of the pressor activity. The pressor content 
of fraction 2 probably resulted from the long tailing ob­
served for the material in fraction 3. Aronoff (8) found a 
plurality of spots resulting when lysine was chromatographed 
in a saturated phenol:water system depending on the pH of the 
aliquot of the sample spotted. The possibility that lysine 
vasopressin may behave in a similar fashion in m-cresol:water 
exists but unfortunately no further experiments have yet been 
conducted to check this observation or to examine the phenom­
ena more completely. 
The CRF assay of the three fractions was conducted at 
a constant pressor level of 10 mU- Fraction 2 gave a 107# 
increase at 10.2 mU of lysine vasopressin while fraction 1 
and 3 at 10 mU and 9.9 mU gave 56.4# and 30# respectively. 
In every case, the elicited response is too great for the 
vasopressin injected but peaks 1 and 3 may be within experi­
mental error of the assay which is further complicated by 
extremely low controls. The activity found for fraction 2, 
if not due to a poor assay, may be due entirely to vasopressin 
within the experimental variation of the assay. It could also 
indicate the presence of a CRF, probably the /3-CRF of 
Guillemin _et al. (37) and Schally ejt al. (109). It will be 
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recalled that the starting material, IRC-50 19, peak -3, con­
tained MSH activity of approximately 25 U/mg. Guillemin et 
al. (37) reported an MSH activity of 0.1-0.3x10^ U/mg. for 
oc-CRF. If one assumes that all of this MSH activity resulted 
from the presence of oc-CRF, then approximately 25T of 
oc-CRF was in the 2 mg. of starting material employed on the 
chromatogram. Also, if all of the oc-CRF was in fraction 2, 
the quantity of oc-CRF Injected would be about 0.02T which is 
far below the minimal effective dose of 1-2 Y reported for 
this material (19, 37, 109). De G-arihle et aJL. (19) gave a 
lower value of 5-6x10^ U/mg. of MSH activity in their CRF 
fraction, however this would result in only 0.08 Y injected 
which is still too small a dose to give a response. 
If the CRF assay was reliable, PC 122 revealed the 
presence of a highly active CRF material which is not lysine 
vasopressin or oc-CRF and which agree with the published data 
on /3 -CRF (37, 108, 109, 115). 
In only one instance after a continuous electrophoresis 
purification step was there found a response of over 185% 
increase for unknown samples at injections of 30 mU of vaso­
pressin . This strange fact coupled with the inability to 
achieve a separation of CRF and pressor activity led to an in­
vestigation of the effects of synthetic lysine vasopressin 
in the CRF assay at various dose levels. Injections of 33.5 
mU of synthetic lysine vasopressin, 262 U/mg., gave a response 
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of 14.7+1.4 Y of compound B per 100 ml. of plasma compared to 
8.1+0.8Y of compound B per 100 ml. of plasma In the controls. 
The response was an 81+18/6 increase over the non-injected 
animals• 
Table 1 gives a compiled listing of the results of CRF 
assays performed on various fractions during the purification 
procedure from Ce 226 to CCD 52. The response of IRC-50 19, 
peak 1 is undoubtedly due, in part, to the presence of oc-CRF 
for the reasons previously discussed. The percent increase 
reported for PC 121, tube 14, can be attributed solely to the 
vasopressin injected. Except for those two fractions, the 
response varied from 38.2 to 185# for injections of 30 mU of 
pressor activity. An interesting fact arises from the assays 
conducted approximately 3 weeks apart on selected tubes of 
CCD 52- The CRF assay of 8/19/60 gave percent increases of 
98.5, l?o, lDii and 148 for tubes 43, 47, 51 and 55 respec­
tively while the 7/29/60 assay resulted in values of 82, 92.5, 
86.5 and 66.8 for the same tuoes. The absolute values of 
these figures maybe questioned because the control reported 
for the assay of 7/29/60 was the result of averaging three 
previous controls obtained in prior assays to the one used 
here. However such a divergence of values exist that vari­
ation of the controls would probably not explain the discrep­
ancy. Since the later assay gave the higher values, arguments 
of possible inactivation were ruled out and it is unlikely 
Table 1. CRF assay of fractions obtained in purification procedure 
LVP 
Fraction U/ml. LVP B No. of B No. of 
or tube If/inj. or mg.* mU/lnj. control rats response rats AB . % inc. 
Ce 2&6 
13-14 1.8 17.4* 31 6.3+1.5 (4) 15.3+1.8 (5) 9.05 145 
15-16 0-6 50.0* 30 lb.5+2-3 (5) 9.2 150 
PC IkO 
14 10.5 25 7.3+0.5 (5) 10.8+.4 
IRC-50 19 
1 60 0.48* 30 4.6+0.6 (5) 24.6+1.3 
2 3 8* 24 5.7+0.85 (3) 11-75+0.3 
3 0.17 160* 27 4.6 13.1+2.5 
IRC-50 19 
Peak 3 
86 49 29 6.0+0.9 (4) 12.3+2.0 
91 66 31.5 6.0+0.9 11.1+1.2 
96 92 30 6.0+0.9 8;3+2.8 
96 91 30 4.6+0.4 (5) 9.0+1.3 
PC Izl , v 
14 0.2 17.1 6.4+0.6 (2) 8.4+0.8 
20 0.7 30 7.6+0.4 (4) 12.25+0.9 
22 4.3 30 6.4 18..0+2.5 
24 0.2 30 7.6 11.8+1.6 
(5) 3.5 50 
(5) 20.0 435 
(3) 6.05 108 
(5) 8.05 185 
(4) 6.3 105 
(4) 5.1 85 
(4) 2.3 38 
(5) 4.75 95 
(5) 2.0 31 
(4) 4.65 61 
(4) 11.6 181 
(3) 4.2 55 
Table 1. (Continued) 
Fraction 
or tube 
LVP 
U/ml. 
T/inj . or mg .* 
LVP 
mU/lnj 
B Ko. of 
. control rats 
B 
response 
No . of 
rats AB % lnc 
C C D  5 2  
7/29/60 
6 . 6 ( calc. )  ( 3 )  4 3  1 0 . 6  3 0  1 2 . 0 + 1 . 6 5  5 . 4  8 2  
4 7  1 6  29 H  1 2 - 7 + 1 . 3  ( 4 )  6 . 1  9 2 .  
5 1  2 2  28 i i  1 2 . 3 + 1 . 4  ( 3 )  5 . 7  8 6 .  
5 5  1 5  3 0  i i  1 1 . 0 + 2 . 8  ( 3 )  4.4 66.1 
5 9  4 . 4  30 n 1 1 . 6 + 0 . 6  ( 4 )  5  . 0  7 6  
b / 1 9 / 6 0  
7 . 1 + 1 . 0  ( 4 )  ( 3 )  4 3  1 0 . 6  3 0  1 4 . 1 + 2 . 4  7.0 9 8 .  
4 7  1 6  3 0  n  1 9 . 5 + 2 . 3  ( 3 )  1 2 . 4  1 7 5  
5 1  2 2  3 0  H  1 7 . 9 + 2 . 4  ( 4 )  1 0 . 8  152 
5 5  1 5  3 1  n  1 7 . 6 + 4 . 7  ( 4 )  1 0 . 5  148 
63 
that potentiation could have occurred. A variation of the 
same order was found in the assay of IRC-50 19, tube 96. If 
the assay has a variation of the magnitude cited here then it 
would appear that the responses obtained for IRC-50 19, frac­
tion 3 and subsequent isolation procedures would be due solely 
to lysine vasopressin unless inactivation of a CRF active 
material occurred; if so, /3 -CRF does not exist. It is inter­
esting to find that an average value obtained for the controls 
was 6.5, with an average response of micrograms of plasma 
compound B of 13-12 giving an average Increase of 105% for 
the 21 assays used in the computations. These very closely 
approximate the values obtained for synthetic lysine vaso­
pressin. 
The investigations reported here showed l) a peptide 
fraction containing lysine v asopressin has strong CRF activity 
at doses of 0-17Y ; 2) a less active peptide, oc-CRF, possess­
ing MSH activity also exists; 3) /3-CRF, if it exists, could 
not be separated from lysine vasopressin when subjected to 
ion-exchange column chromatography, paper chromatography, 
countercurrent distribution and paper electrophoresis; 4) 
none of the fractions obtained here, and elsewhere (19, 37, 
74, 97, 99, 109) have demonstrated a minimal effective dose 
equal to the 30-40 millimicrograms (10 mU) found for synthetic 
lysine vasopressin; and 5) lysine vasopressin appears to be 
as active as, if not more so, than the reported /3-CRF (37, 
109) and since it occurs in greater quantity is probably 
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"the11 CRF physiologically important. 
From an anatomical consideration, vasopressin fits the 
needs of a neurohumor in higher vertebrates, being synthesized 
in the supraoptic and paraventricular nuclei of the hypo­
thalamus and moving down the nerve tract to the posterior lobe 
of the pituitary (116). However, recent elegant studies by 
Sachs (101, ICE) present data which appear to be inconsistent 
with a simple homogeneous two-compartment system as a theory 
of neurosecretion. Daniel and Pritchard (17) reported ob­
servation of short portal vessels which arise in the neural 
lobe and drain blood to the pars distalis and more recent work 
by Holmes and Zuckermann {5'c) showed a vascular connection 
between the neural process and the pars distalis in the female 
rhesus monkey. Metuzals (78) in a detailed neurohistological 
investigation of the cat observed numerous nerve fiber bundles 
in the external layer of the median eminence oriented per­
pendicular to the pars tuberalis. It was concluded that the 
hypothalamic final common path is constructed: 
(a) of neurons which extend into the adenohypo-
physis and terminate probably au.ong the gland 
cells, and (b) of neurons which terminate In 
the external layer of the emlnentla and estab­
lish contact with the gland cells of the adeno-
hypophysia through the hypophysical portal 
vessels. (78, p. 1£3) 
The last three works cited indicate the ease with which vaso­
pressin might reach the adenohypophysis and act to stimulate 
corticotropin release. 
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If vasopressin is to be "the" corticotropin-releasing 
factor, then instances of neurotropic stress should be accom­
panied by responses associated with that hormone, that is, 
antidiuretic activity and increase of blood pressure should 
occur. Mirsky et al. (80), after showing the antidiuretic 
activity of the plasma of normal rats exposed to a variety 
of noxious stimuli, found a marked Increase in the antidiure­
tic activity of the plasma in adrenolectomlzed and hypophy-
sectomized rats exposed to identical noxious stimuli implying 
that neither gland is the source of the responsible factor. 
Casentini et al. (13) in their study of corticotropin release 
in 1959, review the role of ADH in the 11 stress11 reaction, and 
suggest ADH as the neurohumoral substance which stimulates 
the release of ACTH. McDonald et al. (75) investigated the 
effects of fluid deprivation, hypertonic saline, nicotine, 
hand immersion in ice water and insulin induced hypoglycemia 
as stressing conditions in human subjects. An antidiuresis 
occurred under the first four conditions without observation 
of a concomitant release of ACTH. In the five subjects sel­
ected for insulin induced hypoglycemia, a maximum fall of 
blood sugar (54 mg./100 ml.) occurred after an intravenous 
injection of 0.1 U/kg. body weight• One subject gave a con­
current rise in urine osmolality and plasma hydrocortisone, 
three subjects gave a rise in plasma hydrocortisone but no 
increase in osmolality while the remaining subject gave an 
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Increased osmolality and no rise in plasma hydrocortisone. 
The data were interpreted as Indicating an ACTH release with­
out an increase in ADH. However, I to and Machido (56) re­
ported a decrease of ADH content in rat pituitary gland and 
an increase of the antidiuretic substance content in the serum 
after an insulin injection. Miller and Bogdonoff (79), in 
their investigation of the antidiuresis induced by insulin 
injection (20 U i.v.) into human males (45-75 years), con­
cluded that insulin, either directly or indirectly, stimu­
lates the renal tubule to reabsorb filtrate hypotonic to the 
plasma and that the antidiuretic effect is not mediated 
through the pituitary-ADH-distal tubule cycle. In his re­
view, Iv'irz ( 135) proposes a) the descending limb of the 
loop ; b) the distal convoluted tubules; and c) the collecting 
ducts, as the sites of antidiuretic hormone action in the 
mammalian kidney• 
The discrepancy in the experimental evidence cited (56, 
79) for the action of insulin upon antidiuresis places the 
observation by McDonald e^t al. ( 73) in some doubt and further 
investigations into the mechanism of the antidiuresis in 
normal and hypophysectomized animals should be conducted. 
Perhaps the phenomena may be partly due to the difference in 
the insulin dose level employed by these investigators. 
The experiments conducted by McDonald et al. (73) and 
Nichols and Guillemin (84) which show a release of antl-
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diuretic hormone and no concomitant release' of ACTH as meas­
ured by an increase in plasma free blood steroids can probably 
be explained by a difference in the sensitivity of the target 
sites. Nichols and Guillemin (84) argue that a factor of 
3 3 3.5x10 to 7.1x10 exists between maximal antidiuresis and 
the threshold dose of lysine vasopressin for ACTH release. 
Recent studies in this laboratory (133), also reported here, 
indicate that 10 mU of synthetic lysine vasopressin is the 
minimal effective dose necessary for ACTH stimulation in the 
nembutal-morphine blocked rat. Vasopressin in the rat Is 
usually measured by the blood pressure response elicited by 
doses between 4 and 8 mU (£0). Nagareda and Gaunt (83) found 
that 5 mU of pitressin injected intraperitoneally into rats 
had no effect on adrenal ascorbic acid but did exert definite 
physiological actions such as antidiuresis, chloruresis and 
natriuresls. Therefore, there is sufficient experimental 
evidence (20, 83, 133) to show that the antidiuretic and 
pressor activity of vasopressin occur at lower dose levels 
than those required for ACTH release. 
Nichols and Guillemin (84) also measured the 17-hydroxy-
corticosteroia levels of blood samples from dogs in various 
stages of hydration and diuresis. They reported an inhibition 
of the release of ADH simultaneously with evidence of stimu­
lation of ACTH release. Of the approximately 60 experiments 
cited only six show a maximal diuresis (4-10 ml. urine/min.) 
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during some of the highest levels of 17-OHC (8-18T/100 ml.) 
observed. The control values obtained on approximately 150 
single determinations for normal (resting) concentrations of 
17-OHC were 0 to 8 Y/100 ml. of plasma. The observations of 
Nichols and Guillemin may be explained in part by the find­
ings of Nagareda and Gaunt (83) in the rat. They suggest 
that a small amount of body water may be eliminated by a 
suppression of the secretion of ADH but a larger water load 
causes an increased adrenal cortical hormone secretion which 
augments the diuretic response. Verification and further in­
vestigation of the observations reported by Nichols and 
Guillemin (84) would be desirable. 
Recently Kwaan and Bartlestone (60) found a definite 
increase in adrenal 17-hydroxycorticosteroid output in dogs 
with intraventricular injections of 2 mU of synthetic arginine 
vasopressin. A similar injection of oxytocin or the vehicle 
alone failed to increase adrenal corticosteroid output. Since 
an intravenous injection of 20 mU of AVP did not affect the 
hydroxycorticosteroid level, the increase of corticosteroid 
level due to the 2 mU of AVP placed in the third ventricle 
was no-t caused through a peripheral action. Intraventricular 
injections of 5 micromicrograms of either arginine vasotocin 
(arginine oxytocin) or oxypressin (leucine vasopressin) did 
not produce a significant increase in hydroxycorticosterone 
output. 
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If a pressor activity of 480 U/mg. is assumed for the 
AVP used in the study by Kwaan and Bartlestone (60), then a 
dose of 4.17 millimlcrograms was used in the injection. This 
is far more active than any of the partially purified CRF 
preparations assayed in vitro (36) and as active as a highly 
purified CRF reported by Schally et al. (115). It also far 
exceeds the activity of the purest preparation of oc-CRF 
(M.E.D. 2-3 Y in vivo or 0.5 Y in vitro) and /3-CRF (M.E.D. 
0.1 Y in vivo or 0.05 Y in vitro) reported from the Guillemin 
laboratory (37, 109). 
In conclusion, it would appear that vasopressin satisfies 
almost all of the physiological evidence encountered in ex­
perimental observations of the neurotropic stressing stimuli 
and exhibits properties consistent with a role as "the physio­
logical corticotropin-releasing factor". 
An Evaluation of the Published Data 
Comparisons and reconciliation of the experiments per­
formed in this field are frustrated by the many different 
assays employed to measure CRF activity and antidiuretic 
activity. Species differences of starting material used for 
preparation of CRF, and the use of preparations of widely vary­
ing degrees of purification also complicate the problem. 
Schally (115) was not able to confirm work reported by 
Slusher and Roberts (121). However, if the CRF active lipid 
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or lipoprotein material reported by Slusher and Roberts (121) 
were contaminated with peptides, then the ACTH-releasing, 
ninhydrin-positive substance found in an acetone extract of 
beef hypothalamus by Rumsfield and Porter (99) may have con­
tained the same substance. A D fraction prepared from porcine 
hypothalamus gave CRF active ninhydrin-positive material as 
reported in this thesis. 
The purification studies of Saffran and his coworkers 
(103, 104, 105, 108, 115) resulted in a CRF active at 1 milli-
microgram as determined by the In vitro assay; that is more 
active than any other CRF preparation reported since (36, 60, 
109, this thesis). Schally (115) reported synthetic lysine 
vasopressin active at a dose of 0.07y<g. whereas Guillemin 
and Ward as quoted by Guillemln and Schally (36, p. 560), 
using the same In vitro assay method, report a minimal active 
dose of l.Q/*.g. for lysine vasopressin and 2.0yUg. for argl-
nine vasopressin. The CRF activity of the vasopressins found 
In the recent in vitro studies contradict the observations of 
Guillemln and Hearn (32) and cast doubt on the results ob­
tained in their early tissue culture studies in which a 4-day 
incubation was employed. 
Fortier and Ward (26) claimed a ready inactivatlon of 
ACTH on incubation and suggested that the increased release 
of ACTH may reflect a leakage and not a true secretion of the 
hormone. Therefore results based on the rate of ACTH release 
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In the in vitro assay "should be interpreted with extreme 
caution". Roberts (94), in his study of the corticosteroid-
releasing activity of blood concluded that the in vitro assay 
for ACTH may be both "non-specific and non-responsive in the 
presence of interfering protein or protein-bound substances11. 
Having found evidence that ACTH-release by pituitary tissue 
may also be non-specific, he questioned the significance of 
the work on CRF using the in vitro assay• Guillemin and 
Schally (36), in answer to these objections, found no detect­
able destruction of ACTH activity, no potentiation of ACTH or 
inherent ACTH activity by CRF preparations, a high specificity 
and complete agreement of CRF characterization between data 
obtained by In vivo and in vitro assay systems. These in­
vestigators admitted limitations of the method in its inabil­
ity to show linear responses to increasing doses of purified 
CRF. The in vitro assay of Swingle et al. (128) was admitted­
ly found to be non-specific and Irreproducible by the authors 
themselves in an addendum to their reprints, reported by 
Guillemin and Schally (36). 
Since Kwaan and Bartlestone (60) were able to show a CRF 
activity for 2 mil (ça. 0.004/ig• ) of synthetic arginine vaso­
pressin injected intraventricularly, it would be expected 
that the in vitro assay should approximate this activity. 
The fact that it does not suggests either an inactivation of 
the hormone during Incubation or an Inability of the hormone 
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to reach the secretory cells of the adenohypophysis concerned 
with the synthesis of ACTH. Experiments designed to measure 
the inactivatlon of vasopressin alone and as its neurophyslne 
complex (7) in the in vitro system would be very valuable in 
testing this possibility. 
Guillemin et al. (34) reported that their CRF active 
fraction D contained MSH activity and a pressor activity of 
43 mU/mg. If it is assumed that D contained at least 62.5 U 
of MSH activity in the a-4 Y usually tested for in the Land-
grebe and Waring assay, and if it is also assumed that this 
activity was due to a-CRF (MSH activity 0.1-0.3x10^ U/mg.) 
(37, 109), D could contain approximately lr of oc-CRF in a 
100r dose which would explain the CRF activity of this mate­
rial. It was possible that the DA fraction contained all 
of the vasopressin and oc-CRF contained in the D material 
since Sideman and Sobel (120) reported the rapid mobility of 
lysine vasopressin on paper electrophoresis and Schally et 
al. (110) found the vasopressin and oc-MSH active areas at 
nearly the same mobility in zone electrophoresis. Lee (62) 
also indicated a rapid mobility for oc-MSH in zone electro­
phoresis on starch. It is possible therefore, for the DA 
material reported in the publication (34) to contain 1-5.25 
mU/r of lysine vasopressin and a fair amount of oc-CRF. If 
the in vitro assay is 2-4 times more sensitive than the in 
vivo assay as reported by Guillemin and his co-workers (37, 
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109) for the ce- and /3 -CRF, then the activity of D and DZX 
can be easily explained by the presence of oc-CRF and lysine 
vasopressin. 
The early work performed by Porter and Rumsfleld (73, 90, 
100) on portal vessel plasma and the protein fraction IIIQ can 
probably be explained by the presence of vasopressin and its 
protein complex (7). No pressor assays were obtained on 
their active fractions but chemical inactivations performed 
are consistent with the known behavior of vasopressin (120). 
The active fraction prepared from an acetone extraction of 
beef hypothalamus followed by column chromatography (99) gave 
two spots of Rji 0.41 and 0.64 in BAW (4:1:5). Schally et al. 
(110) reported an Rp of 0.61 for oc-MSH in that system and 
because oc-CRF contaminates a-MSH and has its partitioning 
characteristics (37, 38, 109), Porter and Rumsfleld (99) prob­
ably have isolated oc-CRF. An MSH assay and amino acid anal­
ysis of the CRF active material wculd conclusively prove the 
identity of the Rp 0.61 material and its relationship to 
oc-CRF. There is no doubt of the presence of d-MSH in bovine 
and 1 ts identical structure to the oc-MSH of porcine source 
(27). 
The activity of the beef stalk-median eminence extracts 
found by Royce and Sayer could not be attributed to ACTH or 
A VP (96) or a potentiation of ACTH by vasopressin (95). A 
curious result unexplained in the published report (96) was 
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obtained in the pepsin inactivatlon experiment. Table 2 
shows the assay results reported. It will be noted that in 
SME extract, A-23, there are 42 mU (Exp. 6a) of pressor activ­
ity which should give an approximate response of 50 mg./ 
100 gnu of AAAD (Exp. 3) in the ME lesioned rat. The hypo-
physectomized rat shows 39+12 mg./llO gm. of AAAD due to ACTH 
contamination (Exp. 6a), therefore not more than 30-40/6 of 
the ME lesioned rat response could have been due to the CRF 
present in SME extract A-23. Royce and Bayers (97) reported 
that an intravenous dose of 0.025 stalk-median eminence unit 
contained 24-53f of protein. Experiments 6c,d,e indicate 
that neither the pressor or corticotropin activity were 
destroyed by pepsin. If the assays are to be consistent, 
the ME lesioned ret should give a response approximating the 
sum of those two activities, or about 80 mg./lOO gm. of AAAD. 
SME extract, A-23, after pepsin treatment gives only 49+9 
mg./100 gm. of AAAD in Exp. 6c. The CRF activity of extract 
A-23 was probably due to oc-CRF although no MS H assays were 
performed. The hormone, oc-MSH, is known to be present in 
beef (27) and is probably susceptible to hydrolysis by pepsin 
since Harris and Roos (46) used that enzyme to cleave /s-MSH, 
a structural congener. At the present time, oc-CRF is 
thought to resemble oc-MSH because of the difficulty in sep­
aration, high inherent MSH activity and amino acid content 
and sequence (113). Royce and Sayers (98) further purified 
Table 2- Adrenal ascorbic acid depletion in acute median eminence (ME) 
lesioned rats following ACTH, pltressin or stalk-median eminence 
(SME) extracts 
Dose In Adrenal ascorbic depletion 
Exp. Material fraction of Pressor (mg./lOO g• ) 
no. injected SME unit activity, mU Hypox. ME lesioned 
2 a. ACTH, .5 mU 58+6a(20)b 50+12 (13) 
b. ACTH, 2-0 mU 139+5 (14) 150+7 (13) 
3 a. Pltressin 5000 77+11 (9) 172+8 (7) 
b. Pltressin 500 144+11 (5) 
c. Pltressin 100 5+13 (5) 90+15 (8) 
d. Pltressin 20 14+8 (9) 
6 b. SME extract, A-%3 0 .025 42 (35 to 50)C 39+12(11) 117+6 (15) 
c. Idem + pepsin 0 .025 46 (34 to 63 )c 31+10 (6) 49+9 (11) 
d. Idem + ACTH, 1.0 mU 0 .025 141+14 (5) 
e. Idem + pepsin 0 .025 171+7 (5) 
aMean and standard error. 
^Number of animals. 
^Potency with 95# fiducial limits. 
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their SME extracts on a carboxymethyl cellulose column employ­
ing stepwise gradient elution. Corticotropin-releasing frac­
tions were obtained at fractions corresponding to 0.01 and 
< 
0.10 >1 ammonium acetate buffer. The dose of each fraction 
used in the assay systems was equivalent to 0.3 SME or approx­
imately 4-5 nf of protein for the 0.1 M fraction. The criti­
cisms of Schally e_t al. (109) of Royce and Bayers (98) and 
the operation of their column are generally agreed with, al­
though if the 0.01 M fraction resulted from overloading the 
column it should have contained pressor activity which was 
shown to be absent. Royce and Bayers (96) also found no dif­
ference in the sensitivity of the lesioned 'and hypophysec-
tomized rat to ACTH contrary to the published results of 
Guillemin et al. (30) and McCann and Haberland (74); the 
latter two groups disagree on the magnitude of the differ­
ence, however. 
McCann and Haberland (74) repeated the work of Royce and 
Sayers (96) and were in essential agreement with the published 
data except for their inability to repeat the oxycellulose 
behavior of their CRF active extract. They attribute 96# of 
the activity of Royce and Sayers (98) purified 0.1 M fraction 
to a corticotropin-releaslng factor other than vasopressin. 
The purified CRF was inactive In the Porter and Jones assay 
(89) which might have been due to the demonstrated decreased 
sensitivity of this assay (21, 74). 
77 
There appears to be little doubt that De Garihle and his 
coworkers ( 18, 19, 42) were isolating the oc-CRF (109). 
The /3-CRF prepared from a highly purified lysine vaso­
pressin (LVP > 300 mU/mg.) by Guillemin et, al. (37) and 
Schally et al. (109) by paper chromatography employed a 
m-cresol:water solvent system. The minimal effective dose 
of this material in the in vivo assay was found to be O.IT . 
Weber and Hearn (133) have found that synthetic lysine vaso­
pressin (LVP = 262 U/mg.) had a minimal effective dose of 
10 mU (0.04T ) in the identical in vivo assay. In the pub­
lication in which Guillemin et al. (30) reported the CRF 
activity of lysine vasopressin to be ineffective below a 
"threshold of approximately 60-80 mU", a purified natural 
lysine vasopressin prepared by CMC chromatography and paper 
chromatography in m-cresol:water assaying 287 U/mg. was used. 
It is difficult to understand why /?-CRF was found in the 
more highly purified preparation (37, 109) and not in the 
preparation of lower pressor activity. 
Schally (108, p. 102) found a 40# Increase of ACTH re­
lease by a lysine vasopressin preparation (LVP = 200 U/mg.) 
az a level of 0.5T which was not considered statistically 
significant. After chromatography in the m-cresol:water 
system, no CRF activity was detected at doses of 0.2 and 0.5T. 
He reported (p. 120) that synthetic lysine vasopressin (LVP = 
300 U/mg.), which was active at 0.067if in the in vitro 
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assay, lost all of the CRF and most of the pressor activity 
after an attempted purification in m-cresol. The work re­
ported here (PC 122) indicated a strange splitting of the 
pressor activity of a purified vasopressin preparation (LVP = 
160 U/m.g) in the same m-cresol:water solvent system. 
Hilton and his coworkers (48) found that vasopressin 
lost most of its Cortisol stimulatory activation of the iso­
lated adrenal gland of the dog after 2 hours at room tempera­
ture in saline. However the pressor activity was maintained 
and no explanation of this activity separation was offered. 
Therefore, it Is possible that the m-cresol chromato­
graphy employed by Schally (108, 115) and the Schally and 
Guillemin laboratory (37, 109) may produce a pressor active 
but CRF inactive artifact of vasopressin or even the converse, 
a pressor inactive and CRF active material. 
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MATERIALS AM) METHODS 
Materials 
Armour posterior pituitary powder 
A gift of one pound of hog posterior pituitary lobe 
(Armour 851-25) was obtained through the courtesy of Dr. S. 
Steelman in 1956. This material had the appearance of a tan 
lyophillzed powder. It was not clear from correspondence with 
Armour that the fresh tissue had been acetone desiccated; 
therefore, 100 g. of this material was extracted three times 
at 3-5°C with 1500 ml. portions of anhydrous acetone, each 
extraction being carried out with constant stirring for two 
hours. A weight loss of only 8 g. indicated that the mate­
rial had probably been acetone extracted prior to shipping. 
Princeton hog posterior pituitary powder 
Several kilograms of material were donated by the Prince­
ton Laboratories Inc. of Princeton, New Jersey, over the 
period of 1957-1958. This material had a darker brown color 
than uhe Armour product, and was described in correspondence 
as acetone-desiccated, homogenized, lyophillzed hog posterior 
pituitary lobe powder. The label on the powder indicated an 
oxytocin and pltressin potency of about 1500 U/g. This prep­
aration served as a starting material for most of the succeed­
ing experiments. 
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Kamm extraction product 
The Initial extraction employed was essentially that of 
Kamm et al. (57) with minor modification. To 7 1. of 0.25% 
aqueous acetic acid (17.5 ml. glacial acetic acid and 6982 ml. 
distilled water) in a 12 1. round bottom Pyrex flask, was 
added 70 g. of posterior pituitary powder. The mixture was 
stirred by means of a motor-driven teflon paddle while being 
heated to 95° during a 30 minute period by means of a Glass-
col 12 1. heating mantle with both Variacs set at 120 volts. 
After the heating period the flask was transferred from the 
heating mantle to a sink filled with cold flowing tap water; 
stirring was continued until the mixture had cooled. After 
filtration with suction the solid residual was washed on the 
filter with 700 ml. of 0.25# acetic acid. The combined amber 
filtrate and washings were concentrated at reduced pressure 
to 700 ml. in a lc 1. round bottom flask heated to approxi­
mately 50-60° by the heating mantle (Variacs at 70-90 v); 
foaming was prevented by addition of one or two drops of Dow 
antifoaming agent B. Three hundred eighty-five g. of O.P. 
ammonium sulfate was dissolved in the cloudy concentrate with 
stirring and the solution allowed to stand in the cold for 
almost £4 hours. The resulting precipitate was collected by 
suction filtration, pressed dry on the filter, and then dried 
further over calcium chloride in a vacuum desiccator. The 
thoroughly dried precipitate was powdered in a mortar and 
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pestle and divided into four equal parts. Each portion was 
placed in a £50 ml. centrifuge bottle and extracted with 44 
ml. or glacial acetic acid by vigorous stirring, centrlfuga-
tion and careful decanting of the deep amber colored super­
nate • This process was repeated once on each portion and all 
of the supernates were combined in a 4 1. Pyrex beaker. Addi­
tion of 875 ml. of ethyl ether and 1750 ml. of Skelly A to the 
glacial acetic acid extract produced a white flocculent pre­
cipitate • This precipitate was allowed to settle out in the 
cold and the greater part of the supernate was decanted before 
filtration. The precipitate collected on the filter was dis­
solved in .300-400 ml. of ion-exchange water and the solution 
concentrated in vacuo on the rotary evaporator and lyophil­
lzed. Approximately 85 such extractions were performed to 
give yields of Kamm product (corresponding to Fraction B of 
Waring and Landgrebe (13%)) ranging from 0.37 g. to 8.7 g. 
with an average of about 4.7 g. This material assayed 4-5 
units/mg. of pressor activity and had the appearance of a 
light tan powder. 
Methanol extract of Kamm product 
Three grams of the Kamm product was put into a 250 ml. 
centrifuge tube, to which was added 7.5 ml. of ion-exchange 
water and enough glacial acetic acid, up to 30 drops, to dis­
solve the solid. To the dark amber solution was added 75 ml. 
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of absolute methanol; the white precipitate which formed was 
stirred well, centrlfuged, and washed twice with 15 ml. por­
tions of methanol;water (10:1) before discarding. The orig­
inal supernate and washings were combined, concentrated on 
the rotary evaporator, and finally lyophillzed in a 250 ml. 
round bottom flask. Yields from about 100 extractions ranged 
from 0.3 to 1.4 g. with an average yield of 0.8 g. or about 
go.?#. One experiment on recovery of pressor activity after 
methanol extraction of Pooled Kamm (10/9/59) gave the follow­
ing results. A sample of 2.0 g. of Kamm product gave 0.45 g. 
of methanol extract and 1.22 g. of a water extract of the 
methanol-insoluble residue. The original Kamm product had a 
pressor potency of 5.2 U/mg., the methanol extract assayed 
at 6 U/mg. and the water extract assayed at 12 U/mg. The 
total weight recovery was thus 83# and the pressor recovery 
166#. A more accurate recovery experiment is reported In 
the section on Fresh Tissue Posterior Pituitary (Jan.). 
Analytical Methods 
Nlnhydrln spray reagent 
A 0.1# (w/v) ninhdrin (triketohydrindene hydrate) solu­
tion in water-saturated n-butanol was sprayed on paper chroma-
tograms with an atomizer. The paper was hung in a 100-110° 
drying oven for approximately five minutes. Nlnhydrin-posi­
tive spots were preserved by further spraying with a solution 
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of dilute copper nitrate (1 ml. sat1d aq. Cu(N0g)g + 0.8ml. 
10/S v/v HNOg diluted to 100 ml. with ethanol) (11), convert­
ing the rapidly fading purple spots to more stable pink spots. 
Intensities of the ninhydrin positive areas were indicated 
by assigning an arbitrary unit of +4 to the spot of highest 
color and in descending order to +1 for the spot having the 
least color. 
Ninhydrin analysis of solutions 
Countercurrent distribution fractions The methods of 
v. Hofsuen (131) and of Stein and Moore (126) were both em­
ployed during the course of this work. The Hofsten method 
was preferred under the conditions of analysis reported here. 
The sample size was determined by the concentration of mate­
rial in the CCD machine; usually 1.0 ml. of each phase was 
taken from tubes in the machine and 1.0 ml. of the upper 
phase from tubes of the withdrawal segment of the distribu­
tion . In the latter case, an equal volume of lower phase was 
added to the sample being analyzed. One ml. of fresh or 
stored ninhydrin reagent was pipetted with a pipette, an 
automatic syringe or a pipetting machine Into the sample 
contained in an 18 x 150 mm. lipless test tube. The tubes 
in a test tube rack were covered with aluminum caps and 
heated in a covered boiling water bath for 15 minutes, cooled 
In running tap water and diluted with 3 ml. of an ethanol: 
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water (1:1) solution. Absorbancy at 570 mU was determined 
within one hour in a Bausch and Laumb Spectronic 20 against 
a distilled water flask with frequent checking of the in­
strument because of a tendency to drift. Attempts to obtain 
a precise Beer-Lambert curve from peptide sample FD 126, re­
gardless of the conditions employed, proved fruitless. In 
distributions in solvents containing high acid concentrations 
(CCD 39 and CCD 47), the samples were first neutralized with 
the calculated amount of 6 N sodium hydroxide. Whenever the 
absorbance was too high, further dilutions were made until 
valid spectrometer readings could be obtained. 
Papergram fractions Usually the unsprayed paper 
chromatograms were dried and cut Into segments which were 
placed in individual tubes containing a measured volume of 
either 0.25/6 acetic acid or ion exchange water. An aliquot 
from each tube, the volume of which varied with the load 
placed on the paper, was pipetted into an 18 x 150 mm. lipless 
test tube to which was added 1.0 ml. of the Hofsten (131) nin­
hydrin reagent, . Treatment of the s ample from this point was 
identical to the procedure described above for countercurrent 
distribution samples. 
Folin analysis 
Ammonium acetate buffer column fractions The method 
of Lowry et al. (70) was used, usually with 1.0 ml. of sample 
85 
but sometimes with smaller volumes. Four ml. of the Folin-
Lowry Reagent A was added to the sample and the contents of 
the tube mixed by shaking and let stand. The tube was shaken 
vigorously immediately after further addition of 0.4 ml. of 
Reagent E. After 30 minutes the absorbancy was determined 
with a Klett-Summerson colorimeter using a No. 66 filter. 
Fig. 4 shows the result of a Folin analysis of peptide sample 
FD 126, in 1.0 ml. of ion-exchange water end also 1.0 ml. of 
a 0.5 M ammonium acetate solution, pH 6.4; the buffered sample 
gave less color than the aqueous sample. 
Countercurrent distribution fractions Attempts to 
employ the procedure described above with samples containing 
alcohol solvents failed because of precipitation of a white 
solid. This precipitate would not always settle sufficiently 
to permit measurement of the absorbancy of the supernate. 
However, the method of Shepherd et al. (117) could be used 
directly as described; dilutions, when necessary, being made 
with water. As in ninhydrin analysis, equal volumes of both 
phases in a tube were taken, or an equal volume of lower phase 
was added to the sample from a withdrawl series tube. Fig. 4 
shows a curve prepared from a sample of FD 126 using the 
Shepherd technique, which shall be referred to as the cyclo-
hexane-Folln method. 
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Fig. 4. Folin analysis of FD 126 using buffered alcohol and aqueous solvents 
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Weight analysis 
All freshly lyophillzed fractions were weighed on either 
a single-pan Sartorlus Selector automatic balance or a chaln-
omatlc analytical balance• The hygroscopic character of pep­
tide fractions, especially during the humid summer- months, 
made accurate weightings difficult. Some assay samples of 
less than 500><.g. were weighed on an Ainsworth micro-balance, 
type FDJ . 
Paper chromatography 
Paper chromatography was used routinely to follow frac­
tionation progress by revealing the complexity of fractions 
with regard to the number of ninhydrin positive components. 
Samples were applied to Whatman No. 1 paper of an appropriate 
size with a glass capillary tube drawn to a fine tip. Paper-
grams were developed using the ascending technique with either 
of two solvent systems: l) n-butanol:acetic acid:water (BAW 
4:1:1) or 2) n-butanol:acetic acid:water (BAW 4:1:5). Solvent 
BAW (4:1:1) is completely miscible and papers could be placed 
in the tank, a cylindrical Pyrex jar with a light-fitting, 
greased glass lid, after a short period of equilibration of 
solvent vapors in the tank. For solvent BAW (4:1:5), the two 
phases were allowed to equilibrate at the temperature of the 
room in which the chromatograms were to be developed and the 
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upper layer was added to the chromatography tank. A separate 
container of lower phase was not placed in the tank in this 
work. Most of the chromatography was conducted at approxi­
mately 25° which permitted a solvent ascent of about 30 cm. 
in 15 hours. To remove metal ions from the paper in some ex­
periments, the paper was placed flat in a large bakelite 
photography tray, washed three times with a solution of 1.0$ 
EDTA (disodium dihydrogen Ethylenediaminetetraacetate dihy-
drate, "TitraverEach Chemical Company, Ames, Iowa) in ion-
exchange water, and rinsed three times with distilled water 
and three times with ion-exchange water stored in a poly­
ethylene bottle. To avoid tearing, the later washings were 
performed with the aid of a plexiglass support cut to fit the 
tray and drilled with large holes sufficient to allow the free 
passage of the solution. The plexiglass shield was then used 
as a drying rack until the paper regained enough strength to 
remain hanging unsupported. 
Countercurrent distribution procedure 
Three all-glass machines were employed in the course of 
this work. A small "microdistribution11 manually operated 
apparatus based on the design of Bell e_t al. (10) consisting 
of 60 tubes was constructed by the glass shop at Iowa State 
University and mounted on a frame designed and manufactured 
by the Chemistry shop. Special acknowledgement is given to 
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Mr. E. Moore and Mr. Ray Seamore for construction of this 
apparatus, which is operated with 1 ml. of each phase per 
tube • 
A second manually operated machine, made previous to 
this work, and based on the Cralg-Post (15) design consisted 
of 53 tubes with a capacity of 31 ml- for each phase. 
A third countercurrent distribution apparatus used was 
the "Automatic Countercurrent Fractionator200 tube Extrac­
tion Train manufactured by the E-C Apparatus Company, 538 
Walnut Lane, Swarthmore, Penn. This machine was equipped 
with an automatic filling device and a fraction take-off. 
When the single withdrawal technique was employed, the upper 
phase of the last tube siphoned into a funnel leading to an 
automatic fraction collector. The collector was synchronized 
with the Fractionator on a time basis and when once adjusted, 
both gave excellent results and could be allowed to operate 
unattended. The screw caps for each tube of this machine 
were lined with Parafilm (E. H. Sargent and Co., Chicago, 
Illinois) to give a better leak-proof seal, but the Parafilm 
may have been slightly soluble in some of the solvents em­
ployed in this work. 
The solvent system to be employed was first equilibrated 
at the temperature of the room in which the distribution was 
to be carried out. Lower phase was added to the microdis­
tribution machine with a 2 cc• syringe equipped with a long 
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needle. A graduated cylinder was used to fill the large 
manual machine and the automatic filling device was used for 
the automatic machine. During the duration of the distribu­
tion the two phases were always stored in the presence of each 
other. After the lower phase had been distributed throughout 
the apparatus, an additional amount was added to the beginning 
tubes and the machine was run through 10 to 15 cycles to 
insure that lower phase filled the tubes completely. The 
sample to be distributed was placed in the first tube by 
removing the solvent, dissolving the sample In a portion of 
it, returning the solution to the tube, and rinsing the con­
tainer into the tube with the remainder. Upper phase was 
added to the first tube with a 2 cc. syringe, a graduate 
cylinder, or the automatic filling device, respectively, for 
the three machines. A complete transfer cycle, consisted of 
addition of upper phase, 50 to 100 oscillations manually or 
25 with the E-C apparatus, a five minute settling out period, 
and transfer of upper phase to the next tube. Addition of 
fresh upper phase to the first tube was accomplished simul­
taneously with the transfer in the case of the automatic 
machine. After the desired amount of transfers and analysis 
conducted as previously described, contents of the tubes were 
pooled and stored in a refrigerator until processed further. 
For systems containing volatile components, the organic sol­
vent was stripped off in a rotary evaporator with a temper-
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ature bath never above 40°C and the aqueous layer either fur­
ther concentrated or lyophillzed Immediately. For TCA (tri­
chloroacetic acid)-containing systems, the organic solvent 
was stripped off and the aqueous-TCA layer was extracted 
with freshly distilled ether to remove TCA. The remaining 
aqueous layer was again concentrated in the rotary evaporator 
to one-half its volume and again ether extracted. This process 
was repeated until a volume suitable for lyophllization was 
obtained. A preliminary experiment with a TCA solvent system 
indicated that all of the TCA could be removed by 36 .hours of 
lyophilization without ether extraction, but ether extraction 
was employed in experiments reported here. 
Ion-exchange chromatography 
Amberlite IRC-50, a polycarboxylie weak cation exchange 
resin, was treated according to the method of Hlrs _et al. 
(49). The resin was titrated to the pH desired in either of 
two ways: by increment addition of ammonium hydroxide, and 
stirring for periods of at least 30 minutes, lengthening 
the equilibration period as the pH approached the desired 
value, or by repeated addition of the buffer at the desired 
pH and molarity with lengthy equilibrations followed by a 
redetermination of the pH of the supernatant solution. In 
either case, the resin and buffer to be employed were stirred 
for extended periods, usually 8 hours, until the proper pH 
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was obtained; the supernates and fines were then decanted and 
fresh buffer added to the resin. Sufficient buffer, prepared 
according to either Hirs £t al. (49) or Acher et al. (?), was 
usually made up in advance to insure that equilibration and 
elutlon of the column could be conducted with the identical 
buffer. Stepwise elutlon procedures were employed for some 
columns. 
All columns were packed under gravity-flow, usually as 
a slurry, with care to avoid channeling or uneven packing. 
Flow rates of the earlier columns were controlled by a stop­
cock or pinch clamp; later columns were fitted with a constant 
head device employing the "chicken feeder11 principle. A 
closed buffer reservoir was attached through a 10 mm. glass 
tube to an Erlenmeyer flask fitted with a siphon leading to 
the column. The level of buffer in the Erlenmeyer remained 
constant because of the continued addition of buffer from 
the reservoir above it as buffer siphoned out to the column. 
This constant head, once adjusted to the proper height, main­
tained a steady flow through the column, providing no fur­
ther packing of the column resin occurred. With gradient 
buffers of increasing pH, repeated adjustments had to be made 
because of the pronounced swelling of IRC-50 in basic solu­
tion. Flow rates were always maintained at 1.5 to 2.0 ml./ 
£ 
cm. /hr. or less, to insure complete internal equilibration 
of the material being chromatographed with the resin. All 
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resin and buffer pH's were measured at room temperature even 
for columns conducted in the cold room at 3-5°G. 
"Fingerprinting" by paper chromatography 
and electrophoresis 
This two-dimensional technique was utilized successfully 
both as a qualitative method for determining the complexity 
of peptide fractions and as a means of obtaining individual 
peptides in sufficient quantity for qualitative amino acid 
analysis. Essentially the method of Katz et al. (59) was 
used as modified by Pfuderer (86). A sheet of Whatman No. 3 
or 3 MM, 22.5 x 18 1/2 in., was ruled in pencil with three 
lines parallel to the long edge at distances of 2, 6 and 12 
cm. from the edge and a single line 10 cm. from the short 
edge. About 1 mg. of sample was pipetted at the intersection 
of the 12 cm. and 10 cm. lines to form a spot less than 1 cm. 
in diameter. The paper was creased upward at the 2 cm. line 
and downward at the 6 cm. line with the aid of a straight­
edge . The chromatogram was developed with BAW (4:1:5) in 
the descending manner at 25°G in a Ghromatocab (Research 
Specialties Co., Berkeley, California) with equilibrated 
lower phase in the bottom tray. The solvent front moved 30 
to 33 cm. in about 12 hrs. depending upon the type of paper 
used. After the paper was dried, it was trimmed on one side 
to remove the "trash" line at the solvent front, usually a 
distance of 30 cm. from the 12 cm. line, and on the opposite 
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side at about 9.5 cm. from the edge, leaving the 12 cm. line. 
A pyridine-acetate buffer (PYR:HOAC:HgO, 1:10:289 v/v), pH 
3.55, was then carefully pipetted along either side of the 
10 cm. line, with the paper elevated above the glass-topped 
bench by a large glass rod, so that the buffer spread toward 
the line from both sides. After the entire paper had been 
wet with buffer and excess buffer removed by blotting with 
clean paper tissue, it was carefully placed on a glass rack 
and inserted into the kerosene-cooled electrophoresis appara­
tus • The paper was placed so that the side having the 10 cm. 
line was at the anode. Electrophoresis was conducted at 2400 
volts for 90 min. at 55-65 milliamps and a temperature of 
20-22°C. After the kerosene and water had been thoroughly 
removed by drying at room temperature or in a 100° oven, 
the papers were sprayed with a 0.01% alcoholic ninhydrin 
solution and heated to bring out the color of the spots. 
In experiments conducted to determine the amino acid 
content of the ninhydrin positive components, the spots were 
cut out, eluted into small tubes with 1 to 2 cc. of 6 N 
hydrochloric acid, sealed in vacuo and hydrolyzed for 18 hrs. 
at 110°C. Elution was carried out by placing the cut-out, 
further divided into pieces about 2 mm. square in a small 
funnel made from a section of 6 mm. Pyrex tubing with one end 
drawn down to a fine capillary, through which 1 ml. of 6 N 
hydrochloric acid was allowed to percolate into a hydrolysis 
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tube; alternatively and preferably, the hydrochloric acid 
eluant flowed over the cut-out in the form of a wick, drip­
ping into the hydrolysis tube. The hydrolysates in the 
opened tubes were dried in vacuo over sodium hydroxide and the 
light yellow residue spotted on an 8 x 8 inch Whatman No. 1 
paper which was subjected to two dimensional chromatography 
according to Hardy et al. (43). 
Continuous flow electrophoresis 
A number of fractionations were conducted by Miss Evelyn 
J. Weber with the continuous flow Paper Electrophoresis Cell 
Model CP (Beckman Instruments, Inc., Splnco Division, Belmont, 
California) using the Splnco Cons-stat constant current 
supply• The electrolyte, 0.5 N acetic acid, was recirculated 
from a bottle immersed in an ice-bath, and tap water was run 
through the cooling plate at a valve-regulated constant flow 
rate. The sample, made up to a 1% solution in the electro­
lyte, was fed continuously on the proper tab nearest the 
anode; collected fractions were numbered from Ko. 1 at the 
cathode to No. 32 at the anode. Fractions were stored at 
3-5°C until the solvent could be removed in vacuo in the 
rotary evaporator and/or by lyophilization. 
Preparation of "D " 
The solvent system used in the preparation of "D " mate- ' 
rial by paper chromatography was essentially that of G-uillemin 
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et al. (34). Solvent I as employed here consisted of a 
.freshly made solution of acetone:water: diethylene glycol 
(6:3:1) without the addition of urea. An aqueous solution 
of 50 mg. of methanol extract was streaked across the origin 
line of a sheet of 22 1/2 in. by 18 in. Whatman No. 1 chroma­
tography paper and dried at room temperature. The sheet was 
formed into a cylinder with the use of glass or polyethylene 
hooks and developed by the ascending technique for about 15 
hours or to a height of approximately 30 cm. at a temperature 
of 25°C. After drying the paper at room temperature, a ver­
tical center strip was cut and sprayed with ninhydrin. 
Usually a one inch horizontal strip about three-quarters of 
an inch below the solvent front was taken and eluted with 
water in a water-saturated atmosphere enclosed by a bell Jar. 
This region of Hp 0.9 to 1.0 had been reported (34) to con­
tain the greatest corticotropin-releasing activity. The 
eluant from 20 papers was lyophilized to a dark yellow oil, 
to which was added 3 ml. of 90;6 aqueous methanol. The yellow 
solution was transferred to a 30 ml. centrifuge tube and the 
clear supernate decanted from any residue into another 50 ml. 
centrifuge tube. The flask and residue from the centrifuga-
tion were rinsed with another ml. of 90# aqueous methanol and 
the supernate from this washing added to the original super­
nate . Addition of 10 volumes of dry ethyl acetate to the 
combined supernate produced a flocculent., light-yellow pre-
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cipltate, which was centrifuged and washed twice with ethyl 
ether. The air-dried or lyophilized tan powdery precipitate 
was stored in a refrigerated desiccator. Twenty paper 
chromatograms, representing 1.00 g. of methanol extract 
starting material, gave an average yield of 0.049 g. of this 
"D" with a range of 0.0142 g. to 0.1224 g. A pooled sample 
of 588 mg. of this material was labeled FD 126 and stored 
over calcium chloride in the deep freeze. A paper chromato-
gram of this material developed in BAW (4:1:1) gave nlnhydrin 
positive spots at Hp's of 0.0?+3, 0.16"1"4, 0-22+2, 0.28+3, 
0.j%+%, 0.44+2, o.55+4 and 0.74+4. 
Material from the area of Rp 0.5-0.75, corresponding to 
the pressor active fraction reported by Guillemin et al. (34), 
was recovered from the same procedure outlined for D material. 
Assays 
Corticotropin-releasing factor (CRF) 
In vitro method Several assays performed for us by 
Dr. Guillemin at Baylor University College of Medicine em­
ployed the short term pituitary and adrenal incubation tech­
nique originally developed by Saffran and Schally (103) and 
modified as described in detail by Gullleman et al. (34). 
In this assay the estimation of the release of (ring A-A4, 
3 keto) steroids by fragments of rat adrenal glands is taken 
as the criterion of "adrenocorticotropin hormone (ACTH) activ­
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ity which in turn is a measure of corticotropin-releasing 
activity of the sample incubated with the anterior lobe of 
the pituitary. The data are expressed in "potency" of the 
stimulated pituitary as related to the amount of corticotropin 
released by the unstimulated pituitary to which was attributed 
a value of 1 or 100%. 
In vivo method In this laboratory, Miss Evelyn J. 
Weber and several assistants carried out bio assays based on 
the later method of Guillemin et al. (28, 30, 41), in the 
nembutal-morphine blocked rat. The sample was administered 
intravenously and release of AGTH was assessed by the concen­
tration of the plasma free corticosteroids using a fluoro-
metric method. Activity was expressed by either the percent­
age increase of corticosteroids over the level found in con­
trol animals or the increase in micrograms (T ) of Compound B 
(AB) . 
As an aid in determining the efficacy of each purifica­
tion step, it was decided to use Ce 225 peak 13-14 as a 
standard for CRF activity. This was selected because of its 
immediate proximity to the CRF activity peak in a continuous 
electrophoresis experiment. Table 3 shows the results of an 
ACTH and CRF assay on that material. Also included ere the 
results obtained for a sample of synthetic lysine vasopressin 
(Jk V 68/16, LVP 258 U/mg.) generously donated by Dr. Vincent 
du Vigneaud. 
Table 3. Assay ox' a continuous electrophoresis fraction for CRF and ACTH activity 
and a CRF assay of synthetic lysine vasopressin 
Sample f/inj . 
LVP 
U/mg. 
LVP 
mU/inj . 
B 
control 
B 
sample AB % inc. 
Ce 2c5 0.9 17.7 15.95 4, •25+1.2 (4)a 8.3+1.7 (4) 4.05 95 
13-14 
(4) 1.8 17.7 31.90 11.6+1.3 7.35 170 
3.6 17.7 63.7 5 .*5+1.1 (4) 21-8+1.3 (4) 15.55 315 
7.2 17.7 1%7.3 30.4+1.6 (4) 25.15 480 
ACTH 1.0 rnU 2 .85+0.3 (3) 23.4+1.6 (5) 723 
0.25 mU 13.6+3.1 (5) 378 
Ce 225 0.9 17.7 15.95 2-9+0.2 (5) 0 0 
13-14 
(8) 3.6 17.7 63.7 4.0+0.4 1.15 40.1 
Syn.LVP 8.4 8 .0+0.8 (7) 8.5+1.1 (10) 
16.8 8 •2+0.7 (18) 11.4+0.7 (19) 3.2 39 
33.5 8 .1+0.8 (10) 14.7+1.4 (9) 6.6 81 
67 8 .1+1.4 (7) 18.2+1.4 (10) 10.1 125 
aThe number in parenthesis in this and the following assay results indicates 
the number of rats used in the assay. 
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Figure 5 shows a graph of the Increase of B due to a 
log dose of Ce 225, 13-14 as Indicated by Table 3. An arbi­
trary assignment of 1 unit per microgram (l Ce U/r ) was made 
for this material and Is the CRF unit referred to in later 
experiments. Figure 5 also shows the response of steroid re­
lease due to synthetic lysine vasopressin as reported in Table 
3. The low controls found for Ce 225, 13-14 give a much 
greater elevation tha might be expected. It is believed that 
the increase at 0.9r and 1.8 f is due to vasopressin within 
the limitations of the assay. At the higher doses, the re­
sponse is much too great to be explained by the vasopressin 
and ACTH known to be present. The assays conducted on a 
chromatography column (IRC-50 19) using Ce 225 15-16 for 
starting material revealed the presence of melanocyte-stimu-
lating-hormone (MSH); therefore it is possible that the activ­
ity of Ce 225 13-14 at the higher doses may be due to oc-CRF 
which is known to contaminate oc-MSH. 
Melanocyte-stlmulatlng-hormone (MSH) 
Assays for MSH performed on the intact frog by Miss Weber 
and her assistants used the semi-quantitative method of Land-
grebe and Waring (61). Standard preparations made by a water 
extraction of posterior pituitary lobe were assigned a value 
of one unit (1 u) per 0.04Y of material Injected (119). The 
usual injection of 2*5f (62.5 u) gave a response of 3-4 on 
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the Hogben Melanophore Index scale, a criterion dependent on 
the shape of the melanocytes. The MSH activity of an unknown 
sample was evaluated in its relation to the standard response. 
Adrenocorticotropic hormone (ACTH) 
Miss Weber and assistants used the 24 hour post-hypo-
physectomlzed rat for this assay based on the method of 
Guillemin et al. (29). Samples of either the ACTH USP Standard 
or the unknown material were administered intravenously in 
physiological saline and ACTH activity was maeasured by deter­
mining the levels of plasma free corticosteroids. Results are 
reported in terms of units of ACTH as referred to the USP 
standard preparation. 
Vasopressin (LVP) 
Miss Weber and assistants determined pressor activity 
of isolated fractions in rats anaesthetized with methane and 
treated with dibenamine according to Dekanskl (20). Blood 
pressure In the carotid artery was measured by direct cannula­
tion with a polyethylene tube leading to a Statham pressure 
transducer connected to a Sanborn amplifier and recorder. 
Samples were injected intravenously and assayed against USP 
Posterior Lobe Reference Standard. 
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Fresh tissue preparations 
Fresh posterior pituitary (7/20/59) A day1s collec­
tion of whole hog pltuitaries was purchased from the Iowa Pack­
ing Company, Des Moines, Iowa. The glands were collected 
approximately 45 minuses after the animals were slaughtered 
and stored in a tin can at room temperature for the entire 
working day. Approximately 1 pound of the wet glands, stored 
overnight in a deep freeze, yielded 48 g. of wet, posterior 
pituitary lobe. The posterior lobes were placed in a Waring 
Blendor to which was added about 200 ml. of 0.25# acetic acid 
at room temperature. Five minutes of blending produced a 
thick, pink foam which threatened to overflow. This mixture 
was filtered without suction and the extraction and blending 
repeated twice more in like manner. The final combined fil­
trate, about 700 ml. of clear, strawberry-red solution, was 
concentrated to 150 ml. on the rotary evaporator with the bath 
temperature kept below 40°C and foaming prevented through use 
of Dowex antifoaming agent B. The concentrated extract was 
made 5> in trichloroacetic acid (TCA) by addition of 7.5 g. of 
the Mallinkrodt Analytical Reagent. The precipitate which 
formed was removed by filtration, leaving a light yellow, clear 
solution. As described in the Kamm procedure (57), 82.5 g. 
of ammonium sulfate was added to the solution to give a pre­
cipitate which was allowed to stand before collecting on a 
filter. The dried precipitate, weighting 1.1235 g., was 
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extracted three times with 30 ml. portions of glacial acetic 
acid• Completion of the Kamin procedure on this material 
yielded slightly over 50 mg. of product having a pressor assay 
of about 4.0 U/mg. The entire product was streaked on a What­
man No. 1 paper which was then developed in SAW (4:1:5) using 
the ascending technique (PC-7). Nlnhydrln revealed five posi­
tive areas on a center strip at Hp's of 0+2, 0.064+, 0.14+2, 
0.19"1"2, 0.74+4. The fractions at Rp's 0.14, 0.19 and 0.74 
were recovered by cutting horizontal strips, elution of the 
segments and lyophiligation of the final solutions. The 
material at Rp 0.14 (1.7 mg.) gave a pressor assay of 40 U/mg.; 
the material at O.lti (0.6 mg.) assayed at 140 U/mg. Lysine 
vasopressin has an Rp of 0.11 (68, 99) in this solvent system 
and CRF has been reported as found in the area of Rp 0.05 to 
0.20 (115). The eluate from Rp 0.14 gave a CRF response of 
390%, and the eluate from Rp 0.19 a response of 344$, when 
both were assayed at 60T, the dose level at which D is usually 
assayed. The eluate from Rp 0.74 weighed 7.0 mg., giving a 
total weight recovery of 18.6# but a pressor recovery of 76$ 
for the three areas extracted. 
Cold acetic acid extraction of fresh hypothalamus tissue 
(7/£0/59) A small cube of brain tissue adjacent to the 
pituitary, roughly 1 cm. on each side, was dissected from the 
brain of about 100 hogs 45 minutes after slaughter and frozen 
on dry ice immediately. The entire 29.3 g. of tissue was ex-
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trac ted. at room temperature three times with 300, 250 and 200 
ml. of 0.25$ acetic acid for 5 minutes each time in a Waring 
Blendor. The filtrate resulting from the first homogenization 
was a light pink color; subsequent filtrates were water clear. 
The solid residue was saved for a usual Kamm extraction. The 
combined filtrates were concentrated to 85 ml. on the rotary-
evaporator at temperatures below 40°C. Proteins were precip­
itated by addition of 4.3 g. of TCA and the solution was fil­
tered to give a light yellow filtrate. Addition of 49.5 g. 
of ammonium sulfate to the filtrate produced a white gelatin­
ous precipitate which floated to the top. After standing, 
the precipitate was collected by filtration and dried in a 
vacuum desiccator. The resulting 0.16 g. of material was 
extracted twice with 4 and then with 2 ml. of glacial acetic 
acid and the extract diluted with water, lyophilized and 
finally re-lyophilized. The white powder from the second 
lyophiligation weighed 41.6 mg., gave a pressor activity of 
0.072 U/mg. and no CRF activity at levels of 600T . The re­
maining 35 mg. of this material was streaked on a Whatman 
No. 1 paper and developed in SAW (4:1:5)(PC—5) . Four nin-
hydrin positive areas designated 0, A, B and C at Rp's 0.0, 
0.15, 0.19 and 0.68 were recovered with weights of 4.5, 1.0, 
0.5 and 1.7 mg. respectively. Areas A and B gave no CRF 
activity at levels of 80r. The weight of material in the 
areas eluted amounted to of the material chromatographed. 
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The residue from the original extraction was extracted 
with the usual Kamm procedure as a check on the cold acetic 
acid extraction. The white solid was extracted with 750 ml. 
of hot 0.25% acetic acid yielding a cloudy light yellow fil­
trate which was concentrated to a cloudy suspension about 
75 ml. in volume. Addition of 413. g. of ammonium sulfate 
gave a white precipitate weighing 1.02 g. after drying. Ex­
traction of this precipitate with 20 and then 10 ml. of gla­
cial acetic acid and further treatment as described In the 
Kamm•procedure gave a white powder with a pressor activity of 
0.124 U/mg. 
Kamm extraction of fresh posterior : „ 
pituitary tissue (12/59) 
Whole pituitary glands, purchased and handled In the 
manner previously described gave 77.3 g. of wet posterior 
lobe tissue (representing about 1500 hogs). Desiccation (57) 
of the tissue with 6000 ml. of acetone (commercial, not re­
distilled) In the cold room, 3-5°C, once repeated gave 15.1 
g. of dry light pink solid residue. The desiccation process 
took about seven days to complete. The desiccated tissue was 
pulverized in a mortar and pestle and stored for a short 
period in the deep freeze. About 3 g. of this powder was 
added to a Blendor containing 100 ml. of 0.25$ acetic acid 
and homogenized for 5 minutes. This homogenization procedure 
was repeated on the remaining powder in four 3 g. batches and 
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the combined suspension of 15 g. in 1500 ml. was placed in a 
large round-bottomed flask, and subjected to the Kamm procedure • 
Roughly 1.0 g. of Kamm product was obtained which gave 188 
mg. of methanol extract. Three paper chromato grams each 
using 50 mg. of methanol extract gave 7.5 mg. of D material 
(Rp 0.90-1-0 in Solvent I). This material gave the assay 
results shown in Table 4. 
Table 4. CRF assay of D prepared from fresh posterior 
pituitary (12/59) 
LVP 
T/ • LVP mU/ B B % 
inj. U/mg. inj. control sample AB inc. 
FD fresh 
post • 
pit. 100 0.06 6 6.6+0.85(4) 20.4+2.8(4) 13.8 210 
(12/59) 25 0.15 12-6+2.2(5) 6.0 91 
The remaining material, approximately 5 mg., was subject­
ed to countercurrent distribution in the microdistribution 
machine (CCD 43). Fifty-nine transfers employing the solvent 
system sec-butanol-O.5% trichloroacetic acid at 25°C were per­
formed . The distribution was conducted in 56 hours. A 
cyclohexane-Folin analysis was conducted on 0.5 ml. of each 
phase of every third tube. Ninhydrin analysis of similar 
samples failed to yield color; the cause of this failure is 
unknown. The pooling scheme, weights of the fractions and 
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assays on two of the fractions are reported in Table 5. 
Figure 6 shows the results of the cyclohexane-Folln analysis. 
The total weight recovered was obviously much too high; this 
discrepancy could have resulted from inadequate extraction of 
TCA, inadequate drying of the samples, or the presence of 
solvent impurities. Since fractions 4 and 5 failed to show 
any steroid increase in the CRF assay, even at an extremely 
high level, the discrepancy in weight was not investigated 
further. 
Table 5. Pooling scheme, weights and CRF assays of CCD 43 
Peak Tubes 
Wt. 
(mg. ) 
B 
T/inj • control 
B 
sample AB % inc. 
1 0-13 
2 14-25 5.4 
3 26-35 4.1 
4 36-45 5.2 230* 7.8 (5) 6.5 (4) 0 
5 46-59 6.3 262.5a 8.0 (3) — 0 
aThe distribution was conducted on Dec. 20, 1959; assays 
were performed on Jan. 5, 1960. 
D preparation from fresh hypothalamic tissue (1/20/60) 
Hog heads, obtained about 45 minutes after slaughter 
minus the lower jaw and most of the flesh, were split by an 
automatic knife to expose the entire brain (Fig. 7). Brains 
Fig. 6. CCD 43 distribution of fresh posterior pituitary D 
(12/59) 2° BuOH-TCA 
CCD 43 
30 
TUBE NUMBER 
H O 
CO 
cr 
50 60 
Fig. 7. A. Longitudinal section of hog brain along the 
long axis 
T Thalamus 
M.B. Mammillary body 
O.C. Optic chiasms 
Hyp. Hypothalamus 
B. Cross section through the region of the 
thalamus viewed from an anterior position 
III Third ventricle 
M.B. Mammillary bodies 
T Thalamus 
Hyp. Hypothalamus 
Ill 
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were removed from the Dura Mater membrane, leaving the pitui­
tary gland intact when possible. A No. 8 brass cork borer 
was placed posterior to the optic chiasma and centered either 
on the pituitary gland or, in case the pituitary stalk had 
been severed, on the opening of the ventricular system to the 
base of the stalk. The borer was pushed into the brain until 
a core about 2 cm. In length could be lifted out (Fig. 8); 
this core, which was immediately frozen in dry Ice, probably 
included part of the mammillary body, the medial tip of the 
cerebral peduncle, the medial half of the hypothalamus, and 
areas of the thalamus. If the borer remained centered upon 
the third ventrical, the core probably contained areas of 
the pineal body to the floor of the lateral ventrical. In 
some cases the borer may also have entered the meningils. 
Frozen wet tissue (from about 600 animals) weighing 613 
g. (from about 600 animals) was put into 22.5 1. of cold ace­
tone contained in a large glass tank in the cold room at 
3-5°C. The acetone desiccated tissue was collected, homo­
genized in deionized water In a Waring Blendor, lyophilized, 
and weighed• The 145.6 g. of tan powder obtained represented 
£4fo of the original wet tissue; 70 g. of this powder processed 
according to the Kamm procedure gave 6.0 g. of ammonium sul­
fate precipitate and 0.20 g. of Kamm product, assaying less 
than 0.02 U/mg. of pressor activity. The Kamm product gave 
60 mg. of methanol extract (< 0.02 U/mg. pressor act.). A 
Fig. 8. A. Brain with core removed 
B. Core taken for extraction 
a 
METRIC 1 lllllllllllllllll 
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"D" preparation from the methanol extract gave no CRF response 
when assayed at 100 T . An aqueous extract according to the 
method of Shizume (119) of 0.5 g. of the acetone desiccated 
lyophilized powder gave 0.14 g. of product after lyophiliza-
tion which showed no MSH activity at does levels of 2.5 or 
.5.0Y . 
The acetone used in the desiccation process was evaporated 
in the rotary evaporator (bath temperature 35-45°C) and the 
solid recovered. Tnis amounted to 8.16 g. of a eream-colored, 
flaky material. In an attempt to duplicate an experiment by 
Rumsfield and Porter (99), 1.0248 g. of this material was 
dissolved in 200 ml. of freshly distilled ether, and extracted 
three times with 200 ml. portions of 1> acetic acid. Dilute 
acetic acid was employed here rather than 0.9;b*-sodium chloride 
(99) because of its ease of removal by lyophilization. The 
waxy residue from the lyophilized acetic acid extract, weigh­
ing about 10 mg., gave no CRF activity at 100r, but some 
indication of activity at the 400Y level in an inconclusive 
assay. In a paper chromatogram employing BAW (4:1:5) as the 
solvent, ninhydrin positive components were revealed at Rp1 s 
0.0278+1, 0.0874+3, 0.131+3, 0.214 +3 0.282+4, 0.377 + 
0.489+ and 0.544+. 
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D preparation from fresh posterior 
pituitary tissue (1/20/60) 
Immediately upon collection of the entire pituitary gland 
from hogs as performed routinely by the Iowa Packing Company, 
Des Moines, Iowa, approximately 45 minutes after slaughter, 
the posterior lobe was removed and frozen on dry ice. A 
week1s production was stored frozen after collection in this 
manner and when 522 g. of the wet tissue had accumulated, the 
entire block of frozen tissue was dropped into 26 1. of cold 
acetone. The published directions (57) recommended 200 cc. 
of acetone for each 50 posterior pituitary lobes, or approxi­
mately 2.6 g. of wet tissue; for the amount of material used 
here a volume of 40 1. would have been required, but no con­
venient container of this size was immediately available. 
The acetone-dried, homogenized, and lyophilized powder 
weighed 90.3 g. or 17$ of the wet weight. 
When 70.0 g. was processed according to the Kamm pro­
cedure (57), 30.7 g. of ammonium sulfate precipitate was 
obtained which yielded 7.13 g. of Kamm product assaying at 
8.8 U/mg• of pressor activity. Three g. of Kamm product gave 
0.53 g. of methanol extract (2.05 U/mg. pressor activity) and 
the methanol-insoluble residue yielded 1.90 g. of aqueous 
extract (5.0 U/mg. pressor activity). The weight recovery 
was thus 81$ but the pressor recovery only 42$. The D pre­
pared from the methanol extract gave the CRF assay reported 
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In Table 6. When 0.51 g. of the original acetone-dried, 
homogenized, lyophilized powder was extracted with water 
according to the method of Shizume (119), 0.14 g. of a white 
powder was obtained by lyophllization of the aqueous extract; 
•c 
this powder gave melanophor indices of 5+ at levels' of 2-5 and 
5T , compared to indices 6f 3-3.5 for 1.25 Y and 4-4.5 for 
2*5T of the standard MSH preparation (119). 
Table 6. CRF and pressor assay results of posterior pituitary 
D (1/20/60) 
Sample 
T/ 
Inj . 
LVP 
U/mg. 
LVP 
mU/ 
inj. 
B 
control 
B 
sample AB 
% 
inc. 
FD 100 0.4 30 9.4+1.4(4) 17.4+1.9(4) 8.0 85+20 
2/2/60 50 0.3 15 14.4+1.7(5) 5.0 53+20 
(0.2,0.4) 
Chromatopile of protopltultrln 
(chromatopile No. 2) 
Four chromatopile experiments were conducted. A sample 
of pro topituitrin (Parke-Davis, 12.5 U/mg. pressor activity, 
12 U/mg. oxytocic activity) weighing 1.07 g. gave 0.51 g. of 
methanol extract which was dissolved in water and pipetted 
onto 11 circles of 7 cm. Whatman No. 1 filter paper. The 
papers containing sample were air dried, then placed in a 
stainless steel chromatopile at a position of 20 papers from 
118 
the upper end of a 1000-paper pile. The papers were aligned 
and clamped in the apparatus, which was then placed in a 
covered glass chromatography tank containing Solvent 1 to 
saturate the atmosphere. Solvent 1 (containing urea) was 
applied to the chromatopile through a tygon syphon. Develop­
ment was stopped after 9.5 hours and the chromatopile per­
mitted to air dry overnight. Every 50th paper was removed, 
cut into small segments, and extracted with 10 ml. of the 
Folin alkaline-copper reagent; 4 ml. of this extract, filtered 
through sintered glass, was used for Folin analysis. Results 
are shown in Fig. 9. Papers were grouped as indicated in 
Table 7, extracted with 0.5$ aqueous acetic acid in a Waring 
Blendor; the extracts were suction filtered through a sin­
tered glass funnel and concentrated in a rotary evaporator. 
The resulting viscous concentrates were treated as D fractions 
for removal of diethylene glycol. 
Bioassay for CRF in the In vitro system (34) at doses of 
100 f gave a potency of £.0 for fraction 400-550, and 2.1 for 
fraction 550-750. Fraction 750-950 showed no activity at 
that level. 
The green color of fraction 400-550 was found to be due 
to copper salt contamination from contact with metal parts of 
the Waring Blendor. Chromatopile experiments showed low re­
solving power for the time and effort required, and offered 
no advantages over paper chromatography for preparation of D 
CHROMATOPILE NO. 2 
1.0 
0.8 
0.6 
0.4 
0.2 
W 
NO. OF FILTER PAPER 
100 200 300 700 900 1100 
9. Chromatopile of Parke-Davis protopituitrin using Solvent 1 
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Table 7. Weight and chromatography behavior of chromatopile 
2 fractions 
Fraction 
Wt. 
(mg. ) Description Rp (Solvent l) 
20-100 68 Fluffy brown Red spot 0.1 streaking to 
purple spot 0.25 
101-200 67 Fluffy brown Purple spot 0.30, 0.45 
streak at 0.70 
201-300 67 Brown Brown streaking centered 
at 0.51 • 
301-400 36 Fluffy Streaking 0.64 to 0.75 
401-550 43 Green gum Streaking 0.64 to 0.75 
550-750 77 Fluffy Streak centered at 0.70 
750-950 115 Green ppt. Streak from 0.7 to solvent 
front 
material. 
Powdered cellulose columns (Cell. No. 5) 
Some preliminary experiments were conducted using dry-
packed powdered cellulose columns irrigated with Solvent I to 
fractionate methanol extract. Difficulty was encountered in 
obtaining the optimum degree of packing by temping with a 
steel rod; in loosely packed columns, peptide material came 
through with the hold-up volume and in tightly packed columns 
solvent could not be forced through the column. 
However, local success in separation of carbohydrates.on 
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this packing material (129) led to a further attempt using a 
different packing technique. A column, 47.5 cm. by 4.5 cm., 
was prepared by packing a heavy slurry of Whatman Cellulose 
Powder in n-butanol under 60 cm. of positive air pressure. 
A sample of 754.6 mg. of Kamrn product (6/18/58) was dissolved 
in n-butanol containing a little water and acetic acid. This 
solution was placed on the column, and additional cellulose 
packed to a height of 2 cm. above the resulting yellow band. 
Anhydrous n-butanol was continued as the eluant, until tube 
109, each tube containing 5 ml. fractions; the eluant was 
then changed to n-butanol:acetic acid:water (16:1:1 v/v). 
Other solvent changes were made at tube 309 (BAW 8:1:1), tube 
689 (BAW 4:1:1), tube 1323 (ethanol), and tube 1560 (water). 
A maximum flow rate of 1 drop/3.9 sec. was maintained through­
out operation of this column. The contents of every third 
tube were concentrated to dryness in a rotary evaporator, ex­
tracted with 2.0 ml. of water, and 1 ml. of this solution was 
taken for folin analysis. Results are given in Fig. 10. 
Tuces 973 to 982 were inadvertantly overlapped into tubes 
1044 to 1053- Material in the pooled fractions indicated in 
Table 8 was recovered by concentration of the solvent on the 
rotary evaporator and lyophilization. 
Weight recovery was 195.7 mg. or 38.7/2 of the starting 
material corrected for the amount taken for folin analysis. 
Pressor assays showed that peak 16 had no pressor activity 
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Fig. 10. Column chromatography of Kamm product on cellulose powder, BAW 
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Table 8. Weight and pap'er chromatography results of Cell. 5 
Peak Tubes Wt.(mg.) Hp1 s (BAW 4:1:5) 
1 190-224 7.3 0+3 streak to 
0.38+, 0.46+ 
0.13+, 0.16+, 0.23+, 
2 225-253 0.5 0.18+, 0.4+ 
3 254-280 2.4 0.14+, 0.38+, 0.59+, 0.68+, 0.77+ 
4 281-300 1.1 0.14+, 
0.69+, 
0.22+ 
0.77+, 
0.28+. 
0.59+4 
0.60+3 , 0.64+, -
5 301-312 1.7 0.59+4 
6 313-336 1.9 Lt. streaking from 0 .33+ to 0.59+4 
7 337-378 1.1 0.15+, 
streak 
0.25+, 0.29+, 
to 0.89+ 
0.53+, 0.62+4 
8 379-420 3.7 
9 421-441 1.1 
10 442-465 1.5 
11 466-495 3.1 
12 496-534 
13 535-585 2.4 
14 586-621 4.5 
15 622-657 4.3 
16 657-717 5.5 
17 718-762 5.9 
0+, 0.07+, 0.16+4, 0.21+, 0.26+, 0 
0.41+, 0.51+J, 0.55+ streak to 0.81+^ 
streak to 0.13+, 0.22+2, 0.39+4, 
0.46+, 0.54+, 0.6+, 0.68+ 
0.14+, 0.24+, 0.35(yel)+2, 0.40+, 
0.50+ , 0.60+ 
0.93+, 0.16+, 0.19+, 0.26+3, 
0.29(yel) + , 0.35+-3, 0.48+, 0.62 
0.14+, 0.25+4, 0.33+2, 0.40+, 0.59+, 
0.64+ 
0+2, 0.09+, 0.14+, 0.25+3, 0.33+3, 
0.46+, 0.60+, 0.66+ 
0.08+, 0.22+2, 0.29+, 0.60+, 0.64+ 
0.14+4, 0.37+2, o.64+, 0.71+ 
0.15+4, 0.23+, 0.60+, 0.63+, 0.67+ 
0.16 +3 
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Table 8. (Continued) 
Peak Tubes W t.(mg • ) Rf'S (BAW 4:1:5) 
18 763-79% 0.14+4, 0.29+, 0.41+2, o.51+2, 0.62+2 
19 793-804 2«6 0.14+4, 0.28+, 0.41+ 2  It. streaking 
to 0 «69 
20 805-82% 4.2 0.13+4, 0.26*, 0.41+2 it. streaking 
to 0.68+ 
21 823-849 9.0 0.11+2, 0.39+3 streaking to 0.48+2 
22 850-882 9.9 0.11+2, 0.21+2, 0.40+2 
23 683-912 4.1 0+2, 0.10+2, 0.18+2, 0.38+ 
24 913-945 2.9 0+2, 0.09+1, 0.13+2, 0.34+ 
25 944-961 0+2, 0.07+, 0.14+2 It. streaking 
to 0.34+2 
26 982-1044 5.6 0+2, 0.02+2, 0.04+, 0.09+, 0.14+ 
streaking to 0.27+, 0.32+ 
27 1045-1099 2.8 0+3, 0.20+, 0.05+ 0.10+ It. 
streaking to 0.25* 
28 1100-1147 2.6 0+2, 0.01+3, 0.06+ It. streaking 
to 0.23+ 
29 1148-1211 3.7 0+2, 0.01+2, 0.08+, 0.12+ It. 
streaking to 0.25+ 
30 1*13-1274 0+, 0.01+2, 0.08+3, 0.15+, 0-20+2 
It. streaking to 0.30+ 
31 1*75-1382 9.7 0+2 0.02+3, 0.09+4, 0.14+2, 0.21+2, 
0.29+ 
32 1383-1430 9.5 0+3, 0.07+^, very It. streaking to 
0.22+ 
33 1431-14o4 27.1 0+4, 0.05+2 
34 14 5 5-1593 0+3 it. streaking above 
35 1594-1606 53.5 0+4 
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but peak. 21 had approximately 2 U/mg. pressor activity.. 
Apparently well over 30 different peptides were revealed in 
Kamm product. An earlier experiment, employing the two dimen­
sional paper chromatography system of Hardy ejt al. (43), 
showed no free amino acids in the Kamm material. 
Supercel columns 
Early In the work, four columns packed with an uniden­
tified batch of supercel were employed to fractionate methanol 
extract by the method of Gondliffe (14) for separation of 
oxytocin and arginine vasopressin; the complex mixture of 
peptides in methanol extract was poorly resolved. Substitu­
tion of n-butanol saturated with 0.5$ aqueous acetic acid for 
the sec-butanol 0 I/o aqueous acetic acid solvent of Condliffe 
gave equally poor resolution. Difficulty was encountered in 
the Folin analysis of the fractions due to precipitation of 
the reagent. 
Carboxymethyl cellulose columns 
Carboxymethyl cellulose was prepared according to the 
metnod of Peterson and Sober (85). The only variation in 
procedure was in substitution of Whatman cellulose powder 
dry-sieved at 200 mesh for the 325 meah material recommended. 
A potentiometric titration of the final product gave a curve 
similar to that reported by Peterson and Sober. 
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A 1.0 cm. diameter column was prepared by pouring a 
slurry of the carboxymethyl cellulose and 0.2 M ammonium ace­
tate buffer, pH 4.5, and applying pressure of approximately 
5 psi from a nitrogen tank until the height of ion-exchange 
adsorbent remained at 35 cm. A sample of 60 mg. of D-62A 
(some of which failed to dissolve in 8 ml. of buffer) was 
applied to the column set up in the cold room, 3-5°C, and elu-
tion begun with the equilibrating buffer. A maximum flow 
rate of 3.5 ml./hr. was maintained and 7.0 ml. of effluent 
collected per tube. The buffer was changed to pH 4.95 at 
tube 50, "tu pH 5.6 at tube 112, and to 0.2 M ammonium hydrox-
ide at tube 222• Effluent pH measurements were 4.32 at tube 
50, 4.88 at tube 104, 5.26 at tube 156 and 9.86 at tube 281. 
Folin analysis of 1.0 ml. of sample from every other tube 
showed color development only from tube 7 to tube 22, corre­
sponding to the calculated hold-up volume. A weight of only 
24.8 mg. was recovered in that peak which showed almost the 
same pattern in a paper chromatogram using BAW (4:1:1) as 
the starting material. Ninhydrin positive spots having Rp's 
of 0, 0.045, 0.109, 0.168, 0.227, 0.304, 0.417, 0.568 and 
0.728 were found. 
The larger mesh size and lower packing pressure than used 
by Peterson and Sober (85) could account for the apparent 
lack of adsorbtion of peptide material on the column. 
Another column 0.9 cm. x 17.5 cm. of carboxymethyl 
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cellulose In 0.2 M ammonium acetate, pH 4.5, was packed under 
57 cm. of mercury using air pressure. Flow rate was approxi­
mately 3 min./drop and each effluent fraction contained 15 
drops (about 1 ml.). The material obtained from the experi­
ment described above (24.8 mg.) was placed on the column in 
the cold room, 3-5°C. Folin analysis of every third tube is 
reported in Fig. 11. Paper chromatography patterns in BAW 
(4:1:1) of pooled fractions is shown in Table 9. 
Table 9. Paper chromatography results of fractions from 
CM-W2 
Peak Tubes C
O >
 
BAW (4:1:1) 
1 0-13 0, 0.0664 , 0.113, 0.27, 0 407 
2 14-20 0, 0.0746 
0.631 
, 0.133, 0.186, 0.262, 0.34, 0.532, 
3 21-33 0, 0.029, 
0.469, 0. 
0 0746, 0.124, 0.153, 0.257, 0.332, 
577, 0.801 
4 34-46 0.0211, 0 
material) 
.076, 0. 127, 0.198 (insufficient 
5 46-90 0.0126, 0 .0632, 0 .143, 0.30, 0.481 
Carboxymethyl cellulose did not have the resolving power, 
under the conditions employed, to fractionate completely the 
peptide mixtures obtained from paper chromatography of methan­
ol extract of Kamm product. 
Fig. 11. Chromatography of a D extract on carboxymethyl cellulose 
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Carboxyllc acid Ion-exchange resin columns 
. Many columns using varying pH and elutlon schemes were 
employed in attempts to fractionate both Kamm product and 
methanol extract. Results obtained in a typical experiment, 
IRC-50 8, are presented. A 1.0 g. sample of methanol extract 
was applied to a column 4.3 cm. x 34.8 cm- equilibrated with 
0.2 M ammonium acetate at pH 4.69 and set up in the cold room, 
3-5°C. Effluent fractions collected varied between 2.8 ml. 
and 4.2 ml. but were mostly 3.5-3.8 ml. in volume. Folin 
analysis of 1.0 ml. samples of every second tube is shown in 
Fig. 1%. Change of effluent pH resulting from change of 
buffer to 0.2 M ammonium hydroxide is also Indicated. Rp's 
for the various pooled fractions in two solvent systems are 
given in Table 10. 
No bio-assays were available for any of these fractions 
so no estimate of enrichment of bio logical activity can be 
given. The chromatograms of the fractions indicate that all 
are complex mixtures consisting of many ninhydrin positive 
components. 
Countercurrent distribution of 
methanol extract (CCD 6) 
A sample of 108 mg. of methanol extract was distributed 
in the 60 tube, 10 cc. manually operated countercurrent dis­
tribution apparatus in an n-butanol-0.09 M p-toluenesulfonic 
Column chromatography of methanol extract on Amberlite 
IRC-50, 0.5 k NH4OAC 
300 
250 
IRC - 50 8 
O 
200-
I50> 
_'50f 
Ï 140-
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3 0 -
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Table 10. Paper chromatography results of IRC-50 8 fractions 
obtained from methanol extracts 
Fraction Tubes Rp (4:1:1) 
1 74-112 0(heavy), 0.09, 0.18, 0.31 
2 113-135 0(v.lt. ), 0.074 , 0.18 , 0.29 
3 136-151 0(v.lt.), 0.17, 0.28, 0.34 
4 152-185 0, 0-077, 0.15, 0.22, 0.32, 0 42 
5 186-210 0.165, 0.35 
6 211-232 0.17, 0.35 
7 233-270 0.06, 0.11, 0.30, 0.35, 0 59 
8 271-315 0.42 
9 316-350 0.42 
10 351-428 0.42 
11 492-510 
12 511-534 0, 0.05, 0.124 
13 535-56d 0, 0.05, 0.124 
14 567-610 
15 611-640 
16 641-670 solvent front 
17 671-700 solvent front 
18 701-720 solvent front 
19 721-740 
20 741-770 0, 0.65, 0.73, 0.79, solvent front 
21 771-795 — — 
22 796-856 
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acid solvent system at approximately-25°C for 59 transfers. 
Cyclohexane-Folin analysis of 1.0 ml. of each phase from 
every second tube is shown in Fig. 13. Each of the five 
pooled fractions taken showed several ninhydrin positive com­
ponents on paper chromatography using either Solvent I or a 
methyl ethyl ketone:propionic acid:water ( 120:40:48$ solvent 
system. 
Countercurrent distribution of D (CCD 24) 
A sample of 210 mg. of FD 126 was dissolved in 10 ml. of 
the lower phase of an equilibrated sec-butanol-O.trichloro­
acetic acid solvent contained in the first tube of the Auto­
matic Countercurrent distribution apparatus and subjected to 
450 transfers at 25°C. Fig. 14 shows results of ninhydrin 
analysis on 1.0 ml. of each phase of every other tube and 
also the pooling scheme employed. Paper chromatography of 
the first four fractions only was carried out because at 
that time published data (34, 115) indicated that lysine vaso­
pressin and corticotropin-releasing-factor should occur in 
these areas. Table 11 summarizes the results obtained from 
this distribution. 
The number of peaks indicated the presence of at least 
eight components In D and paper chromatography showed all 
peaks to be heterogeneous. 
Fig. 13. Distribution of methanol extract; n-Bu0H-0.09 M tosyl acid 
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Fig. 14. Distribution of FD-126 in 2 BuOH-O.5% TCA 
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Table 11. Weight, paper chromatography and partition 
coefficients of fractions obtained from a 
CCD of FD 126 
Fraction Wt.(mg.) K Rp's BAW (4:1:1) 
1 28.5 0.142 0.064, 0.11, 0 70 
2 38.0 0.223 0.071, 0.17, 0 .70 
3 21.4 0.332 0, 0.07, 0.11, 0.272 
4 21.3 0.574 0, 0.08, 0.12, 0.26, o. 42, 0. 54 
FD 126 0, 0.08, 0.15, 
0.62, 0.73 
0.26, o. 33, 0. 47, 
"Fingerprinting" by paper chromatography 
and electrophoresis 
Five "fingerprinting11 experiments (59 , 86) on 1 mg. 
samples of FD 126 on Whatman No• 3 chromatography paper gave 
the typical results shown in Fig. 15. Elution of ninhydrin 
positive spots with 6 N hydrochloric acid and hydrolysis in 
sealed tubes at 100°C showed the following amino acids as re­
vealed by paper chromatography (43): 
D-l arg, lys, glu, gly, his, ale, val, leu 
D-2 arg, gly, his, ala (trace lieu/leu) 
D-3 arg, asp, lys, gly, his, glu, ala, val, 1leu/leu, 
tyr, phe (trace cys, thr) 
D-4 arg, gly, ala, his, val, leu 
D-5 arg. lys (or gly), his, glu, leu/ileu (trace val, 
thr) 
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Fig. 15. Two dimensional paper chromatography and electro­
phoresis of pituitary and hypothalamic extracts 
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D-6 arg, asp, lys, his (or ser), glu, val, leu/ileu 
D-7 arg, gly, his, glu, lleu/leu (trace val, asp) 
D-8 arg, gly, his, glu (trace val, ileu/leu) 
D-9 arg, lys, gly, glu, his, ileu/leu 
D-10 arg, gly, glu, his, val, ileu/leu 
An area of the fingerprint paper taken as a blank and 
treated identically showed spots in areas corresponding to 
glycine, and arginine, and a light spot at alanine. Thus it 
is unknown whether all of the peptides actually contain 
arginine and glycine or whether some of these are artifacts. 
The isoleucine and leucine spots could not be distinguished 
in the concentrations employed. A different elution proce­
dure was used in a repetition of this experiment. Ninhydrin 
positive areas were cut into smaller, 2 mm. segments and 
placed in glass funnels with fine capillary tips. Hydrochlor­
ic acid was permitted to percolate through the paper into 
hydrolysis tubes. The following results were obtained after 
hydrolysis and paper chromatography: 
D-l gly (trace asp, ala) 
D-% gly, ala, pro (trace lys, ser, val, lleu/leu) 
D-3 gly, ala (trace lys, ser, val, ileu/leu) 
D-4 gly, lys, thr 
D-5 — 
D-6 gly, ala, val, asp, ileu/leu (trace his) 
D-7 gly (trace asp, ala, ileu/leu) 
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D-8 gly 
D-9 gly (trace lys, ala) 
D-10 gly, asp, ala (trace his, leu/lieu) 
D-ll gly (trace lys, ala) 
D-12 gly, ala, pro (trace lys, ser, thr, val, leu/ileu) 
D-13 (trace gly, lys) 
D-14 gly, ala, pro (trace arg, lys, ser, val, leu/ileu) 
Better results were obtained with the first method and 
greater reliability was placed on that experiment. 
The "fingerprinting11 technique was employed to determine 
the number of ninhydrin positive components in various other 
extracts. Fig. 16 shows the pattern obtained for D material 
obtained from hypothalamic tissue• Fig. 16a shows the result 
from Kamm product of posterior pituitary tissue and Fig. 16b 
an aqueous extract of this same tissue. Fig. 16c and 16d show 
the patterns derived from Kamm product and aqueous extracts 
of hypothalamic tissue respectively. 
Countercurrent distribution of pooled 
Kamm product (10/9/59) (CCD 59) 
Two hundred milliliters of the lower phase of a solvent 
equilibrated at 25-30°C consisting of n-butanol:acetic acid: 
water (4:1:5) was added to each of 15, 500 cc. separatery 
funnels. Ten grams of combined Kamm product (LVP = 5.2 U/mg.) 
made up of material collected on 6/18/58, 7/24/58 and 6/16/58 
were added to the first tube. The distribution was conducted 
Fig. 16. Two dimensional chromatograms of pituitary and 
hypothalamic extracts 
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with 200 ml. of upper phase for 14 transfers; emulsion forma­
tion was encountered in the first three tubes. The upper 
phase was transferred by means of a siphon attached to a 
water aspirator. The cyclohexane-Folln analysis reported 
in Fig. 17 was carried out by addition of 0.25 ml. of 6 N 
NaOH to samples of 0.5 ml. of each phase from each tube, fol­
lowed by the usual procedure. Samples were treated in the 
same manner for ninhydrin analysis. The material from each 
tube was recovered by evaporating the organic solvent in a 
rotary evaporator at bath temperatures of 40-45°C and lyophll-
izing the aqueous solution remaining. Information obtained 
from this experiment is compiled in Table 12. 
The highly amber colored material which moved rapidly 
through the distribution gave very little Folln or ninhydrin 
color. Although weight recovery from this experiment amounted 
to only 80.8$, pressor recovery of 112.2$ was obtained. This 
is probably within the experimental error of the assay. 
Continuous electrophoresis of CCD 59. 
peaks 2 and 3 (Ce 208-2,5) 
G-uillemin et al. (34) employed paper strip electrophor­
esis in their preparation of a peptide material having a high 
cortlcotropin-releasing activity. The supporting electrolyte 
they used was employed in this work on the Beckman continuous 
electrophoresis apparatus, a 0.5 M acetic acid solution. Flow 
rate settings were 6.5 on the left and 7.0 on the right. 
Fig. 17. Distribution of Kamm product in BAW (4:1:5) 
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Table 12- Weight, pressor and paper chromatography results 
of CCD 39 
Tube 
Wt. 
(g- ) 
LVP 
U/mg. Hp's (BAW 4:1:5) 
0 2.7770 8.0 0+4 streaking to 0.14+2 
1 2.1462 9.99 0+4, 0.04+2, 0.08+2, 0.13+2, 0.18+ 
2 1.0881 9.62 0+2, 0.06+3, 0.11+4, 0.14+3, 0.19+2, 
0.27+2 
3 0.7120 4.22 streaking from 0 to 0.3, similar 
pattern to tube 2 
4 0.4457 2.56 0+2, 0.08+3, 0 13+3 0.19+4, 0.26+3, 
0.29+2, 0.33+, 0.40 , 0 53+, 0.60+ 
5 0.1974 0.64 0.15+2, 0.20+2, 0.26+3, 0.31+3, 
0.35+4, 0.44+2, 0.52+2, 0.58+ 
6 0.1533 0.13+ streaking to 0.29+2, 0.37+3, 
0.47+3, 0.53+4, 0.68+ 
7 0.1411 streaking to 0.38+2, o.48+3, 0.56+4 
streaking above 
8 0.0720 streaking to 0.37+2, q.50+3, 0.59+4 
streaking above 
9 0.0706 It. streaking to 0.37+2, 0.46+, 
0.54+3, 0.63+, 0.75+3 
10 0.0577 0.38+, 0.49+, 0.61+2, 0.67+, 0.79+4 
11 0.0513 It. streaking of yellow material to 
0.63+, 0.79+4 
12 0.0640 mostly yellow material moving at 
high Rp 
13 0.0592 ii 
14 0.0436 » 
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Voltage indicated on the power supply was 510-530 at 30 milli-
amps. Feed control was set at 5.5 giving a flow rate of 
0.88 ml./hr• with the 15 mm. tube containing a 1.0$ solution 
of the material being fractionated. Results of the pressor 
assay and paper chromatography are given in Table 13. The 
results of CRF and ACTH assays on the fractions obtained from 
Ce 208-2 are reported in Table 14. 
The continuous electrophoresis was continued with a 
sample of 1.0688 g. of CCD 39 peak 2 (LVP = 9.62 U/mg.) using 
the same conditions noted for the fractionation of peak 3. 
Results of this experiment are given in Table 15. 
Ce 208-3 gave a weight recovery of 295.9 mg. (66$) and 
a pressor recovery of 62.5$. However Ce 208-2 gave a weight 
recovery of 733.7 mg. (69$) but only a 46.6$ pressor recovery. 
The reason for this difference in pressor recovery is unknown 
since both experiments were conducted similarly and inactiva­
tion of the vasopressin does not seem a likely explanation. 
A rough calculation of the amount of CRF material in 
Ce 208-2 (21-22) was made in the following manner. The two 
different responses reported for the ACTH assay were labelled 
A and B as reported in Table 16 and graphed as shown in Fig. 
18. An average figure for ACTH-like activity was obtained 
for Ce 208-2 ( 21-22) from A and B and subtracted from the 
CRF-like and ACTH-like activity given by CRF assay. A correc­
tion in milliunits of ACTH was made for the amount of pressor 
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Table 13. Pressor, weight and paper chromatography results 
of Ce 208-3 
Peak 
LVP 
(U/mg.) 
Wt. 
(mg.) Hp's (BAW 4:1:5) 
1-2 — — 0.28+3 
3-4 •— — 0.12+, 0.25+3 
5-6 0.0, 0.01+2, 0.08+, 0.13+3, 0.26+, 
0.34+ (streak to 0.34) 
7-8 16.5 streaking 0.13+3, 0.16+4, 0.22+3, 
0.40+4, 0 58+3 
9-10 0. 065 65.9 0.0+3, 0.01+3 streaking to 0.07 
11-12 1. ,03 84.8 0.0+2, 0.02+3, 0.04+2, 0.20+3, 
0.%3+ streaking 
13-14 19. ,3 35.8 0.02+2, 0.04+3, 0.09+2, 0.13+4(yel.), 
0.17+2 streaking to 0.26+2 
15-16 28. 2 12.9 0.0+2 0.02+2 0 04+4, 0.07+2, 
0.09+3, 0.11+4 streaking to 0.19+2 
17-18 0. 53 12.9 streaking to 0.12+4, 0.15+4 to 
0.28+2 
19-20 o. 44 17.9 0.12+4, 0.19+5 clear spots, some 
streaking beyond 
21-22 0. 64 19.5 0.11+4, 0.14+4, 0.20+3, 0.39+3, 
0.56+3 
23-24 0. 03 21.1 0.12+2, 0.16+6, 0.32+3, 0.38+2, 
0.50+ 
25-26 0.4 0.05+2, 0.14+5, 0 18+4, 0 %5+2, 
0.30+2, 0 34+^ 
27-28 (yel .)8.2 0.04+2, 0.07+2, 0.11+3, 0.17+3 
29-30 0.07+, 0.12+3 
Table 14. CRF and ACTH assays of fractions obtained from Ce 208-2 
Date of 
assay & 
sample 
LVP 
T/inj. U/mg. 
LVP 
mU/lnj. 
B 
control 
B 
sample AB % inc 
2/16/60 
13-14 
2/16/60 
15-16 
2/8/60 
17-18 
2/10/60 
19-20 
2/8/60 
1/18/60 
21-22 
2/10/60 
23-24 
2/10/60 
25-26 
2/16/60 
27-28 
0.6 
0.6 
2.4 
2.4 
45 
45 
45 
45 
45 
17.4 10.43 8.1+0.5 (5) 
50 30 
6.74 16.1 
1.25 56.3 
0.44 19.8 
1.10 49.5 
0.79 35.6 
19. 4+2.1 (5) 11.3 140+25 
7.4+2.1 (4) 25.1+4.8 (3) 17.7 240+65 
1.06 2.54 5.8+1.5 ( 4 )  4.8+0.9 (4) — 0 
47.8 7.4+2.1 (4) 35.4+2-8 (5) 28.0 380+35 
6.7+1.7 (3) 31.8+1.3 (3) 25.1 375+20 
5.8+1.5 (4) 18.2+2-4 (5) 12-4 210+40 
I 
27.9+4.0 (4) 22.1 380+70 
7.95+0.5 12-7+1.4 ( 5) 4.75 60+15 
Table 14. (Continued) 
Date of 
assay & 
sample 
A 
ACTH 
LVP LVP B 
T/inj. U/mg. mU/lnj. control 
B 
sample AB 
1.0 mU 
ACTH assay for Ce 208-2 (21-22) 
3.45+0.3 (5) 18.1+0.5 (3) 14.6 
% inc 
426 
2/12/60 0.25 mU 5.1+1.0 (3) 1.65 47 
21-22 90 1.25 112.5 29.4+1.8 (4) 25.9 752 
D 
22.5 28.1 9.7+0.9 (3) 6.25 181 
D 
5/10/60 1.0 mU 2.4+0.1 (4) 26 • 7+2 • 6 (4) 24.3 1025 
ACTH 0.25 mU 8.1+2.4 (4) 5.7 238 
21-22 112.5 1.25 140.5 23 • 6+5.8 (3) 21.2 884 
ii 28.1 35.1 13.1+3.2 (4) 8.7 446 
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Table 15. Pressor, weight and paper chromatography results 
of Ce 208-2 
Appear. 
LVP Wt. on Ce 
Fraction (U/mg.) (mg.) sheet %1 s (BAW 4:1:5) 
1-2 1 .7 — 
3-4 5 • 3 — 
5-6 6 .1 — 
7-8 0 .02 38 • 1 (8)+2 
9-10 0 .02 124 • 6 +3 
11-12 0 i 5 169 .6 +3 
13-14 17 .4 92 .0 + 2 0.0+, 0.06+2,.0.09+3 0.13+2, 
0.15^, 0.18 , 0.20 , 
0.30+^, 0.38+ streaking to 
0.47 
15-16 50 .0 52 .3 (lo)+2 0.0+2. 0.07+2 o.U+3 0.15+4, 
0.16+5, 0.23+4, 0.29+2, 
0.34+2, 0.37+2 streaking 
17-18 6  .7 46 .3 
- -
0.0+3 0.02+2 0.04+'3, 0i0?+2 
0.11+4, 0.22+& It. streaking 
to 0.54+ 
19-20 1 .1 42, . 8  (20)+2 0.0+2 0.02+2, 0.04+3, 0.10+4 
0.18+5 little streaking 
21-^2 1 .25 42 .9 + 2 0.0+2 0.03+2 0.07+2 Q.11+4 
0.16+4 0.24+5, 0.48+3, 
0.65+ 
23-24 0 .  6 43 .3 4-3 0.0+, 0.11+3, 0.15+2, 0.19+5, 
0.22+4, 0.27+2, 0.31+(yel.), 
0.36+, 0.50+, 0.60+, 0.70+ 
25-26 1. 1 17. 1 (25)+3 
27-28 0 .  , 6  20, ,6 
29-30 0 .  ,02 13. ••3 
•51-32 7 .  9 
Table 16. CRF, pressor and ACTH assays of Ce 208-2, 21-22 expressed in mU ACTH 
Experiment T/inJ• 
LVP 
mU/inj. AB 
ACTH 
mU/lnj. 
ACTH act. 
mU/r sample 
A 
ACTH 1.0 mU 14 .65 
0.25 mU 1.65 
21-an 
21-2% 
90 
22-5 
112.5 
26.1 
25.95 
6.25 
3.39 
0.408 
0.0377 
0.01815 
0.05585/2 = 
0.02792 
B 
ACTH 1.0 mU 24.3 
0.25 mU 5.7 
21-22 
21-22 
112-5 
28.1 
140.5 
35.1 
21.2 
8.7 
0.795 
0.313 
0.00706 
- 0.01115 
0.01821/2 = 
0.00911 
CRF assay 
A 21-2^ 45 56.3 25.1 3.09 0.0687 
B 45 56.3 25.1 1.06 0.0235 
Syn LVP 
A 67 10 0.6 0.0133 
B 67 10 0.35 0.0078 
Fig. 18. ACTH assay results from two separate experiments 
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activity injected in the CRF assay but neglected in the ACTH 
assays because of its small amount of ACTH activity. Lysine 
vasopressin has been shown to have CRF (133) and ACTH (48, 
95) activity. No corrections were made for any possible 
potentiation effects (95). 
The results of Experiment A show that 40$ of the activity 
could not be explained by the known amount of ACTH and vaso­
pressin present in the sample; only 28/5 remained in Experiment 
B. It appears that only a very small amount of corticotropin-
releasing factor, if any, could be present in Ce 208-2 (21-22). 
Countercurrent distribution of 
CCD 59 peak 1 (CCD 1ÏT 
The first tube of the all-glass 53 tube, 30 ml. per 
phase, manual countercurrent distribution machine was charged 
with 1.5 g. of peak 1, CCD 39 (LVP = 9.99 U/mg.). The machine 
contained the lower phase of a sec-butanol-0.5)& TCA solvent 
system equilibrated at 25°C. After 50 transfers, 1.0 ml. of 
sample was removed from every second tube and analyzed for 
peptide material by both the cyclohexane-Folin and ninhydrin 
methods giving the results reported in Fig. 19. A total of 
13 ml. of diluent was necessary in the ninhydrin analysis. 
The pressor assay was conducted on safely diluted samples of 
lower phase from tubes 15, 18 and 21. Solvent from the tubes 
combined as indicated in Table 1? was evaporated and the re­
maining aqueous layer ether extracted several times and 
Fig. 19. Distribution of peak 1, CCD 39, 2° BuOH-O.5# TCA 
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Table 17. Weight, pressor and paper chromatography results 
of fractions obtained from CCD 41 
Peak Tubes 
LVP 
(U/mg.) 
wt. 
(g-) Rf'S (BAW 4:1:5) 
1 0-9 0 .2044 0+4 with some streaking upward 
2 9-14 10.8 0, 1496 0-07+, 0.12+2, 0.16+4, 0.21+3 
short streak above 
3 15-21 61.3 0, .1066 streak to 0.09+, 0.15+4, 
0.19+2 streaking 
4 22-30 5 o, .1017 streak to 0.09+, 0.15+, 0.02+ 
5 31-42 0. 2054 streaking 0.12+3 streaking 
beyond 
6 43-50 o. •2211 + 3 streaking 0.18 streaking to 
finally lyophilized to yield a TCA-free white powder in each 
case. 
Weight recovery of 66/6 was obtained with a pressor re­
covery of 57$. Although the pressor recovery is low, this 
experiment afforded a rapid means of obtaining pressor activ­
ity in potency nearly equal that of commercial pitressin (192) 
and giving a five-fold purification. 
To gain further knowledge of the area included in peak 5 
of CCD 41, 30 mg. of this material was distributed (CCD 45) 
in the "microdistribution" apparatus using the same solvent 
system as in CCD 41. Fig. 20 shows the cyclohexane-Folin and 
ninhydrin analyses, each conducted on 0.25 ml. of each phase 
Fig. 20. Distribution of peak 5, CCD 41, 2° Bu0H-0.5$ TCA 
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of every second tube. Unfortunately the tubes designated as 
peak 1 were already pooled prior to the ninhydrin analysis and 
peaks 2 and 3 immediately afterward so that the ninhydrin 
results which appear spurious could not be repeated. The 
peaK, from its shape, shows that the starting material was 
heterogeneous and the higher K value of the main peak appears 
greater than that of the original area; however this might be 
explained by overlapping of the faster moving material into 
peak 5 of CCD 41. All three peaks after Isolation gave a 
similar pattern when subjected to paper chromatography using 
BAW (4:1:5) solvent for development. Hp's were 0.03+, 0.05+, 
0.08+, 0.12+2, 0.15+3, and a spot around 0.67+, which may have 
been an artifact. 
Column chromatography of CCD 41. 
peak 3 (IRC-50 18) 
A glass chromatography column 2.1 cm. in diameter and 
59.5 cm. long, topped with a 24/40 standard taper female joint 
was gravity-packed to a height of 42 cm. with IRC-50 ion ex­
change resin (200-400 mesh), buffered with 0.5 M ammonium 
acetate at a pH of 6.4. The column, equilibrated and run at 
room temperature (20-25°) was charged with 98.8 mg. of CCD 41 
peak 3 (LVP = 61.3 U/mg.) at tube 13. The effluent fractions, 
collected in an automatic drop counter fraction collector,, 
p 
at a maximum rate of 1.5 ml./cm. /hr., had volumes of 2.5 to 
3.0 ml. Fig. 21 shows the Folln analysis on a 1 ml. sample 
IRC- 50 18 
98.8 MGL CCD 41-3 
600 
500 
e> 
9 400 
LU 2.3 V 
%- 300 
200 
100 
TUBE NUMBER 
Fig. 21' Column chromatography of CCD 41, peak 3 
156 
taken from every second tube. At tube 398, the developing 
solvent was changed to 0.5 M ammonium hydroxide; however the 
effluent did not read pH 9 until tube 548. The column was 
stopped at tube 658. Table 18 shows the pooling scheme and 
peak number designation.• 
Table 18. Weight, pressor and paper chromatography results 
of fractions obtained from IRC-50 18 
Tubes Wt. LVP 
Peak pooled (mg.) (U/mg.) Rp1 s (BAW 4:1:5) 
1 42--72 12 .8 0. 52 0.02% 0.06+2 0.09+2 0.13+3 
0.17+4, 0.21+4, 0.31+5, 0.37+2, 
0.66+2 
2 73-•9 a 4 .9 220 slight streak to 0.09+, 0.16+2, 
streaking to 0-28+4 
3 93-196 4 .7 0.02+ 0.04+, 0.11+, 0.18+2, 
0.26+3, 0.30+3 streaking higher 
4 197-•250 2 0. 43 0.06+, 0.11+2, 0.14+, 0.18+3, 
0.32+, 0 40+, 0.05, 0.59+ 
5 251--300 1 .9 ii 
6 301-350 1 .8 H 
7 351-•400 1 .8 0.06+, 0.12+2, 0.19+2, 0.42+, 
0.61+ 
8 401-•450 2 0. 09 
9 451-•500 1 .1 
10 501-550 2 • 1 0.07+3, 0.13+, 0.20+ 
11 551-•600 2 .9 0.07+, 0.13+2, 0.17+2, 0.20+2 
streaking 0.59+ 
12 601-656 3 .1 II 
157 
Assuming that 81.2 mg. of starting material was not used 
up for Folin analysis, only 50.6/° of the recoverable weight 
was actually isolated. This poor recovery might be explained 
by: 1) column retention - it is difficult to envision peptide 
materials being retained on IRC-50 after treatment with 0.5 M 
ammonium hydroxide, however - 2) ammonium salts present in the 
starting material, which were subsequently sublimed when the 
peaks were lyophilized, 3) loss through manipulation or an in­
correct starting weight. Moisture retention by these peptides 
during storage and weighing can cause large inaccuracies un­
less precautions are taken to prevent this error. 
The pressor recovery amounts to only 24.9$ of the start­
ing material accounted for in the peaks assayed. The approxi­
mate weights reported for peaks 4 arid 8 resulted when re-
lyophilization of the peaks prior to weighing for pressor 
assays caused a loss of material. 
Countercurrent distribution of 
Ce 208-2 (21-22) (CCD 44) 
The lower phase of an equi-volume equilibrated sec-
butanol-0.5$ trichloroacetic acid (26°C) was distributed in 
the one milliliter "microdistribution machine". The first 
tube was charged with 32.2 mg. of Ce 208-2 (21-22) and the 
distribution was conducted for 59 transfers. Fig. 22 shows 
the curve which resulted from the cyclohexane-Folin analysis 
conducted on 0.25 ml. of each phase of every third tube. The 
CCD 44 
32.2 mg. Ce 208-2(21-22) 
CYCLOHEXANE-FOLIN 
NINHYDRIN 6ML. DILUENT 
NINHYDRIN 9ML. DILUENT 
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Fig. 22. Distribution of Ce 208-2 (21-22) in 2° Bu0H-0.5# TCA 
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same sample size was employed In the ninhydrin analysis except 
that 6 ml. of diluent was used. The inset shows the curve re­
sulting when 9 ml. of diluent was used to allow reading of the 
tubes in the peak ninhydrin area. Peaks indicated by the 
pooling scheme of Table 19 were obtained by repeated evapora­
tions at temperatures below 40°C on the rotary evaporator, 
ether extractions and lyophllization. 
The theoretical amount of material remaining after Folin 
and ninhydrin analysis was 26.8 mg.; actual recovery was 
110.2% by weight and 114.3/2 by pressor activity. 
Greatest interest was centered on peaks 3 and 5 as a 
result of the CRF assay. These areas were very near the K 
• — 
values reported for lysine vasopressin, 0.37, and oc-MSH, 
2.1, (63) for this system. The CRF assay was repeated for 
these two fractions as well as an ACTH assay. An ACTH assay 
was performed on fraction 1. These results are reported in 
Table 20. 
As reported in Ce 208-2, the starting material showed an 
ACTH activity present; however, no ACTH could be found in 
fraction 1, 3 or 5 in this experiment. Shepherd et al. (117) 
reported that oxycellulose treated "clinical" ACTH gave a 
slow and a fast moving peak having intermedin (MSH) and cor­
ticotropin (ACTH) activity. These components would correspond 
*See footnote of Experiment CCD 52• 
Table 19. Weight and. partition coefficients with pressor and CRF assay results of 
fractions obtained from CCD 44 
LVP 
Frac- Wt. LVP mU/ B B 
tion Tubes mg. U/mg. K inj . T/inj. control sample AB % inc. 
1 0-10 7 .7 0.04 
2 . 11-19 7 .6 0.67 0. 439 30. 5 50 . 5 .0+0.7( 5) 16.45+2.8(5) 230 
3 20-26 4 • 1 4.8c 0. 553 48. 2 10 4 .15+0.9(5) 18.25+3.9(3) 14 .1 340 
4 £7-33 3 .8 2.04 20. 4 10 4 .15+0.9( 5) 10.6+1.8(5) 155 
5 34-40 3 .9 1.09 1. 68 27. 3 25 5 .0+0.7(5) 21.1+4.2(4) 16 .1 320 
6 41-50 2 .7 0.5 25 50 5 .0+0.7(5) 16.95+1.6(5) 11 .94 240 
7 51-59 1 .9 0.5 25 50 6 .55+1.3(5) 8.95+2.0(5) 37 
Table 20. CRF and ACTH assay results obtained from fractions 1, 3 and 5 of CCD 44 
Frac­
tion 
ACTH 
mU Vin J 
LVP 
mU/Inj. 
B 
control 
B 
sample AB Inc. 
a 
.D 
1.0 
0.25 
1.0 
0.25 
20 
50 
5 
25 
10 
25 
96 .4 
54.5 
24.1 
27.25 
48.2 
27.25 
3.5+0-2(3) 
7.0+0.5(2) 
3 .2+0.4( 5) 
26.9(?)(1)' 
7.95+1.7(2) 
4.3+0.9(2) 
2.5+0.3(4) 
14.6+1.3(5) 
23.8+2.7( 5) 
14.8(1) 
5.75(1) 
1.45+0.2(2) 
1.75+0.0(2) 
0 
0 
110 
240 
362 
79.7 
0 
0 
H 
CD 
H 
^Assayed 2/25/60. 
^Assayed 3/17/60 using CRF assay. 
0Assayed 3/25/60. 
Table <30. (Continued) 
Frac­ ACTH LVP B B 
tion niU r/inj . mU/lnj. control sample AB % inc. 
"
o
 
I—1 
'9 
i 3.0(1) 29.6+5.1(3) 886 
0 • 25d . 9.1+1.9(4) 203 
1.0e 2.5+1.0(2) 16.75+2-5(3) 570 
0.25b 3.2+0.2(3) 28 
Ie 20 8 2.8+0.4(3) 0 
5 2 - 2.5+0.5(2) - 0 
^Assayed 5/4/60, ACTH repeat. 
eAssayed 5/4/60. 
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to fractions 1 and 7 o£.this experiment. The possibility 
exists either that the ACTH activity was destroyed during the 
experiment or that it was present in the untested peaks. The 
results of this experiment showing the possible existence of 
two corticotropin-releasing factors was consistent with the 
work reported by Gros and De&arlhle in 1959 (42) and Guillemin 
et al. in 1960 (37, 109). 
Table 21 shows Ftp values of ninhydrin positive components 
developed in BAW (4:1:5) for the starting material Ce 208-2 
(21-22) and the fractions of CCD 44. 
Table 21. Paper chromatographic results of Ce 208-2 (21-22) 
and fractions obtained from CCD 44 
Material Hp's (BAW 4:1:5) 
Ce 208-2 
(21-22) 
°+2 Q. 
0.65+3 
03+2, 0.075+2, 0.11+4, 0.24+5, 0.48+3, 
> 
1 0+3, 0. 07+ 
2 0.02+. 
0.26+*, 
0.05+.0.08+, 0.13+3 streaking, 0.22+4, 
0.33 , 0.33+3 streak 0.67+ 
3 0.13+, 0.17+3, 0-24+4, 0 34+, 0.44+2, 0.59+ 
4 0.14+, 0.18+, 0.25+, 0.46+, 0.61+, 0.69+3 
5 0.13+, 0.19+, 0.49, yellow spot below 0.73+4 
6 0.11+, 0.18+, yellow spot below 0.74+3 
7 o
 
o
 
0.16+, 0.64+ 
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An assay performed in the Intact frog (61) showed no 
melanocyte stimulating activity in either peak 3 or 5 of this 
experiment or in Ce 208-2, 21-22, the starting material, at 
the 2.5T level. In a preliminary experiment, conditions 
identical to CCD 44 were used except that the microdistribu­
tion machine was charged with 10.1 mg. of Ce 208-2 (21-22)• 
The Folin and ninhydrin analysis results are Indicated by 
Fig. 23 with no additional dilutions necessary (CCD 42). 
Unfortunately the tubes 33-41 were pooled before the ninhydrin 
analysis could be performed. It can be seen that both curves 
are similar to CCD 44 although not identical. An explanation 
for this difference has not been found. Table 22 shows the 
result of a CRF assay on the isolated material corresponding 
to peaks 0, 1 and 2. 
Table 22. CRF assay of fractions obtained from CCD 42 
Sample T/inj. 
LVP 
mU/inj. 
B 
control 
B 
sample AB % inc. 
CCD 42 
Peak 1 100 
50 
100* 
50 
4.1+0.7(4) 19.1+4.7(4) 
11.9+3.4(4) 
15.0 
7.8 
365 
190 
Peak 0 50 6.8+2.1(3) 10.9+1.8(3) 4.1 60 
Peak 2 50 11.7+1.7( 2) 4.9 70 
No pressor assays were performed; an estimate of this 
value is possible from consideration of the activity obtained 
in CCD 44 of material derived from a similar area. 
200 
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A paper chromatogram of peak 1 developed In BAW (4:1:5) 
shows ninhydrin positive materials having Rp values of 0.18+, 
0.50+2 (yellow), 0.73+3 with a yellow spot directly below it. 
Gountercurrent distribution of 
pooled Kamm (4/20/60) (CCD 477 
Six hunared milliliters of lower phase of an equilibrated 
n-butanol:acetic acid:water (4:1:5) solvent system was placed 
in each of 15 commercial acid bottles. The n-butanol was 
taken from a drum, product of Commercial Solvents Corporation, 
Peoria, Illinois. The entire distribution was conducted at 
a room temperature of about 24°C. The first bottle was charged 
with 28.86 g. of "Pooled Kamm, April 20, I960" which contained 
Kamm isolation yields of 5/E3/58 (3.88 g.); 5/5/58 (5.43 g.); 
6/26/59 (2.62 g.); 6/3/56 (5.67 g.); 6/17/58 (7.91 g.); 
6/12/57 (3.97 g.) and which gave a pressor assay of 4.2 U/mg. 
This sample dissolved readily In the lower phase of the first 
bottle, giving a dark amber, translucent solution. The dis-
tricution was conducted with additions of 600 ml. of equi­
librated upper phase with 75 oscillations and a settling out 
period of 1/2 to 3 hours. The actual transfers were performed 
by using a siphon connected to a water aspirator. Emulsions 
occurred in the first two bottles after several transfers and 
this lengthened the time necessary for each settling period. 
The Folin curve reported in Fig. 24 was obtained by using 0.5 
ml. of each phase of sample neutralized with 0.3 ml. 6 N 
m 
CO 
CCD 47 
28.86 GM. POOLED KAMM 
CYCLOHEXANE-FOLIN 
WEIGHT 
PRESSOR ACTIVITY 
10.0 
400-^ 8.0 - c 8.0 
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< 
lu 
C E  
200- 4.0 
6.0 
-4.0 
d 100- 2.0- - 2.0 
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Fig. £4. Distribution of Kamm product in BAW (4:1:5) 
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Table 23. Weight, pressor and paper chromatography results 
of CCD 47 
Tube 
Wt. LVP 
U/mg RF's (BAW 4:1:5) 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
10.0347 
6.1813 
£•9624 
2•5040 
1.1800 
0.7306 
0.4622 
0.1997 
0.2014 
0.1527 
U.1202 
0.0918 
0.1145 
U.0998 
0.0895 
4.1 
6.3 
6.85 
3.3 
1.8 
0.65 
0 >4 It. streaking to 0.15 
0+4, 0.07+2, 0.10+1, 0.15+1 It. 
streaking above to 0.34 
0.02+~, 0.08+2 o.lS*2, streak to 
0.27+ , 0.31 , 0.37+ It. streak beyond 
0.03+3, 0.07+2 0.11+2, 0.15+2, 0.19+3, 
0.28+4, 0.32+ streak to 0.557* 0.23"* 
streaking from 0 to 0.40, It. streaking 
to 0.57 
It. streaking to 0.11+2, 0.15+2, 
0.19+2, streaking to 0.29+2 0.33+2, 
0.37+^, 0.45+2, 0.54+4 
0.12+ streaking to 0.25+, 0.37+3 
streaking to 0.71+3 
0.2 streaking, It. streaking from 0.4 
to 0.65+ 
0.17+, It. streaking to 0.61+3, streak­
ing to 0.796+2, streaking to 0.89 
0.17+x v.It. streaking to 0.61+, 
0.80+%, 0.89+ 
0.17+, v.lt. streaking to 0.09 with 
no distinct spots 
It. ninhydrin pos. mat. 0.75 to 0.93 
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sodium hydroxide and the cyclohexane procedure. The color was 
too intense for readings so further dilution with 5 ml. of 
water was necessary. The upper phase was removed on the 
rotary evaporator and the remaining solvent removed by lyoph-
ilization in 3 1. round-bottom flasks which were refrozen 
when melting occurred. Fig. 24 also shows the weight and 
pressor assay curve. The amber colored material moved with 
a high K value which was not reflected by the Folin or weight 
distribution curves• 
The higher number tubes (9-14) contained very little 
ninhydrin positive material and, as also indicated by the 
Folin analysis, probably were not very rich in peptides. 
Weight recovery in this experiment was 87# and pressor re­
covery was 91$. 
Countercurrent distribution of large scale 
CCD fractions (CCD 48. 49. 50 and 5ÎT 
The 54 tube, 30 ml. per phase, manually operated machine 
was employed, using equal volumes of freshly distilled see-
but anol and 0.5# trichloroacetic acid, equilibrated in the 
cold room, 3-5°C. Seventy-five oscillations were employed 
with a 15 min. settling time. Folin analysis was conducted 
oa 0.5 ml. of each phase using the cyclohexane modification 
(10) and 0.25 ml. of each phase was used for the ninhydrin 
analysis. Further dilution of ninhydrin solution was made 
when necessary. Results are shown in Fig. 25, A, B, C and D. 
Fig. 25. Distributions of peaks 2 and 3 of CCD 47, 2°Bu0H-0.5$ TCA, 
3—5 C 
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Table 24. Weight, paper chromatography and pressor assay 
results obtained from CCD 48, 49, 50 and 51 
Peak Tubes Wt.(g) Hp's (BAW 4:1:5) 
CCD 48 (Fig. 25A) 1.5 g. peak 3 of CCD 47, 
56 transfers 
0 0.10 Lost Large area at 0.0 to 0.1, weakly 
ninhydrin positive 
1 11-26 0.2510 
2 27-3 5 0.3143 0.05+1, 0.11+2, 0.15+3, 0.19+2, 
0.28+1, 0.4+1, 0.67+2 
3 36-44 0.2972 streaking from 0 to 0.4, 0.65, 0.75 
4 45-53 0.2957 
Pressor: tube 15 = 1, 19 = 2.2, 23 = 7, 
27 = 16.7, 31 = 10 U/cc. 
CCD 49 (Fig. 25B) 0.9473 g. peak 3 of CCD 47, 
0.5559, peak 2 of CCD 47, 52 transfers 
0 0-15 0.0595 same as 48 
1 16-23 0 2539 O.07+2, 0.13+3, 0.2+2 It. streaking 
to 0.64+2 
2 24-32 0.3078 0.15+}, 0.19+2, 0 22+3, 0.25+2, 
0.31+1, 0 60+1, 0.67+1 
33-40 0.2761 0.03+. 0.08+2 0.13+3. 0.15+3 0.19+3, 
0.22+3, 0.25+2, 0.28+1, 0.31+1, 
0.57+, 0.61+ 
41-52 0.2571 streaking to 0.22. 
Pressor: tube 21 = 5.9, 25 = 13.4, 29 = 4.0 U/cc. 
CCD 50 (Fig. 25C) 1.5 g. peak 2 of CCD 47, 
49 transfers 
3 
0 0-15 0 .1743 same as 48 
1 16-23 0 3377 same as 49 
2 24-32 0 .3479 
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Table 24. (Continued) 
Peak Tubes Wt. ( g . )  Hp's (BAW 4:1:5) 
3 33-40 0.3207 0.03, 0.06, 0.10, 0.16, 0.21 
4 41-53 streaking to 0.1+4, 0.13+4, 0.15+3, 
0.22+3, 0.25+2, 0.29+2 streaking to 
0.43 
Pressor: tube 21 = 13.5, 25 = 27.4, 29 = 5.1 U/cc. 
CCD 51 (Fig. 25D) 1 g. peak 2 of CCD 47, 
53 transfers 
0 0-15 0.0649 same as 48 
1 16-23 0.&324 same as 49 
2 24-32 0.1859 streaking from 0 to 0.7, predominant 
spot 0.22 
3 33-40 0.1472 streaking from 0 to 0.26, 0.6 • 
4 41-53 0.1900 
— — 
No pressor assays conducted 
The pressor area was located in CCD 48, 59 and 50 by assay of 
the indicated tubes. 
A CRF assay of CCD 48, peak 2 gave a 320/* increase in 
blood steroids at 3.0 T (29 mU pressor act.) and 25$ increase 
at 0.75T ( 7.3 mU pressor act.). 
The K. value for lysine vasopressin in this system is 
0.37; the three distributions assayed gave values of 1.0 
(CCD 48), 0.926 (CCD 49) and 0.89 (CCD 50). The fact that 
these distribution coefficients are higher than the reported 
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value maybe due in part to the temperature difference. How­
ever, during the run, in each esse, it was noted that there 
was a loss of lower phase in the second decade of tubes which 
appeared to have a symmetrical pattern. Fig. 250 shows a 
graph of this phenomena, which occurred in the area of heavy 
ninhydrin color. Peak 0 in every experiment gave a spot on 
paper chromatography similar to that obtained for ammonium 
sulfate in the BAW (4:1:5) solvent system. Peak 0 also gave 
a white precipitate on addition of barium chloride and gave 
off ammonia readily when heated with 6 N sodium hydroxide. 
This evidence hinted strongly at the presence of ammonium 
sulfate in the sample which was introduced in the Kamm pro­
cedure . Decrease in solubility of the organic phase by ex­
cess salt concentration could explain the curious displace­
ment of lower phase in these experiments. This salt effect 
may have been largely responsible for the larger partition 
coefficient found for lysine vasopressin. 
Continuous electrophoresis of 
countercurrent distribution 
fractions (Ce 225 and Ce 226) 
Experimental conditions.were identical to those reported 
for Ce 208-2, 3. Results are given in Tables 25 and 26 and 
shown in Fig. 26. Samples were material from fraction 2, CCD 
43, 49, 50 and 51; Ce 225 was run on 0.6108 g. and Ce 226 on 
0.5338 g., respectively. 
Table 25. Weight, pressor, CRF and ACTH assay results of fractions from Ce 225 
Frac­
tion 
WT. 
g-
LVP 
U/mg. T/inj . 
LVP 
mU/ B 
inj• 100 ml. 
B 
control 
B 
inc. 
CeU 
per 
inj . 
CeU 
per 
% 
inc. 
11-1% 36.4 2.0 15 30 26.6+2.8(4) 6.25+1.5(4) 20.35 5.5 0.367 330 
13-14 63.3 17.4 1.8 31 15.3+1.8(5) II 9 .05 1.85 1.0 145 
15-16 49.4 50.0 0 6 30 15.45+2.3(5) H 9.20 1.87 3.12 150 
17-18 39.3 12.4 2.4 30 22.2+2.3(5) 6 • 2+0 . 5( 5) 16.0 3.6 1.5 260 
19-fcO 40.0 1.6 18 29 17.6+0.7(5) H 11.4 2.3 0.128 180 
21-22 46.4 1.4 21 29 16.2+2.7(5) ii 10.0 2.03 0.097 160 
23-24 31.5 1.1 27 31 19.6+2-2(4) 5.3+0.5(4) 14.3 3.08 0.114 270 
25-26 22-8 0.8 36 29 18.2+1.4(5) II 12.9 2.67 0.0741 240 
27-28 1.2 24 29 13.3+1.7(5) II 8.0 1.7 0.0709 150 
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Table 26. Weight and pressor assay results of Ce 226 
fractions 
Fraction Wt. 
(me. ) 
Pressor Fraction Wt. 
(mg. ) 
Pressor 
11-12 57.7 4.8 1-2 — — 
13-14 . 54.3 47.8 3-4 12.2 
15-16 43.1 76.0 5-6 21.2 
17-18 32.5 10T1 7-8 25.2 0.04 
19-20 29.5 0.13 9-10 47.3 0.10 
21-22 33.8 1.1 25-26 19.4 
23-24 27.6 27-28 
29-30 
16.8 
19.9 
Combined 
1.2 
In each case, the pressor peak occurred at fraction 
15-16 coinciding very closely.with the CRF activity. Using 
the assayed value of 9*.7 U/mg. for CCD 48 peak 2 and the cal­
culated value of 10.7 U/mg. for CCD 49 peak 2, the total 
amount of pressor activity in Ce 225 amounted to 6228 units. 
The recovery as assayed equaled 4274 units. The pressor activ­
ity recovery was thus 68$ in comparison with a weight recovery 
of 771.9 mg. or 67% on the combined Ce 225 and Ce 226 experi­
ments . 
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Paper chromatograph of continuous 
electrophoresis sample (PC-12Ô7 
A 10 mg. sample of Ce 225, 17-18 (LVP 12.4 U/mg.) was 
streaked along a 19 cm. line of an EDTA-washed Whatman Ko. 1 
paper measuring £2 cm. x 44 cm. The paper was developed in 
the cold room (3-5°C ) for 36 hours in BAW (4:1:5) solvent 
which ascended to 31.8 cm. origin. After being allowed to 
dry in the cold room for 8 hours, a 2 cm. center strip and 
1 inch strips from each edge were cut and sprayed with nin-
. hydrin. Ninhydrin positive material had skewed upwards from 
left to right. The ninhydrin stained test strips were re­
placed and taped to the original chromatogram and a mark was 
placed 1 cm. from the colored area on all three strips. A 
line was drawn at 4 cm. connecting these points of equal Rp 
and segments 3 mm. in width were marked and cut crosswise to 
a height of 16 cm. These segments were cut into approximately 
3 mm. squares and the resulting "confetti" placed Into 4 inch 
lipless test tubes. The paper In each tube was extracted 
twice with 20 ml. of 1% cold acetic acid solution. It was 
found to be unnecessary to centrifuge the paper if the pipet­
ting was conducted carefully. One milliliter aliquots were 
taken for the Folin analysis and 0.5 ml. samples for the nin­
hydrin analysis reported in Fig. 27. Table 27 gives a sum­
mary of the pressor and CRF assays conducted (6/10/60). 
The ninhydrin and Folin curves appe ar to accurately 
CM. FROM ORIGIN 
10.0 11.5 13.0 
PC 120 
MG. CE 225 17-18 
FOLIN 
NINHYDRIN 
O PRESSOR ACT 
A CRF ACT. 
0.22- 0.25 0.3 0.33 0.504 
— 60 
5 50 
o 
200 -
15 25™ 30 35" 
SEGMENT NUMBER 
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Table 27. Pressor and CRF assay results of selected tubes 
of PC 121 
Tube 
LVP 
U/cc. 
LVP 
mU/ 
inj. 
B 
control 
B 
sample AB 
% 
inc. 
CeU 
per 
ml. 
10 0.082 16.4 7.3+0.5(5) 9.05+3.0(2) 1.75 25 4.6 
14 10.5 25 10.8+0.4(5) 3.5 50 452 
16 4.85 23 9.15+0.4(5) 1.85 25 195 
19 0.056 14 7.5+0.7(3) 0.2 3 3.0 
reflect the Information contained on the ninhydrin stained 
center and side strips. There are at least eight ninhydrin 
positive components in the area depicted in Fig. 27 with an­
other component at 22.5 cm. (Rp 0.708). The Rp value for 
lysine vasopressin in this experiment was 0.25. This is 
higher than the 0.12 reported by Rumsfleld and Porter (99) and 
the 0.11 by Acher et al. (7) for the n-butanol:acetic:acid: 
water (4:1:5) solvent system. Schally et al. (115) gave an 
Rp of 0.05-0.20 for CRF in this sytem. Assays show the CRF 
activity in this experiment to have a slightly higher Rp, 
coinciding with the pressor peak at 0.25. 
A comparison of effects of pretreatment of the paper and 
of solvent temperature was conducted during some preliminary 
experiments performed prior to PC 120. In the first two 
papers an attempt was made to equllize the concentration of 
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Table 28. Effects of temperature and washing of paper on 
the mobility and Rp of solvent and Ce 225 (17-18) 
Paper 
Time 
hrs. 
Ht. of. 
solvent' Temp. Rp 
Untreated 15.5 24.4 25 0.05+ 0.0*8+ 0 
0.18+3 0.22+3, 
0.32+2, 0.38+2, 
0.57+ 
.13+3 c.15+2 
0.25+4, 0.29+3 
0 41+2, 0.53+ , 
EDTA 
washed 15.5 30.5 25 0.049+, 0.08+,. 
(streak) 0.21I4 
0.27+3, 0 31+3, 
0.39+2, 0.43+2, 
0.14+2 0.16+3, 
' 0 Q iPv 
0.61+, 0.69+ 
EDTA a 
washed 36 33.7 3-5 0.16+2(streak. 
0.25+3, 0.29+3, 
0.37+3(streak), 
0.43+2, 0.46+2, 
0.21+2(streak), 
0.35+4, 
0.39+3, 
0.65+ 
a0.6 mg. Ce k.c5 (17-18) streaked on 2 cm. line. Results 
essentially that found in PC 120. 
Ce 225 (17-18) on the paper by alternating the spotting from 
the same capillary pipette. 
Reduction of the temperature slows the solvent ascent 
considerably without improving the resolution noticeably. In 
fact, the lower moving components are undetectable on the 
papers developed at 3-5°C. Washing of the papers caused a 
more rapid movement of the solvent with no apparent effect 
on the resolution of the many components found in this con­
tinuous electrophoresis fraction. 
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Ion exchange chromatography of continuous 
electrophoresis sample (IRC-50 19) 
A glass tube 2.16 cm. In diameter was filled to a height 
of 52 cm. with IRC-50 cation exchange resin buffered with 0.5 
M ammonium acetate at pH 6.41 (68). After packing the column 
was moved to the cold room. The column was charged with 47.5 
mg. of Ce 225 (15-16), LVP 50 U/mg.; and 26.9 mg. of Ce 226 
(15-16) LVP 76 U/mg. A fraction collector with a drop 
counter was used to collect the effluent flowing at a rate of 
approximately 1.5 ml./cm.2/hr. Effluent volume varied from 
1.8 to 4.59 ml. because of erratic behavior of the collector 
after tube 59. Most tube volumes were in the 2-3 ml. range. 
Addition of 0.5 M ammonium hydroxide to the column 
occurred at tube 186, and the column continued until tube 
306- pHydrion paper revealed a pH of 9 at that point and the 
column was stopped. No detectable folin color was encountered 
after tube 126 until tube 286 when a slight rise was detected 
just prior to the pH change. 
The Folin analysis curve shown in Fig. 28 was obtained 
from 0.5 ml. of sample. One-tenth milliliter of sample was 
removed from tubes 82, 86, 91, 96 and 100 for pressor and CRF 
assays. Before the assays were completed, the tubes were 
pooled into their various peaks as indicated in Table 29. 
Weight recovery from this column amounted to 67#; recov­
ery of both pressor and CRF activity approximated 30#. Some 
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Table 29. Pressor and CRF assay results of tubes selected from IRC-50 19, peak 3; 
weight, pressor, MSH and CRF assay results of peaks from IRC-50 19 
Tube 
or 
peak 
LVP 
U/cc . 
or mg . Wt. MS H 
LVP 
mU/ 
inj . 
r/ 
inj . Control 
B 
100 
ml. AB 
CeU 
per 
inj . 
Dilu­
tion 
f ac to r 
CeU/ 
cc. 
or f 
% 
inc. 
82 24 U/cc. 
86 49 U/cc. 29 
6.0+ 
0.914) 
12.3+ 
2.0(4) 6.3 1.43 1650 2460 105 
91 66 U/cc. 31.5 
6.0+ 
0.9Î4) 
11.1+ 
1.2(4) 5.1 1.26 2060 2595 85 
96 92 U/cc. 30 
6.0+ 
0.914) 
8.3+ 
2.8(4) 2.3 0.96 3003 2899 38 
96 91 U/cc. 30 
4.6+ 
0.4 
9.0+ 
1.3(5) 4.4 1.18 3003 3543* 96 
100 40 
1 
3 2™ 50 •48 U/mg. 35.3 5+b 30 60 
4.6+ 
0.6(5) 
24.6+ 
1.3(5) 20.0 5.3 0.088 435 
2 
51-78 8 U/mg. 6.1 24 3 
5.7+ 
0.8(4) 
11.75+ 
0.3(3) 6.05 1.38 0.461 108 
3 
79-110 160 U/mg. 8.3 3-4b 27.2 .17 
4.6+ 
o.eTs) 13.1+ 2.5(5) 8.5 1.75 10.3 185 
aRepeat experiments conducted giving better results. 
cInj . at 2 . 5  Y  .  
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inactivation may have occurred; It is interesting that both 
activities had the same percentage recovery within experi­
mental error. 
The vasopressin peak, peak 3, came off at 3.2 holdup 
volumes which is earlier than the 5 holdup volumes reported 
by Light et al. (68) on a column conducted at room tempera­
ture . They also reported pressor recovery yields of 75-100% 
of the starting activity using materials of much higher 
potency (210 U/mg.). 
The Rp values shown in Table 30 were obtained for the 
three peaks in the BAW (4:1:5) solvent system. Calculation of 
the pressor recovery using the curve experimentally obtained 
by assay of the selected tubes would account for 85% of the 
starting activity. It is unknown why the actual recovery 
was only 30>. 
Table 30. Paper chromatography results of peaks obtained 
from IRC-50 19 
Peak Rp1s (BAW 4:1:5) 
1 0.19, 0.23, 0.28 (trace amounts) 
2 0.15+,5, 0.19+3, 0.c3+4, 0.29+4, 0 37+1, 0.48+1, 
0. 54+1 
3 0.12+1, 0.19+3, 0.25+4, 0.31+2 (streaking) 
185 
Two dimensional "fingerprint" 
of IRC-50 19. peak 3 
One-half milligram of IRC-50 19, peak 3 was spotted on 
a Whatman 3 mm. sheet marked as previously described. The 
solvent front reached 31 cm. Ninhydrin spray after electro­
phoresis at right angles revealed two positive areas. One 
faint spot measuring 1.5 cm. in diameter at an Rp of 0.155 
and a distance of 6.9 era. A double spot roughly five times 
as intense in ninhydrin color and measuring 4 cm. x 5 cm. was 
found at Rp 0.197 and 18.8 cm. This area was unusual in that 
the lower third in the electrophoresis direction gave a 
lighter somewhat yellowish spot. 
Paper chromatography of 
IRC-50 19. peak 3 (PC 121) 
A sample of 2 mg. of IRC-50 19, peak 3 was streaked on 
a 4 cm. line of an 8 cm. strip of Whatman 3 mm. paper. The 
developing solvent of acetone:water (3:2 v/v) was that of 
Schally et al. (115) with the modification that urea was ex­
cluded (108). At a temperature of 25-26°C in a period of 
9 hours and 15 minutes, this solvent attained a height of 
28.6 cm. The strip was dried in the cold room, then 1 cm. 
strips were cut crosswise for the entire length of the paper-
gram after a 1 cm. test strip was cut lengthwise and sprayed 
with ninhydrin. The crosswise centimeter segments were cut 
into 1 cm. squares and extracted first with 2 ml. of 0.1% 
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acetic acid and then with 1 ml. of the same solvent. Fig. 29 
shows the result of Folin analysis of 1 ml. samples and also 
two ninhydrin curves resulting from 0.5 ml. and 0.3 ml. 
samples. Also included are the results of the CRF and pressor 
assay reported in Table 31. The center strip shows a predomi­
nant ninhydrin-positive area at Hp 0.77 and a barely percept­
ible area at Rp 0.54. It will be noted that the biologically 
active areas coincide with the material analysis curves. A 
preliminary qualitative paper chrometogram run under the 
same conditions gave a large ninhydrin positive area at Rp 
0.645 with some streaking beyond that and a faint spot at 
0.47. Schally et^ al. ( 115) reported the Rp of lysine vaso­
pressin in this system to be 0.69 and that of CRF at 0.35-
0.46. . Segment 14, corresponding to an Rp of 0.47, showed no 
CRF activity. Calculation of the pressor recovery from tubes 
20 through 25 shows that 85/2 of the activity was lost. This 
loss was dlfilcult to explain solely on the basis of mechan­
ical loss of material. An experiment was conducted to investi­
gate effects of acetone and temperature on pressor activity. 
A sample weighing 99T was weighed into a vial and to it was 
added 1 ml. of acetone : water (3:2 v/v). This was allowed to 
remain at room temperature, 25°C, for 20 hours. Re assay of 
this material at dilutions where no solvent effects were 
encountered showed a loss of about Q7% of the pressor activ­
ity. It is unknown at this time whether the urea employed by 
Fig. 29. Paper chromatogram of IRC-50 19, peak 3 
(PC 121 acetone:Hg0) 
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Table 31. Pressor and. CRF assay of tubes from PC 121 
Tube 
LVP 
U/cc 
LVP 
. U/l'nJ 
B 
100 ml. Control AB 
CeU/ 
inj . 
Dilu­
tion 
CeU/ 
cc. 
% 
inc . 
14 0.2 17.1 8.4+0.8(5) 6.4+0.6(2) 2.0 0.96 11.55 11.1 31.3 
20 0.7 30 12.25+0.9(4) 7.6+0.4(4) 4.65 1.2 23.1 27.8 61 
22 4.3 30 18.0+2.5(4) 6 .4+0 . 6( 2) 11.6 2-35 142 333 .0 181 
24 0.2 30 11.8+1.6(3) 7.6+0.4(4) 4.2 1.15 6.6 7.6 55 
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Schally (108) lends stability to this activity. Ressler (93) 
showed inactlvation of oxytocin, a similar peptide to vaso­
pressin, in 7 M urea and suggested this was due to hydrogen 
bond breaking in the molecule. 
Calculation of the recovery of CRF activity showed a loss 
of approximately 86> resembling that of vasopressin very 
closely. The Folin color obtained is that to be expected 
from the amount of materiel placed on the paper. 
Countercurrent distribution 52 
A sample of 2.5 mg. of IRC-50 19, peak 3 was dissolved In 
the first tube of the 60 tube, 1 ml. all-glass "microdistribu­
tion machine" (10). The solvent system employed was 0.5# 
trichloroacetic acid equilibrated with an equal volume of 
freshly distilled sec-butanol at 3-5°C. The result of 130 
transfers is given in Fig. 30. The Folin analysis reported 
was obtained from 0 5 cc. of each phase using the technique 
of Shepherd et al. (117). Addition of 0.5 cc- of lower phase 
to tuces 66 to 130 was used to give equivalent volumes. The 
ninhydrin curve was the result of using 0.6 cc. of the homo-
'•V 
geneous contents of each tube obtained by rapid shaking and 
then applying the procedure of Stein and Moore (126) ss modi­
fied by Hoften (131). Tuces 39, 43, 47, 51, 55 and 59 were 
set aside and 0.5 ml. of lower phase was taken for CRF and 
pressor assays. The results are shown in Table 32 and in 
Fig. 30. Distribution of IRC-50 19, peak 3 in 2°BuOH:0.5°TCA 
(3-5 C) 
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Table 32. CRF assays of CCD 52 (7/29/60 and 8/19/60) 
Tube 
J3 
response 
LVP 
mil/ 
inj . 
LVP 
U/cc . Control AB 
Dilu­
tion 
factor 
i 
CeU/ 
inj . 
CeU/ 
ml. 
CRF 
LVP 
39 2-8 
43 1%.0+1.65(3) 30 10.6 6.6* 5.4 347 1.3 451 . 0434 
47 12.7+1.3(4) 29 16 II 6.1 528 1.4 739 .0483 
51 12.0+1.4(5) 28 22 11 5.7 777 1.36 1048 .0482 
55 11.0+2.8(3) 30 15 II 4.4 508 1.18 600 .0393 
59 11.6+0.6(4) 30 4.4 II 5.0 146.6 1.25 183 • 0'417 
Repeat 8/19/60 
43 14.1+2.4(3) 30 7.1+1.0(4) 7.0 547 1.52 528 .0507 
47 19.5+2.3(3) 30 ii 12-4 533 2.55 1360 .0851 
51 17.9+2.4(4) 30 H 10.8 740 2.2 1626 . 0734 
55 17.6+4.7(4) 31 H 10.5 493 2.12 1045 .0684 
aNot experimentally determined, calculated from three experiments preceding 
tnis one which had excellent precision. 
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Fig. 30 and Fig. 31. The calculated partition coefficient for 
vasopressin, taking tube 51 as the peak tube, is 0.646. This 
is higher than the 0.37 reported by Ward* at room temperature 
and obtained also in this laboratory using a sample supplied 
by him. Recovery of CRF calculated from the bio assay curve 
and correcting for the partition coefficient constant in 
assigning values for the upper phase (approximately 0.5) was 
66> for the 7/29 data and 108/o for the 8/19 data. Recovery of 
pressor activity using the same technique equalled 94$, show­
ing liutle inactlvation, if any, during the course of the 
experiment. 
Tubes 39 to 45 were pooled and designated CCD 52, peak 
1; tubes 46 to 59 were pooled and called CCD 52, peak 2• 
Material was recovered as previously described and lyophilized 
finally in glass vials. A pressor assay conducted on a weight 
of 9ir showed peak 2 to have an activity of 120-150 U/rng. 
This indicated that the maximum purity was equal to or greater 
than the original starting material, IRC-50 19, peak 3 (LVP = 
160 U/mg.) since the weight of sample taken in the assay of 
peak 2 was so small and subject to possible error. The nin­
hydrin and Folin curves coincide fairly well with the CRF and 
pressor activity curves showing that negligible impurity could 
'""Darrell Ward, k.D., Anderson Hospital of the University 
of Texas, Houston, Texas. Partition coefficient of lysine 
vasopressin in sec-butanol-0.5/i trichloroacetic acid. Private 
communication. 1959. 
CCD 52 
CYCLOHEXANE-FOLIN 
X- PRESSOR ACTIVITY 
A CRF ACT (8/19/60) 
0  CRF ACT (7/29/60) 
80 
370 
•20 15005 u. 
3 
"
60
"t |5 
H 
1000 
LU CC 
û: 50-O IO 
o 
LU 
CL 
500 
40 
30 35 40 45 50 
TUBE NUMBER 
55 60 
Fig. 31. CCD 52, peak 1 and 2 pressor and CRF assay results 
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have been present in this area and that the peak consisted 
almost entirely of CRF and LVP. 
Amino acid analysis of CCD 52, peak 2 
The hydrolysis technique was essentially that of Hirs 
et al. (51) with minor modifications. A sample weighing 
approximately 1 mg. was dissolved in 0.6 ml. of constant 
boiling hydrochloric acid contained in a 16 mm. x 150 mm. 
lipless Pyrex test tube. The sample was hygroscopic and so 
was weighed rapidly. The tube was immersed in a dry ice: 
acetone bath until the solution was frozen and then evacuated 
with an oil pump and sealed with an oxygen:gas hand torch. 
The tube was placed in a brass centrifuge cup in an oven at 
100-110°C for 22 hours. When the cooled tube was opened an 
implosion occurred without loss of any of the light yellow 
solution, which was then evaporated to dryness over sodium 
hydroxide in a vacuum desiccator at room temperature over 4,3 
hours. The hydrolysate was dissolved in 1.0 ml. of ion ex­
change water and the tube rinsed twice more with 0.5 ml. of 
ion exchange water. This solution of pH of 1.7 was titrated 
to a final pH of 6.21 with 6 N NaOH and permitted to stand 
unstoppered for 7 hours to oxidize the cysteine to cystine. 
Total volume was Drought to 4 ml. and the pH to approximately 
2 by addition of 2.0 ml. of 0.02 N HCL- The procedure used 
for analysis of the hydrolysate was that of Spackman et al. 
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(123) using a fraction collector instead of the automatic 
recording apparatus. Results are shown in Table 33 and Fig. 
33. The positive ninhydrin areas at tubes 190-200 and 257-
261 cannot be explained since their effluent volumes do not 
agree with any usual hydrolytic products. It is to be noted 
that all of the amino acids identified are found in lysine 
vasopressin except serine (87). It is not known whether this 
is a free amino acid which came through the purification steps 
Table 33. Amino acid content of peak 2, CCD 52 
/«M leuc• Color /<M A.A. /<M A.A. 
Amino acid 0.D. equiv. yield sample ml. 
Cysteic acid 0. 49 0. 152 0. .99 0 .1535 0. 1024 
Aspartic acid 0. , 52 0. 162 0. .94 0 .172 0. 115 
Serine 0, .15 0. 048 o. .95 0 .051 0. .0406* 
Glutamic acid 0, .56 0. 172 0. 99 0 .174 0. ,116 
Pro line 0. 15 0. 048 0, .225 0 .213 0, .142 
Glycine 0, ,62 0. 192 o. 95 0 .202 0. ,135 
Cystine o. .06 0. 022 0. 55 0 .018 0. 012 
Tyrosine 0. 32 0. 100 1. 00 0 .100 0. ,0747* 
Phenylalanine 0, .59 0. 184 1. 00 0 -184 0, 1225 
Lysine 0, .21 0. 066 1. 10 0 .060 0, .12 
Ammoni a 1, .096 0. 34 0. 97 0 .35 0. ,70 
^Corrected for hydrolytic decomposition (51). 
Fig. 32. Spackman, Stein and Moore amino acid analysis 
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or whether It is an integral part of another peptide present 
in amounts roughly equal to one-half the amount of the start­
ing material on a molar basis. This is consistent with the 
pressor activity of the starting material, 160 U/mg., which 
show it to be approximately 57% vasopressin, assuming a value 
of 280 U/mg. for pure lysine vasopressin. 
If this peptide is assigned a concentration of 0.04/iM 
per milliliter, then subtraction of this amount from the other 
amino acids will permit insufficient molar quantities of 
tyrosine and cystine to permit these amino acids to appear in 
the non-vasopressin peptide. The appearance of cysteic acid 
instead of cystine may be the result of oxidation by elemental 
chlorine in the constant boiling hydrochloric acid used in 
the hydrolysis which had been prepared almost a year prior to 
its use.* Disagreeable amounts of ammonia are ordinarily 
found in acids exposed to the laboratory air and it is ex­
tremely difficult to obtain ammonia-free hydrochloric acid. 
A correction for ammonia contamination is customarily 
applied. 
Paper chromatograph of IRC-50 19. 
peak 5 (PC 122) 
A sample of 0.25 mg. of IRC-50 19, peak 3 was pipetted 
*C. H. W. Hirs. Brookhaven National Laboratory, Long 
Island, N.Y. Effect of commercial reagent grade hydrochloric 
acid on amino acid analysis. Personal communication. 1960. 
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onto an 8 in. x 8 in. sheet of Whatman No. 1 chromatography 
paper at the intersection of two lines 1 inch from the left 
edge of the paper and 1.5 Inches from the lower edge. The 
edge with the larger margin was stapled together so that the 
rust which develops after Irrigation in SAW (4:1:5) can be 
cut off and still allow sufficient edge for irrigation of 
the chromatogram with m-cresol:water (95:5) in the other 
direction. Ninhydrin spray gave three spots at Rp's of 
0.0+2, 0.303, 0+3 and 0.35, solvent front (with tailing)*4, 
for BAW (4:1;5) and m-cresol:water (95:5) respectively. A 
second papergram gave a similar result. 
Since Schally et al. (115) reported that lysine vaso­
pressin and corticotropin-releaslng factor have Rp's of 0.85 
and 0.46-0.64 in the m-cresol:water system, this gave a 
method for separating lysine vasopressin from the other com­
ponents known to be present in IRC-50 19, peak 3. The re­
maining material in the vial containing IRC-50 19, peak 3 was 
dissolved in 50 X of ion-exchange water and 40À of this 
solution was streaked over a 1.5 cm. center area of an 8 in. 
x 8 in. Whatman No. 1 chromatogram. The chromatogram was 
developed In a solvent using freshly distilled m-cresol and 
wate<r (95:5) In the cold room, 3-5°C. The remaining 10 A 
—s 
which was unspotted was used for a pressor assay and gave an 
activity of 57.5U, thus the total units placed on the paper 
amounted to £3OU. The chromatogram was removed after 13.5 
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hours with the solvent front at 10.? cm. and allowed to remain 
hanging in the cold room for 3 additional hours. A 1 inch 
strip centered on the middle of the streaked area was cut 
out and divided into three areas corresponding to Hp's of 
1 cm. below the origin to 0.33, 0.33 to 0.66, and 0.66 to 
1 cm. above the solvent front. Each area was cut into seg­
ments of 1 square centimeter and extracted three times with 
5 ml. portions of cold 0.25# acetic acid solution. The com­
bined extracts were lyophiYized and the flasks rinsed three 
times with 0.5 cc• portions of ion-exchange water. The com­
bined rinses were centrifuged to remove the paper and lint 
and pipetted into vials and relyophilized. Results of the 
pressor and CRF assay are reported in Table 34. 
Since 126 units of pressor activity were recovered, this 
amounted to 54.8# of the original activity. Inactlvation, 
mechanical loss, or incomplete extraction are all possible 
explanations for this low recovery. The curious splitting 
Table 34. Pressor and CRF assay results of fractions 
obtained from PC 122 
Frac- LVP LVP B B % 
tion Rp U/cc. mU/inJ. control sample B inc. 
1 0-0.33 83-8 10 4+0.6(3) 5.9+1.0(5) 1.86 46.5 
2 0.33-0.66 12-2 10.2 8.3+1.0(4) 4.29 10? 
3 0.66-1.00 30 9.9 5.2+0.6(4) 1.26 30 
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of the pressor activity might be explained by the possibility 
of multiple spots occurring due to the lysine e-amino and 
cc-amino group of cysteine; lysine is known to form two spots 
under certain conditions (8). Another possibility might be 
overloading of the chromatogram, but a subsequent experiment 
showed that 1.0 mg. of a similar peptide fraction (LVP = 
167 U/mg.. X gave no indications of overloading under similar 
conditions. 
This CRF assay may be inaccurate because of the unusually 
low controls encountered. If the controls were raised to 5.0, 
then the value for peak 2 would become a 66$ increase; this 
is still considerably higher than the known CRF activity of 
10 mU of lysine vasopressin in this assay (1% increase). The 
lowered values for peeks 1 and 3 would not be unreasonable with 
a control value of 5. 
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SUMMARY 
A Kamrn product (Pitressin Intermediate B) was shown to 
contain at least 30 ninhydrin positive components, pre­
sumably peptidic in nature. 
An acetone extract of hypothalamic tissue was shown to 
contain at least eight ninhydrin positive components and 
an aqueous extract to contain 16 ninhydrin-staining com­
ponents . 
Chromatographic "Fraction D11 was shown to contain 
pressor, MSH and CRF activity. Analysis of this mixture 
revealed the presence of 10 to 14 peptides ranging in 
size from 5 to 13 amino acids. 
No CRF or MSH activity was obtained from cold or hot 
0.25;v acetic acid extracts of hypothalamic tissue at the 
levels tested. 
Experiments (FD (12/14/59), CCD 44 and IRC-50 19, peak l) 
indicated the presence of a CRF containing no pressor 
activity but possessing either inherent or contaminat­
ing MSH activity. This mixture of peptides gave a CRF 
activity at relatively higher doses. 
A peptide fraction containing lysine vasopressin (160 
U/mg. ) showed strong CRF activity at doses of 0.17 . 
The CRF activity contained in the purified pressor active 
fraction could not be separated from lysine vasopressin 
by column chromatography, paper chromatography or 
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countercurrent distribution. 
8. The CRF activity of the purified pressor active fraction 
could be accounted for by the known CRF activity of 
synthetic lysine vasopressin. 
9. Vasopressin is shown to fit the anatomical and physio­
logical criteria necessary to the role of the neuro­
humoral mediator in neurotropic stress. 
10. Therefore, vasopressin, because of its high ACTH-releas­
ing activity and concentration, is concluded to be the 
most probable "physiological corticotropin-releasing 
factor11. 
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APPENDIX 
Abbreviations 
AAAD Adrenal ascorbic acid depletion 
ACÏH Adrenocorticotropic hormone 
ADH Antidiuretic hormone (vasopressin) 
AVP Arginine vasopressin 
B Corticosterone 
BAW Butanol:acetic acid:water 
CCD Countercurrent distribution 
CeU Continuous electrophoresis units for CRF 
(Ce 13-14) 
CMC Carboxymethyl cellulose 
CRF Corticotropin (ACTH)-releasing factor 
DOC or Desoxycorticosterone or desoxycorticosterone acetate 
DOCA 
EDTA Ethylenediaminetetraacetic acid 
F 17-Hydroxycorticosterone 
Y Gamn.a (microgram) 
IRC-oO Amcerlite carboxylie acid resin 
A Lamcda (microliter) 
LVP Lysine vasopressin 
mf Mi 111gamma (millimicrogram) 
MSH Melanocyte, stimulating hormone 
17-OHC 17-Hyaroxycorticosterone 
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Rp Ratio of the component mobility to the solvent 
front mobility 
TGA Trichloroacetic acid 
U Units of biologicsl activity 
